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Summary 
 
Background. Burkholderia cepacia complex (Bcc) are well known for their ability to 
produce antifungal agents. However, the majority of past studies have screened only a 
limited number of isolates, which were not taxonomically well characterized. In addition, 
while the activity of Bcc bacteria against plant pathogenic fungal species has been 
characterized, very few studies have examined the interaction between Bcc and 
saprotrophic wood decay basidiomycete species. The overall aim of this study was to begin 
to the characterization of the interactions of Bcc and other Burkholderia with the model 
ascomycete Candida albicans and woodland basidiomycete fungi. 
 
Methods. The study made use of a large collection (397 isolates) of taxonomically well 
identified Burkholderia species. A systematic screening of the antifungal activity of this 
collection was made against C. albicans and various wood decay basidiomycetes: 
Bjerkandera adusta, Trametes versicolor, Hypholoma fasciculare, Resinicium bicolor and 
Phanerochaete velutina. A wide range of media were evaluated for Burkholderia growth, 
antifungal metabolite production and the ability to support the mycelial growth of 
basidiomycetes. An agar overlay assay was used to examine the anti-candidal activity of 
Burkholderia isolates, while a novel overlay assay was developed using homogenised 
mycelial material for the basidiomycete species. Novel and existing extraction techniques 
were evaluated for their ability to partially purify active Burkholderia metabolites. The 
purification and identification of the active Burkholderia antibiotics were performed using 
both preparative thin layer chromatography (TLC) and liquid chromatography combined 
with mass spectrometry (LC-MS). A novel TLC-bioautography assay was also developed 
to reveal the presence of active Burkholderia metabolites in the antimicrobial extracts. The 
minimum inhibitory concentration (MIC) of the semi-purified Burkholderia antifungals 
was also determined. The natural diversity of Burkholderia and other bacteria associated 
with different rhizosphere environments was evaluated by cultivating isolates from local 
maize crops and examining a collection of Burkholderia isolates obtained from the 
rainforest in Sabah, Malaysia. The genetic basis for the secretion of antifungal agents by B. 
ambifaria was examined using transposon mutagenesis and screening for the mutants 
which had lost their anti-candidal activity. Additional transposon mutants that had lost 
their anti-bacterial activity and had been obtained in a previous screen were also examined 
for alterations in antifungal activity. Finally, the Burkholderia genome database and 
bioinformatic techniques were used to genetically characterize these mutants and other 
genetic loci that had been previously implicated in antibiotic production.  
 
Results. The majority of Burkholderia isolates possessed the same antagonistic activity 
towards C. albicans as they did towards B. adusta. Of the 397 isolates examined, 
antifungal activity was the greatest in the following Burkholderia species: B. ambifaria, B. 
cepacia, B. cenocepacia and B. contaminans. Interestingly, no antifungal activity was 
observed for B. multivorans (27 isolates) and B. stabilis (18 isolates) under the 
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experimental conditions tested. The type of medium used to study the interaction between 
Burkholderia and the fungi considerably effected antifungal activity, with the most suitable 
media for studying antagonistic activity being Sabouraud agar and an acidic minimal salts 
medium (BSM; pH 6) supplemented with 0.4% glycerol. Of the 397 isolates screened, 
47.85% were anticandidal (190 isolates; 89.47% of these were Bcc species and 10.53% 
were other Burkholderia species), while 48.10% were active against B. adusta (191 
isolates; 93.19% of these were Bcc species and 6.81% were other Burkholderia). 
Extraction using Amberlite XAD16 resin binding followed by elution with methanol was 
an excellent means to isolate active Burkholderia antifungals. Fractionation of these 
extracts using silica gel TLC and ethyl-acetate:methanol:water (20:1:0.5) as the elution 
solvent was optimal for the separation of the majority of the active metabolites. A TLC-
bioautography assay was developed in this current study as a preliminary screening 
technique to detect anti-microbial components of novel Burkholderia extracts. The assay 
was very useful for detecting anti-candidal and anti-bacterial compounds and was adapted 
for use for the first time with basidiomycetes. Antifungal Burkholderia isolates produced 
between 1 and 10 antifungal metabolites. Several antifungal agents were identified as 
enacyloxin, pyrrolnitrin, bactobolin and quinolines. Novel compounds and novel 
bactobolin derivatives were also present. For B. ambifaria strain AMMD a number of 
chromosomal loci were found to be involved in the production of antifungal metabolites. 
Quorum sensing was essential for the expression of antifungal activity as transposon 
mutations in the CepI synthase-encoding gene prevented the biosynthesis of all B. 
ambifaria anti-candidal compounds. B. ambifaria AMMD extracts containing enacyloxin 
IIa also produced an inhibitory effect at low concentration against E. coli, B. multivorans 
and A. baumannii. 
 
Conclusions. Burkholderia are potentially a very large reservoir of known and novel 
antimicrobial agents, especially with nearly 50% of isolates screened exhibiting antifungal 
activity. Antimicrobial compounds such as enacyloxin IIa were discovered for the first 
time to be produced by Burkholderi and novel extraction and bioassay methods for anti-
fungals were developed in this study. Overall, we now have the tools to considerably 
advance the isolation and characterization of antifungal Burkholderia metabolites. 
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General introduction 
 
 
The search for novel microbial metabolites has been motivated by the need for new 
antibiotics to combat microbial multidrug-resistance to current antimicrobial agents. 
Microorganisms are an important source of potentially useful metabolites. Up to now, 
bacterial species of the genus Streptomyces and fungal species of the genus Penicillium 
have mainly been investigated and used for the isolation of antibiotics. Burkholderia are 
soil bacteria able to use a wide range of organic compounds and produce a wide range of 
potent antimicrobial agents (Parke & Gurian-Sherman, 2001, Vial, et al., 2008, 
Mahenthiralingam, et al., 2011). Nearly all of Burkholderia antibiotics characterised to 
date have been identified from B. cepacia isolates which have not been characterized at the 
species level in terms of the B. cepacia complex (Bcc) taxonomic group 
(Mahenthiralingam, et al., 2008). Further, no studies have looked at the antimicrobial 
activity within large collections of taxonomically-defined Bcc isolates. Burkholderia 
should be investigated in more detail as producers of antimicrobial metabolites and 
potentially developed as new sources of clinically useful antibiotics. 
 
1.1 Interaction between bacteria and fungi 
Bacteria and fungi are evolutionarily very distinct microorganisms. However, they often 
live in close contact with each other, regularly share common substrates, and their spatial 
proximity in many environments has led to either synergistic or antagonistic interactions 
between them. The biosynthesis of natural products by microorganisms is affected by 
biotic and abiotic factors. Each microorganism has the ability to produce particular 
metabolites through distinctive mechanisms. In the natural environment the growth 
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substrates and conditions may vary considerably and alter the metabolites secreted by 
microorganisms. In the laboratory, the components of synthetic media and different factors 
such as pH, temperature and incubation period have been shown to alter antibiotic 
biosynthesis in many producer strains (Kadir, et al., 2008). For detailed chemical 
characterization and commercial production it is necessary to optimize the antibiotic 
production conditions (Duffy & Defago, 1999, Raaijmakers, et al., 2002, Kadir, et al., 
2008). Understanding these production conditions in the laboratory will also provide 
means to explore what antimicrobial agents are produced in nature by known biological 
control organisms such as Burkholderia. 
 
The interaction between bacteria and fungi, especially pathogenic species, has been studied 
by many researchers for long time, but limited attention has been given to interactions 
between wood decay basidiomycetes and bacteria. There are many of B. cepacia complex 
(Bcc) strains known to be antimicrobial producers and suggested as bio-pesticides (Parke 
& Gurian-Sherman, 2001). Bcc strains designated as type Wisconsin and proposed as bio-
pesticides were submitted to US Environmental Protection Agency (EPA) for registration 
in the late 1980s. Many Bcc bio-pesticides were registered between 1992 and 1996. Later, 
polyphasic taxonomic studies and genetic analysis demonstrated clear relationships 
between Bcc bio-pesticidal and clinical strains. These results led to consideration of the 
hazards of continued use of Bcc as bio-pesticides and (EPA) cancelled registration and 
prohibited the use of Bcc bio-pesticides (Parke & Gurian-Sherman, 2001).   
 
The interaction between bacteria and wood decay basidiomycetes ranges from highly 
competitive to mutulistic. Antagonistic interactions can be mediated via volatile or 
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diffusible antibiotics or following contact (Boddy, 2000). Many fungi acidify culture 
media during growth by production of organic acids (Petrson & Mclennan, 1948, Espejo & 
Agosin, 1991), and this might be expected to be inhibitory to bacteria even in the absence 
of other antibiotics (Tsuneda & Thorn, 1995). Attack of bacteria by wood decay 
basidiomycetes and their use as a source of nutrients is a well-known phenomenon 
(Tsuneda & Thorn, 1995, Elsas, et al., 2007). The most aggressive bacterial attackers are 
often the fast growing wood decay basidiomycetes (Tsuneda & Thorn, 1995). 
 
Currently, the control of phytopathogenic fungi depends heavily on the use of synthetic 
chemicals as primary control agents in agriculture. However, the interest in biological 
control has steadily increased for a number of reasons such as the costs of chemical 
fungicides, concerns over their environmental impact, public worry about the hazards 
associated with these chemicals, safety problems and development of resistance by certain 
plant pathogens (Weller, 1988, Whipps, 2001, Elsas, et al., 2007). 
 
1.2 Burkholderia  
Burkholderia species were originally recognized as phytopathogenic bacteria which cause 
sour skin rot of onion bulbs (Burkholder, 1950). Burkholderia are β proteobacteria, Gram 
negative, mostly motile, aerobic, morphologically straight or slightly curved bacilli (1 to 5 
µm in length and 0.5 to 1.0 µm in width). They do not form spores and their optimal 
growth temperature ranges between 20ºC and 37ºC. They are able to utilize a variety of 
simple and complex carbohydrates including alcohols, amino acids (Vermis, et al., 2003) 
and even hydrocarbon fuels (O'Sullivan & Mahenthiralingam, 2005) as carbon sources. 
The genus Burkholderia contains more than 40 different species, which inhabit a large 
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array of ecological niches. They exist in soil, water, plant rhizosphere, endophytically and 
are associated with fungi (Parke & Gurian-Sherman, 2001). 
 
1.2.1 Burkholderia cepacia complex 
Burkholderia cepacia complex (Bcc) is a group of closely related species. These species 
share a high degree of 16S rRNA gene (98 to 100%) and recA gene (94 to 95%) sequence 
similarity (Vermis, et al., 2003). They all also hold unusually complex and plastic genomes 
that consist of two or more chromosomal replicons which harbour multiple insertion 
sequences (Mahenthiralingam & Vandamme, 2005). 
 
Bcc were recognised as opportunistic human pathogenic bacteria responsible for a variety 
of infections, but only in individuals with an underlying vulnerability. Bcc bacteria are 
very problematic in cystic fibrosis (CF) patients because of their native resistance to a wide 
range of antimicrobial agents and their ability to spread from patient to patient (Tablan, et 
al., 1985). Also within the genus Burkholderia is B. mallei, the causative agent of glanders 
in horses, mules and donkeys, and B. pseudomallei, the causative
 
agent of melioidosis, an 
infectious disease of humans and animals
 
in tropical areas (Berriatua, et al., 2001, Coenye 
& Vandamme, 2007). 
 
1.2.2 The diversity of Burkholderia 
Bcc are ecologically versatile bacteria able to metabolise a wide range of carbon 
compounds. They are also one of the dominant bacterial groups found in the plant 
rhizosphere. Bcc bacteria have also been isolated from diseased plants, such as onion 
(Burkholder, 1950, Saddler, 1994), ryegrass (Nijhuis, et al., 1993), maize (Dalmastri, et 
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al., 1999), pea (King & Parke, 1996), cotton (Hallmann, et al., 1999), coffee (Estrada, et 
al., 2001), sugar-cane (Bramer, et al., 2001) and papaya (Kadir, et al., 2008). 
 
Microbial rhizosphere community structure and density may be affected by biotic factors 
(eg. other microorganisms and their metabolites, and animal and plant populations) and 
abiotic factors (eg. temperature, water content or pH). The diversity of the culturable 
Burkholderia communities in rhizosphere soils is affected by several factors. Di Cello, et 
al., (1997) suggested that the diversity and density of the B. cepacia community associated 
with maize-root depended on plant growth stage and root exudates. Dalmastri, et al., 
(1999) found that the type of the soil was the main factor which affected the diversity of 
the B. cepacia population associated with maize-roots.  
 
Burkholderia species have also been shown to occur in symbiosis with fungi. Yara et al. 
(2006) described the presence of a bacterium belonging to Bcc associated with Brazilin 
white-rot fungus Pleurotus sp.  Lim et al. (2003) characterized and proposed the B. 
sordidicola KCTC
T
 12081 and KCTC 12082 as a novel species which was associated with 
fungus Pleurotus sordid, collected from the plants Quercus acutissium and Prunus 
serrulata.  
 
Bacteria are often found attached to fungal hyphae, spores and within fruiting bodies. A 
range of species including Pseudomonas, Bacillus, Paenibacillus and Burkholderia have 
already been found to have a connection with fungi (Elsas, et al., 2007). The fungus may 
provide both nutrients and colonization sites for the bacteria and the bacteria may also 
attack and use fungi for their own nutrition, or they may produce antibiotics that inhibit or 
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kill fungi (Highley & Dashek, 1998). 
 
Nearly all species within the Bcc have been isolated from both the clinical and 
environmental isolates, however, isolates within the Cardiff collection (> 1600 isolates of 
Burkholderia species) have an interesting distribution (Mahenthiralingam, et al., 2008). 
Environmental isolates were not detectable within the B. cenocepacia ΙΙΙ D and only a few 
environmental isolates of B. multivorans, B. cenocepacia ΙΙΙ A, B. dolosa and B. stabilis 
were present in the collection (Mahenthiralingam, et al., 2008). All 16 isolates of B. 
cenocepacia ΙΙΙC were environmental isolates. Moreover, for B. ambifaria, B. pyrrocinia, 
unclassified species groups BCC5 and BCC6, more than 89% of isolates were from natural 
environments (Mahenthiralingam, et al., 2008). Although such collections of bacteria help 
with understanding the diversity of environments that Burkholderia bacteria can be 
cultivated from, further studies based on prospective collection of isolates or cultivation-
independent analyses are needed to fully explore sources of these bacteria in nature. 
 
1.3 Fungi  
Fungi play a major role in the function and dynamics of ecosystems. Fungal mycorhiza 
with plant root are crucial for host nutrient acquisition. Fungi are the main agents of 
decomposition and hence of nutrient release. Fungi may also cause serious economic 
problems in agriculture. Several important plant and human pathogenic fungi such as 
Fusarium, Rhizoctonia, Cryptococcus and Candida spp have been used as target organisms 
screened for the discovery of new antifungal substances. In this study, ten representatives 
of wood decay basidiomycetes and C. albicans were used as target fungal species in order 
to screen for antifungal biosynthesis by Burkholderia bacteria.  
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The Basidiomycota comprises a large phylum containing about 22,000 known species. 
Some basidiomycetes are facultative parasites, for example Armillaria sp causes root rot. 
Smuts and rusts are obligate parasites causing plant diseases that cause damage worth 
millions of pounds yearly. Saprotrophic basidiomycetes are the major agents of wood 
decomposition in forest soils and form about 60% of living microbial biomass (Boddy, et 
al., 2008).  Wood rots are categorized either as white rots, brown rots or soft rots. White 
rots attack and destroys all compounds of wood including lignin, cellulose and 
hemicellulose. Brown rots attack and destroy cellulose and hemicellulose but not lignin. 
Soft rot operate a more local scale, and cause different patterns of decay, and again do not 
utilize lignin (Highley & Dashek, 1998). Basidiomycetes are known sources for the 
production of a large number of secondary metabolites. For example they produce a wide 
range of potent extracellular enzymes such as lignin peroxidase, glyoxal oxidase and 
laccase (Boddy, 2000), and are also able to produce antibiotics (de Boer, et al., 2008). 
 
Chemically synthesised or petrochemical industry-derived wood preservatives have been 
banned in several countries because of both health concerns and environmental issues. 
Thus, there is an urgent need for new approaches to preserving wood and preventing 
fungal wood decay (Highley & Dashek, 1998). Secondary metabolites produced by 
microorganisms in the field of biocontrol, especially from B. cepacia complex (Bcc) have 
shown promising activity as anti-fungal agents (Rousk, et al., 2008). 
 
C. albicans belongs to Ascomycota and the family Saccharomycetaceae. It is commonly 
found as part of the normal microflora on the skin and orifices of humans. It is the major 
opportunistic fungal pathogen causing potentially fatal disease in immunosuppressed 
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human hosts (Pfaller & Diekema, 2007). Since C. albicans is a very common cause of 
fungal infections in humans, it has been a major target species for the discovery of new 
anti-fungals. 
 
1.4 Biological control  
Biological control agents (BCAs) are those microorganisms which can be used to reduce 
pathogens or to decrease damage caused by them (Elsas, et al., 2007). This is of increasing 
importance because of the cost of pesticides, legislation against their use, and increasing 
immunity to them. Biological control of soilborne pathogens has been studied for over 85 
years. Bacterial biocontrol agents improve plant development by suppressing pathogens 
(Weller, 1988). Biocontrol may also provide control of diseases that cannot be controlled 
by other approaches (Cook, 1993).  
 
Microbes that can grow in the rhizosphere are often used as biocontrol agents. Many 
different bacterial genera and species have been studied. Many studies have used Bacillus, 
Pseudomonas, Agrobacterium, Streptomyces, Alcaigenes, Enterobacter, Erwinia, 
Xanthomonas and Burkholderia as biocontrol agents (Barea, et al., 2005).  Pathogen 
suppression by antagonistic microorganisms occurs via different mechanisms such as 
parasitism, competition for sites of colonization, carbon, nitrogen and iron sources, and 
inhibition of the pathogen by antimicrobial agents (Whipps, 2001, Barea, et al., 2005), 
secretion of bacteriocins (Fravel, 1988), and volatile organic compounds (Cartwright, et 
al., 1995, Wheatley, 2002). Several microorganisms attack pathogens by excreting cell 
wall hydrolysis enzymes such as chitinase and β-1,3-glucanase. Fridlender et al. (1993) 
showed that B. cepacia produces β-1,3-glucanase that can destroy Rhizoctonia solani, 
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Sclerotium rolfsii and Pythium ultimum cell walls.  
 
1.4.1 Fungi as biological control agents  
There are a range of different types of interaction between fungi and bacteria, including 
mutualism, parasitism, competition or predation.  Among the fungi, many species have 
antagonistic properties and have been applied in biocontrol, such as Trichoderma species. 
Trichoderma spp have been widely researched and have potential in control of wood decay 
by fungi. Some fungi, such as Pleurotus ostreatus and Agaricus brunnescens attack 
bacteria such as Pseudomonas and Agrobacterium, lysing them by secreting specific 
enzymes and using them as a source of nutrients. The white rot fungi Hypholoma 
fasciculare and Resinicium bicolor have bactericidal and bacteriostatic properties, which 
may involve in the production of toxic compounds (Folman, et al., 2008). Such 
interactions may give the fungi a considerable advantage in obtaining nutrients in different 
environments (Elsas, et al., 2007). 
 
Ejechi (1998) studied the interaction between four species of wood decay fungi, 
Gloeophyllum sepiarium, Gloeophyllum sp., Pleurotus sp. and Trametes sp., and two 
ureolytic bacteria, Bacillus sp. and Proteus sp., on artificial media and wood.  The biomass 
of wood decay fungi was clearly reduced in a medium containing urea, as a result of 
bacterial activity.  In contrast, the biomass of wood decay fungi was not affected by the 
presence of urelytic bacteria in non-urea containing media. The bacteria produced volatiles 
which reduced the growth of wood decay fungi.  
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Murray and Woodward (2003) investigated the effects of bacteria, isolated from stumps of 
Sitka spruce, on the ability of wood decay fungi (Heterobasidion annosum, Hypholoma 
fasciculare, Resinicium bicolor, Melanotus proteus, Sistotrema brinkmannii, and S. 
sanguinolentum) to grow and cause wood decay. Inoculating wood with these bacteria 10 d 
after inoculation with H. annosum resulted in a highly significant decrease in weight. The 
interaction between different fungi and these bacteria on agar and broth media fluctuated 
depending on the medium type. Bacterial isolates had a greatest inhibitory effect on H. 
annosum when grown on sporulation agar and yeast dextrose peptone agar compared with 
corn meal agar and NLM liquid medium. 
  
Folman et al. (2008) studied the effect of two white rot fungi, H. fasciculare and R. bicolor 
on community composition and the number of bacteria colonizing sterile beech wood.  
Their results suggested that the white rot fungi reduced the number of bacteria occupy 
beech wood and the composition of the bacterial community was also altered. Bacteria 
belonging to 18 families were detected in wood samples and soil beneath colonized wood 
and fungal mycelium. Burkholderiacae were dominant in the un-colonized and 
basidiomycete colonized beech wood. Xanthomonasaceae were also prevalent species in 
un-colonized beech wood and in H. fasciculare colonized beech wood. 
 
1.4.2 Burkholderia as biological control agents  
Bcc strains designated as type Wisconsin and at the time known as “Pseudomonas 
cepacia” were registered as bio-pesticides in United States and obtained EPA approval in 
the late 1980s. Available data at that time indicated that clinical and environmental strains 
had several different phenotypic properties. Several Bcc bio-pesticides were registered 
    
 12 
between 1992 and 1996. Polyphasic taxonomic studies and genetic markers later revealed 
no key differences between Bcc bio-pesticidal and clinical strains. These results led to 
consideration of the hazards of continued use of Bcc as bio-pesticides and EPA cancelled 
registration and prohibited use Bcc bio-pesticides (Parke & Gurian-Sherman, 2001). 
Sequence-based typing methods such as multilocus sequence typing demonstrated that Bcc 
strains from environmental and clinical sources may be clonal (genetically identical) 
(Baldwin, et al., 2008). 
 
Despite the current moratorium on the registration of Bcc biopesticide strains, several 
studies have shown that they are highly potent biocontrol species. Heungens and Parke 
(2000) studied biocontrol activity of B. cepacia strain AMMDR1 against two Oomycete 
pathogens of pea, Pythium aphanidermatum and Aphanomyces euteiches. AMMDR1 
exhibited strong biocontrol activity against both of these fungus like species, and in 
particular protected pea and sweet corn seeds from Pythium damping-off disease . Li et al. 
(2002) illustrated an aggressive effect of B. ambifaria isolate BCF against Pythium 
ultimum that caused cucumber and soybean damping-off disease, and reported broad 
spectrum antifungal activity against P. ultimum, R. solani, P. capsici and F. oxysporum . 
Chul-Hoon et al. (2004) showed a strong inhibitory effect of a B. ambifaria isolate against 
both Erysiphe graminis and Puccinia recondite, the causative agents of barley powdery 
mildew and wheat leaf rust, respectively. 
 
1.4.2.1 Burkholderia antimicrobial agents 
Antimicrobial agents are a chemically heterogeneous group of organic, low molecular 
weight compounds produced by microorganisms that, at low concentrations, inhibit the 
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growth or metabolic activity of other microorganisms (Duffy, et al., 2003). Antimicrobial 
agents play an important part in the disease suppression by bacteria and fungi (Weller, 
1988). Various antibiotics have been isolated from both fungal and bacterial species. 
 
There are many Bcc species that produce metabolites with antifungal activity (Table 1.1). 
These include pyrrolnitrin (Cartwright, et al., 1995), altericidins (Kirinuki, et al., 1977),  
cepacin A and cepacin B (Parker, et al., 1984), pseudoanes and cepacidines A and B 
(Meyers, et al., 1987), pseudane (Homma, et al., 1989), phenazine (Cartwright, et al., 
1995), cepaciamides A and B (Jiao, et al., 1996), quinolinone (Moon, et al., 1996), lipo-
peptides and AFC-BC11 (Kang, et al., 1998), and CF661(Quan, et al., 2006). Examples of 
well characterized Bcc antibiotics are described in Table 1.1.  
 
1.4.2.1.1 Pyrrolnitrin 
Pyrrolnitrin (Figure 1.1) is a chlorine-containing phenylpyrrole derivative, with strong 
antifungal activity that is produced by Gram negative bacteria (Loper & Gross, 2007). It 
was first discovered in a “Pseudomonas cepacia” strain that was subsequently reclassified 
as the Bcc species B. pyrrocinia (Vandamme, et al., 2002). Other Gram negative bacteria 
are also known for their ability to produce pyrrolnitrin (Arima, et al., 1964, Cartwright, et 
al., 1995) and it has now been found to be produced by several Bcc species (Schmidt, et 
al., 2009). 
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Table 1.1 List of known Bcc isolates with their reported antifungal agents and susceptible fungi
Antimicrobial agents Bcc strain Susceptible fungi ( tested against) Author 
Quinoline  P. cepacia strain PCII -  Moon et al. 1996  
AFC-BC11 (Lipo-
peptides) 
B. cepacia isolate BC11 R. solani Kang et al. 1998  
Altericidins  
P. cepacia 
 
Alternaria kikuchiana 
Kirinuki et al. 1977  
Cepaciamids A and B Jiao et al. 1996 
Cepacin A and B Parker et al. 1984  
 
CF66I 
 
B. cepacia strain CF-66 
Colletorichum lindemuthianum, R. solani,  A. alternate, 
Bipolanis sorokiniana, Curvularia lunata and 
Monochaetia hirta 
C. albicans and F. solani 
Quan et al. 2006 
 
Li et al. 2007, 2008 
Phenazine B. cepacia strain 5.5B R. solani Cartwright et al. 1995  
Pseudane  
B. cepacia strain RB425 
 
Pyricular oryza, R. solani and Verticillium dahliae 
Homma et al. 1988  
Pseudoanes Meyers et al. 1987; Lee et al. 
1994 
Pyrrolnitrin  
 
 
 
 
B. cepacia strain RB425 
B. cepacia isolate B37w 
B. cepacia strain 5.5B 
B. cepacia NB-I 
B. cepacia strain 5.5B and 
RR 21-2 
B. cepacia isolates J2535, 
LMG 1222 and ATCC 51671 
B. cepacia strain B23 
P. oryza, V. dahliae and R. solani. 
Fusarium sambucinum 
R. solani 
 
Trichoderma pseudokonigii 
 
 
C. gloeosporioids 
Arima et al. 1964 
Homma et al. 1989 
Burkhead et al. 1994 
Cartwright et al. 1995 
Roitman et al. 1990 
El-Banna and Winkelmann 1998 
Kadir et al. 2008  
Sultan et al. 2008 
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 Figure1. 1 The structure of pyrrolnitrin 
 
 
Several studies have confirmed that pyrrolnitrin produced by Bcc has a broad spectrum 
activity that includes Gram-positive bacteria such as Streptomyces species. However, it is well 
characterized in terms of its antifungal activity against a wide range of basidiomycetes and  
ascomycetes, including several economically important pathogens e.g. Fusarium sambucinum, 
R. solani, Botrytis cinerea and Sclerotinia sclerotiorum (Burkhead, et al., 1994, El-Banna & 
Winkelmann, 1998, Ligon, et al., 2000). Homma, et al., (1988) showed that B. cepacia strain 
RB425, which was isolated from a lettuce root, produced three different kinds of antifungal 
agents, pyrrolnitrin, and two derivatives of pseudane. In combination, these antibiotics gave 
the strain high activity against several fungal pathogens including Pyricular oryza, R. solani 
and Verticillium dahliae . Burkhead, et al., (1994) also reported that pyrrolnitrin was produced 
by B. cepacia isolate B37w which was very effective against the economically important 
potato pathogen fungus, Fusarium sambucinum  . El-Banna and Winkelmann (1998) extracted 
pyrrolnitrin produced by B. cepacia NB-I, which exhibited a broad spectrum of antimicrobial 
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activity against 8 filamentous fungi (Trichoderma pseudokonigii was the primary test species), 
2 yeasts, 1 Gram negative and 19 Gram positive bacteria. 
 
Hwang et al. (2002) compared and quantified the production of pyrrolnitrin by four different 
strains of B. cepacia by TLC and HPLC, and showed that B. cepacia strain 5.5B and RR 21-2 
produced large quantities of pyrrolnitrin . De Souza and Raaijmakers, (2003) extracted and 
identified pyrrolnitrin by TLC in several B. cepacia isolates J2535, LMG 1222 and ATCC 
51671, that were suppressive against Gaeumannomyces gramimis var. tritici . Kadir, et al., 
(2008) extracted pyrrolnitrin and three other antifungal compounds produced by B. cepacia 
strain B23, which inhibited the growth of Colletotrichum gloeosporioids . Sultan, et al., 
(2008) isolated pyrrolnitrin and two novel oxidized derivatives from B. cepacia K73, which 
inhibited the growth of R. solani . 
 
1.4.2.1.2 Bactobolin 
Bactobolin (Figure 1.2) is a highly polar compound with strong antimicrobial and antitumor 
activity, and is structurally related to actinobolin produced by Streptomyces griseoviridis 
(Seyedsayamdost, et al., 2010). Bactobolin was first isolated from Pseudomonas BMG13-A7 
(Kondo, et al., 1979), and later isolated from the Burkholderia species, such as B. 
thailandensis E264 and B. pseudomallei  (Seyedsayamdost, et al., 2010).  
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Figure1. 2 The structure of Bactobolin A 
 
1.4.2.1.3 Quinolines 
Quinolines (HMQ) (Figure 1.3) are strong antimicrobials that also act as iron chelators and 
signalling molecules; they are produced by many bacteria including Pseudomonas aeruginosa 
and several Burkholderia species (Vial, et al., 2008). Moon, et al., (1996) isolated three 
quinolines metabolites (3-methyl-2-pentyl-4-quinolinone, 2-heptyl-3-methyl-4-quinolinone 
and 3-methyl-2-nonyl-4-quinolinone (HAQs and HMAQs)) from “P. cepacia” PCII. HMQs 
inhibited the growth of Phytophthora capsici, the causal agent of red pepper blight (Moon, et 
al., 1996).  
 
 
                                                
 
 
Figure1. 3 The structure of 4-hydroxyl-3- methyl-2-alkyl-quinoline 
 
N
O
H
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1.5 The production of Burkholderia antimicrobial agents 
The production of antimicrobial agents, which are often secondary metabolites, is dependent 
on the primary metabolites that are produced by the catabolism of carbon, nitrogen and other 
important nutrients utilized by the microorganisms. These primary metabolites are considered 
to be precursors and suppliers of building blocks for secondary metabolism through different 
pathways. Multiple reports have demonstrated that the production of antibiotics occurs late in 
the stationary phase, as a result of exposure to extreme conditions, nutrient deficiency or 
feedback phenomena (Martin & Demain, 1980, Roitman, et al., 1990, El-Banna & 
Winkelmann, 1998). 
 
Various media have been used to grow bacteria and fungi in biological control studies. 
Microorganisms growing on different media can produce different metabolites and show 
different growth patterns (Jayaswal, et al., 1990, Sfalanga, et al., 1999, Hwang, et al., 2002). 
The production and activity of antimicrobial agents fluctuates and is a very sensitive process 
that needs special conditions to actually have an effect on a target organism. These conditions 
are different and vary from organism to organism (Leisinger & Margraff, 1979, Duffy & 
Defago, 1999, Sfalanga, et al., 1999, Raaijmakers, et al., 2002, Bae, et al., 2007, Li, et al., 
2007).  
 
The production of secondary metabolites, which exhibit antimicrobial activity by Bcc isolates, 
is controlled by several factors such as media composition, pH and temperature (El-Banna & 
Winkelmann, 1998). Carbon, nitrogen and phosphate are the major requirements for the 
growth and metabolic activities of microorganisms. Carbon source greatly influences 
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microbial secondary metabolite production. The production of antimicrobial agents, such as 
pyrrolnitrin, by Bcc was affected by changing the source of carbon, with enhanced production 
occurring after growth on glycerol (Roitman, et al., 1990, El-Banna & Winkelmann, 1998, 
Bae, et al., 2007).  
 
Nitrogen is one of the major requirements because it is needed for the synthesis of cell 
components and functional proteins. It is well-known that the different kinds of nitrogen 
source greatly influence microbial secondary metabolite production. Nitrogenous compounds 
may influence the biosynthesis of antibiotics directly at the level of secondary metabolism, 
either through their availability as substrates for antibiotic biosynthesis or through the 
modulation of biosynthesis and activities of the enzymes. The biosynthesis of many different 
types of antibiotics is also regulated by phosphate (Aharonowitz, 1980). Inorganic phosphate 
controls the synthesis of a large number of antibiotics that belong to different classes such as 
macrolides, tetracyclines and aminoglycosides (Martin & Demain, 1980, Martin, 2004). 
However, high concentrations of inorganic phosphate can repress the biosynthesis of 
antibiotics (Kishimoto, et al., 1996). The pH of growth media also exerts an effect on the 
production of antimicrobial agents. The pH may change the ionizing state of important 
essential molecules such as proteins and enzymes. The production of antimicrobial agents is 
dependent on multiple enzyme catalysed reactions. Therefore, pH is one of the most important 
physical factors affecting antimicrobial production and activity. In general, pH ranging from 
6.0 - 8.0 was optimal for antibiotic production by Burkholderia bacteria (Roitman, et al., 1990, 
El-Banna & Winkelmann, 1998, Li, et al., 2007). 
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1.6 Extraction, purification and identification of antimicrobial 
agents  
 
Microbial secondary metabolites are chemical compounds with low molecular masses that are 
often formed during the stationary phase in response to the limitation changes in the growth 
conditions (Ruiz-Lozano & Bonfante, 2000). These metabolites may or may not exhibit 
antimicrobial activity. Many studies demonstrated various methods of extraction, 
characterization and identification of antimicrobial agents produced by Bcc and other 
Burkholderia bacteria.  
 
1.6.1 The extraction of antimicrobial agents  
After the detection of antimicrobial activity in a pure culture, the extraction of active 
compounds is the next important step if the structure and specific activity of the antimicrobial 
agents are to be characterized in detail. The development of suitable sample preparation 
techniques is needed to provide high quality, active and pure natural products in sufficient 
quantities. Several studies have used various methods of extraction and identification to 
characterize antimicrobial agents produced by Burkholderia. Antifungal Burkholderia 
compounds have been extracted from Burkholderia metabolites using extraction techniques 
such as maceration, followed by liquid partition in a wide range of different solvents with 
different polarities and concentrations. Solvents such as methanol (Moon, et al., 1996, Kadir, 
et al., 2008), acetone (Roitman, et al., 1990, Burkhead, et al., 1995, El-Banna & Winkelmann, 
1998), chloroform (Homma, et al., 1989) and a mixture of chloroform and methanol (Jiao, et 
al., 1996) have been used to extract active Burkholderia metabolites. 
    
 21 
Another successful method for the extraction of antibiotics from microbial cultures, which 
reduces the reliance on solvent extraction, is to use adsorption onto neutral resins such as 
Amberlite. For example, Amberlite XAD-16 has been shown to be a very efficient means to 
purify erythromycin from solution (Ribeiro & Ribeiro, 2003). These resin extraction protocols 
were recently applied by Mahenthiralingam, et al., (2011) to purify the polyketide enacyloxin 
from B. ambifaria AMMD, however, the wider exploration of utility of the resin adsorption 
methods in extraction of Burkholderia antibiotics remains to be carried out. 
 
1.6.2 Purification of antimicrobial agents  
Chromatography is a very commonly used technique in chemistry for separation, 
characterization and identification of compounds, firstly introduced by the Russian botanist 
Micharl Iswett. There are many types of chromatography with Thin Layer Chromatography 
(TLC) being one of the simplest, most rapid and economical of the procedures available. TLC 
separations take place in the thin sorbent layer such as silica gel, alumina or ion exchange 
resins which are supported on a glass, metal or plastic plate. Each extracted component is 
subjected to the same total separation time, but different migration distances occur based on 
the nature of the chemical components. These TLC chemical profiles can be visualized, 
depending on the nature of the compounds, in either normal day light, UV light (254 and 365 
nm), or located using a stain procedure with iodine/other chemical spray reagents.  
 
The degree of TLC fractionation depends on the nature of the chemical mixture under 
investigation, the type of adsorption layer and the power (polarity) of the mobile phase (Fritz 
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& Schenk, 1987). The retention (retardation) factor (Rf) is commonly used to describe the 
specific chromatographic fractionations observed in a given TLC profile. The Rf value is the 
ratio of the distance the solvent travels to the distance the compound travels, with the center of 
each spot taken as the point from which the measurement of the migration in relation to the 
solvent front is made. Rf values and other characteristics such as the colour of metabolites 
make it possible to qualitatively study the nature of complex chemical mixtures; it is ideal as a 
simple method to examine microbial secondary metabolite mixtures. TLC can be further 
expanded to measure the bioactivity of secondary metabolites if, for example, the fractionated 
compounds are overlaid with a soft agar containing an indicator microorganism or cell 
suspension. A microbial bioassay was developed in this current project to study the diversity 
of antifungal agents present in Burkholderia secondary metabolites (chapter 4).  
 
1.6.3 Identification of antimicrobial agents 
A number of methods can be used to characterise the active antimicrobial compounds 
including liquid-liquid chromatography (LC), mass spectrometry (MS), infrared spectrometry 
(IR), ultra-violet (UV) absorption and nuclear magnetic resonance (NMR). A combination of 
LC-MS can be used to study multi-component mixtures and detect specific compounds within 
them. This method can be used to help identify known classes of compounds by mass when 
searching for novel bioactive compounds. Molecular weight and UV absorbance data of 
bioactive natural products in MS databases allow rapid identification of compounds. MS is 
also used in conjunction with NMR spectroscopy to determine the molecular formula of 
compounds. These data can then be compared to a database of compounds that have already 
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been identified. NMR is the ultimately method used to confirm the structural identity of a 
compound (Petr, 2008). 
 
1.7 Antimicrobial activity testing 
There are several different methods which can be use to investigate the efficacy of novel 
antimicrobials against susceptible microorganisms; these are often based on diffusion or 
dilution concepts. Diffusion methods include agar well diffusion assays, agar disk diffusion 
assays and bioautography assays, while dilution methods include agar dilution assay and broth 
dilution assay. The diffusion assay has been widely used to test biological extracts for 
antimicrobial activity. It is considered as a preliminary test used to determine the efficacy of 
biologically active compounds against susceptible microorganisms. The broth dilution assay 
can also provide useful information and define values, such as the Minimum Inhibitory 
Concentration (MIC), in terms of microbial growth suppression. MIC is the lowest 
concentration of an antimicrobial that can inhibit the visible growth of testing microorganism 
and is an important measure of the potency of new antimicrobial agents (Lorian, 2005). 
Bioautography assays were used for the first time by Goodal and Levi (1946) in their study of 
penicillin. Bioautography conducted TLC is a very helpful assay for testing active biological 
extracts for their antimicrobial effects (Rios, et al., 1988). 
 
1.8  The genetic basis of Burkholderia antifungal agents 
The emergence of drug resistance among microorganisms is a major challenge of humankind. 
There is an urgent need to develop and discover new antibiotics to treat microbial infections. 
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In addition to using classical inhibition assays and chemical analysis to characterise 
antimicrobial agents, in the last few decades considerable research into the genetics of 
antibiotic production has been carried out. The first bacterial genome, published in 1995, was 
for Haemophilus influenzae, and we now have over 2000 complete bacterial genomes and 
multiple draft genomes available for analysis (www.genomesonline.org). Currently, the 
complete genomes of 20 strains of Burkholderia from different species and ecological 
categories can be examined online at the Burkholderia Genomes Database (BGD; 
www.burkholderia.com). Genomic information available on the publicly accessible databases, 
such as Genbank or BGD, can be investigated to increase our understanding of the genes 
responsible for biosynthesis of metabolites with antimicrobial activity. 
 
One of the most powerful approaches used to identify the function of microbial-encoded genes 
is to introduce mutations into the bacterial genome and screen for mutants which have lost 
specific biological functions. Mutation of genes using transposons is a particularly useful 
approach to characterize gene function in bacteria (Steiniger-White, et al., 2004). 
Transposition is a recombination process in which transposable elements, such as Mu, Tn3, 
Tn5 or Tn10, move from one site on a genome to a new site on the same genome, or move 
from a mobile element such as plasmid into a completely new genome. The movement of 
transposons in this way can cause genetic rearrangements such as deletions, inversions or 
duplication of DNA sequences, as well as inactivation of the genes within which they insert, 
and sometimes activation of genes adjacent to the site of insertion (Steiniger-White, et al., 
2004). Transposon mutants lacking the ability to produce antimicrobial agents have been used 
to investigate the role of antibiotics in the biocontrol of microorganisms (Fravel, 1988).  
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There are multiple bioinformatic tools available that can aid the identification of known 
secondary metabolite genes within genomes. In addition, such genome mining may also lead 
to the discovery of novel antibiotics within Burkholderia genomes such as B. ambifaria 
AMMD. Artemis is a genome sequence visualisation and analysis tool developed by 
Rutherford et al., (2000) (http://www.sanger.ac.uk/resources/software/artemis/). The software 
allows, on one screen, the viewing of the sequence of an entire genome in a graphical format; 
additional tools such as the Artemis Comparison Tool (ACT) also enable the display of pair-
wise comparisons between two or more genomes (Carver, et al., 2005). Genome annotation is 
the identification of putative functional roles for genes encoded within a DNA sequence 
(Lukashin & Borodovsky, 1998). The BGD (www.burkholderia.com) provides similar 
features to Artemis but allows Burkholderia genomes to be viewed and compared over the 
web. Hence, this tool can allow the comparison of B. ambifaria AMMD to all the additional 
Burkholderia genomes available. It is a very powerful tool with which to identify the presence 
of orthologous genes in Burkholderia genomes. 
 
Genomics is a fast-growing field and provides a major resource for screening and 
identification of gene(s) and pathways that might have a potential role in solving many 
worldwide biological problems. Bioinformatics is a good tool for identification of known 
secondary metabolite gene homologs. This may lead to the discovery of novel and existing 
antifungal antibiotics.  
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Aims 
 
Secondary metabolites produced by biocontrol microorganisms, especially from Bcc bacteria, 
show considerable potential as antimicrobial agents. The overall aim of the current work 
was to screen, isolate, characterise and identify Burkholderia antifungal agents, 
investigating their natural diversity and activity on both ascomycete and basidiomycete 
fungi. A broad range of research covering the following objectives was carried out: 
 
Objective 1: Screening of Burkholderia isolates for the antifungal 
production. 
 A large collection of accurately identified Burkholderia isolates held by Mahenthiralingam 
group at Cardiff University was screened for the production of antifungal agents. A general 
hypothesis for this work was “all B. cepacia complex bacteria are capable of producing 
antifungal agents” (Chapter 3). The objectives were to:  
 Evaluate a range of growth media for their ability to support bacterial growth, and 
allow the production of antimicrobial metabolites. 
 Systematically screen a collection of Burkholderia cepacia complex species for the 
production of antifungal metabolites. 
 Examine the secretion of antifungal metabolites by Burkholderia species outside the B. 
cepacia complex and compare this with a range of non-Burkholderia species. 
 Develop an overlay-inhibition assay suitable for screening antifungal activity against 
filamentous basidiomycetes. 
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Objective 2: Analysis of the chemistry of antifungal substances 
secreted by Burkholderia.  
A range of different chemical methods were used to purify and explore the chemistry of 
Burkholderia antibiotics. The general hypotheses for this chapter were: “Burkholderia bacteria 
produce more than one antimicrobial compound and TLC-bioautography can be used to 
examine Burkholderia antimicrobial diversity.” (Chapter 4)  The objectives were to: 
 Investigate the nature of Burkholderia secreted products by development of rapid 
extraction methods.  
 Optimize conditions of thin layer chromatography to enhance fractionation and 
visualization of Burkholderia active metabolites.  
 Optimize the bioautography assay to detect active agents in each extract. 
  Study the diversity of antimicrobial agents within Burkholderia.  
 Purify, isolate and identify Burkholderia active metabolites using TLC, liquid 
chromatography and mass spectroscopy. 
 Determine the minimal inhibitory concentrations of crude and semi-purified 
Burkholderia active metabolites. 
 
Objective 3: Optimization of antibiotic production in antifungal 
Burkholderia isolates. 
The components of synthetic media and different factors such as pH, temperature and 
incubation period were investigated, with enhancement of antimicrobial production by 
Burkholderia as the overall aim. A general hypothesis was „„chemical and physical factors can 
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influence anti-candidal production and activity of Burkholderia‟‟, (Chapter 5) and the 
specific objectives were to: 
 Examine the effects of six different factors: carbon, nitrogen, phosphate, pH, 
incubation time and temperature on the activity of anti-candidal agents of 
Burkholderia. 
 Create an optimal medium to increase anti-candidal activity of Burkholderia 
metabolites. 
 
Objective 4: The natural diversity of antifungal producing 
bacteria associated with different rhizosphere environments. 
This was investigated with a culture-dependent approach using selective media to enrich for 
antibiotic producing bacteria and molecular methods to identify these bacteria. A general 
hypothesis for this research was “a rhizosphere bacterial isolates are capable of producing one 
or more antifungal agents”, (Chapter 6) and the specific objectives were to: 
 Isolate antifungal producing bacteria from different rhizosphere environments. 
 Identify the antifungal producing bacterial species using 16SrRNA. 
 Extract antifungal agents synthesised by different isolates. 
 Study the presence and diversity of antifungal agents in antifungal producing bacteria 
using a developed TLC-bioautography assay. 
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Objective 5: Identification of the genetic basis for the secretion of 
antifungal agents by Burkholderia. 
This research examined the genetics behind the production of anti-fungal agents by 
Burkholderia using molecular genetics techniques such as transposon mutagenesis and 
genome sequence analysis. A general hypothesis was „„mutation and bioinformatics analysis 
can predict the genes involved in antimicrobial secretion by B. ambifaria AMMD‟‟ (Chapter 
7). The specific objectives were to: 
 Identify the genes responsible for the production of antimicrobial agents in B. 
ambifaria AMMD by transposon mutagenesis. 
 Detection the presence or absence of anti-candidal agents in isolated transposon 
mutants using antimicrobial extraction followed by TLC-bioautography assay. 
 Use bioinformative analysis to characterise orthologs of B. ambifaria secondary 
metabolites genes (upregulated during growth on glycerol) in other Burkholderia 
genomes. 
  Characterise the kinetics and physiology of Burkholderia metabolite secretion over 
time. 
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CHAPTER TWO 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GENERAL MATERIALS AND METHODS 
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Materials and Methods 
 
2.1 Microbial growth media  
The media used in current study (Table 2.1) were basal salts minimal growth media (BSM) 
with glycerol as a carbon source (BSM-G), Tryptone Soya broth/ agar (TSA/TSB), Potato 
dextrose agar (PDA), Sabouraud agar (SA), 2% Malt agar (MA), Muller Hinton agar (MHA); 
Muller Hinton broth (MHB), Isosensitest agar (ISOA), soft Isosensitest agar (SISOA, see 
below), Casein meat agar (CAM) and Peptone Lactose agar (PLA). All premixed media, 
individual nutrient components and agar were obtained from Oxoid UK unless indicated 
otherwise. BSM-G was composed of (gl
-1
): K2HPO4.3H2O, 4.25; NaH2PO4.H2O, 1.0; NH4Cl, 
2; nitrilotri acetic acid (C6H9NO), 0.1; MgSO4.7H2O; 0.2, FeSO4.7H2O, 0.012; MnSO4.H2O, 
0.003; ZnSO4.7H2O, 0.003; CoSO4.7H2O, 0.001; 0.05% Cas amino acids; 0.05% yeast extract 
and 0.4% glycerol as a carbon source (m/m). To make solid BSM-G media, 15 gl
-1
 of purified 
agar was added. The carbon source in BSM was altered as described (Section 2.7.1) for the 
experiments to examine the induction of antimicrobial biosynthesis. 2% Malt agar medium 
(MA) consisted of (gl
-1
): malt, 20 and purified agar, 15. Soft Isosensitest agar medium 
(SISOA) was prepared by addition of purified agar 10 gl
-1
 (1%), to standard Isosensitest broth 
prepared to the manufacturer‟s recipe. Casein meat agar (CAM) was prepared by combining 
(gl
-1
) pancreatic digest of casein, 5.0; meat extract, 5.0; and purified agar 15. Peptone Lactose 
agar (PLA) was prepared by mixing (gl
-1
) Neo Peptone, 10; Lactose, 10 and purified agar 15. 
All media were prepared with sterile polished water and sterilised by autoclaving at 121°C for 
15 minutes. 
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Table 2.1 Formulation of growth media used in this study. 
 
 
 
Medium (supplies) 
 
Abbreviation 
 
Carbon source 
 
Protein source 
 
pH (25C) 
Basal salts media 
 
BSM Glycerol Amino acids 7.0± 0.2  
Tryptone Soya broth/agar (Oxoid) TSA &TSB Unidentified  Peptone 7.0± 0.2  
Potato dextrose agar (Oxoid) PDA 
 
Starch & 
glucose 
Unknown 5.6± 0.2  
 
Sabouraud broth/agar (Oxoid) SB & SA 
 
Dextrose Peptones 5.6± 0.2  
 
2% Malt agar MA Starch Unknown 5.6± 0.2  
 
Muller Hinton agar/ broth (Oxoid) MHA 
 
Starch Beef & Casein 7.0± 0.2  
 
Isosensitest agar / broth (Oxoid) ISO& ISOB 
 
Starch & 
glucose 
Peptones, 
Casein & amino 
acids 
7.0± 0.2  
 
Casein meat agar CAM Unidentified Casein & meat 5.6± 0.2  
 
Peptone Lactose agar PLA Lactose Peptone 6.0± 0.2  
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2.2 Microorganisms storage and maintenance 
2.2.1 Bacteria 
A total of 421 bacterial isolates (397 Burkholderia isolates; Table 2.2) from a variety of 
sources including cystic fibrosis infection (designated as CF), various clinical infections 
(designated as Non-CF) and the environment (designated as ENV; these included plant 
pathogenic, soil, and isolates from various environmental sources including industrial 
contamination) were obtained from the Cardiff University collection (Mahenthiralingam, et 
al., 2008). Reference and type strains were obtained from the Belgian Co-Ordinated 
Collections of Microorganisms (LMG BCCM) (http://bccm.belspo.be/about/lmg.php). Control 
strains included: Staphylococcus aureus (NCTC12981), B. multivorans (ATCC17616; 
BCC0011), E. coli (NCTC12241), Pseudomonas aeruginosa (NCTC12903), and other 
multidrug resistance bacteria S. aureus Eagles, S. aureus EMRSA15, S. aureus MRSA Mu50, 
B. cenocepacia (LMG16656) [BCC0665], P. putida (LMG 2257
T
)  P. fluorescens (LMG 
1794
T
), Stenotrophomonas maltophilia (LMG 958
T
), Acinetobacter baumannii (OXA-23) and 
Enterococcus faecalis (ATCC 51299). 
 
Bacterial isolates (a suspension of fresh plate or liquid growth) were stored at –80ºC in vials 
containing TSB medium with 8% (vol/vol) di-methyl sulphoxide (DSMO). To revive isolates, 
vials were removed from the -80ºC freezer, the bacterial stock surface swabbed with a sterile 
cotton swab while deep frozen, immediately plated onto a fresh TSA plate and streaked out to 
single colonies by a sterile loop. Plates were incubated at 30ºC or 37ºC as appropriate for the  
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Table 2.2 List of Burkholderia isolates and other bacteria used in this study. 
 Burkholderia species  No. of tested 
isolates 
Habitat 
CF 
 a
 Non-CF 
b
 ENV 
c
 
B. cepacia complex (339 isolates) 
B. ambifaria  101 6 (1 Control d) - 95 (1 Control) 
B. cenocepacia   61 27 (8 Control) 9 (4 Control) 21 
B. cepacia   30 11 (1 Control) 4 (1 Control) 15 (4 Control) 
B. multivorans  27 14 (3 Control) 4 (1 Control) 6 (1 Control) 
B. vietnamiensis  18 5 (1 Control) 3 10 (3 Control) 
B. stabilis  18 5 5 6 
B. pyrrocinia  16 2 - 14 (2 Control) 
B. anthina  14 5 (2 Control) - 9 (4 Control) 
B. lata 11 1 - 9  (1 Control) 
Bcc novel groups Bcc 6  10 1 - 9 
B. dolosa  8 8 - - 
B. contaminans  6 4 (1 Control) - 2 
Bcc novel groups Bcc 5  5 1 1 3 
B. arboris  3 1 (1 Control) - 2 
Bcc novel groups Bcc 4  3 1 (1 Control) - 2 
B. lateens 2 2 (1 Control) - - 
B. seminalis 2 1 - 1  
Bcc novel groups Bcc Kc 2 - - 2 (1 Control) 
B. diffusa   1 - - 1 (1 Control) 
Bcc novel groups Bcc 8  1 1 - - 
Burkholderia species not Bcc (58 isolates) 
B.  gladioli 12 9 - 3 
B.  fungorum 3 3 - - 
B.  terricola 1 - - 1  (1 Control) 
B. kururiensis 1 - - 1(1 Control) 
B. mimosarum 1 - - 1 (1 Control) 
B. oklahomensis LMG23618 1 - - 1 (1 Control) 
B. phenazinium 1 - - 1 (1 Control) 
B. phenoliruptrix 1 - - 1 (1 Control) 
B. phymatum 1 - - 1 (1 Control) 
B. phytofirmans 1 - - 1 (1 Control) 
B. plantarii 1 - - 1 (1 Control) 
B. sacchari 1 - - 1 (1 Control) 
B. xenovorans 1 - - 1 (1 Control) 
B.  glathei 1 - - 1  (1 Control) 
B.  glumae 1 - - 1  (1 Control) 
B.  graminis 1 - - 1  (1 Control) 
B.  hospital 1 - - 1  (1 Control) 
    
 35 
a
 : Isolates from the natural environment. 
b
 : Isolates from cystic fibroses patient. 
c
 : Clinical isolates not from cystic fibroses patient.  
d : Fully identified isolates from the LMG BCCM (http://bccm.belspo.be/about/lmg.php).  
G+: Gram-positive bacteria. 
G-: Gram-negative bacteria. 
Control: Reference and type strains (LMG, ATCC or NCTC strains) 
Table 2 Continued 
B.  andropogonis 
1 - - 1 (1 Control) 
B.  caledonica 
1 - - 1 (1 Control) 
B.  caryophlli 
1 - - 1 (1 Control) 
B.  phenaziniumi 
1 - - 1 (1 Control) 
B.  tropica 
1 - - 1 (1 Control) 
B.  tuberum 
1 - - 1 (1 Control) 
B.  caribensis 1 - - 1 (1 Control) 
Unidentified not Bcc 
18 14 - 4 
Other G
+
 and G
-
 bacteria (24) 
Comments 
S. aureus NCTC12981 
Antibiotic reference strain 
S. aureus Eagles 
Multidrug resistance  strain  
S. aureus EMRSA15 
Multidrug resistance  strain  
S. aureus MRSA Mu50 
Multidrug resistance  strain  
B. multivorans ATCC17210 
 
B. cenocepacia LMG16656 
Multidrug resistance  strain 
P. aeruginosa NCTC12903 
Antibiotic reference strain 
P. fluorescens 
Multidrug resistance  strain 
P. putida LMG 2257 
 
P. stutzeri 
 
Pand. Apista 
 
Pand. pnomenusa 2 isolates 
 
R. mannitolytica 
 
E.  coli NCTC12241 
Antibiotic reference strain 
A. baumannii 
Multidrug resistance  strain 
A. xylosoxidans 
 
E. faecalis 
 
S. maltophilia 
 
microorganisms until suitable confluent growth had been obtained. For inoculation of 
liquid growth media and soft-agar overlays an inoculum suspension of fresh growth for 
each strain was prepared as follows: A few colonies of a freshly grown bacteria were 
inoculated aseptically into with 3 ml of a TSB medium (contained with a 15 ml tube) and 
incubated horizontally with shaking (New Brunswick; at 150 rpm) at 37ºC for 6 to 8 h. The 
liquid culture was then diluted to an optical density (OD) of 1 at 600 nm (corresponding to 
an approximate viable count of 1x10
8
 colony forming units per ml; cfu ml
-1
). Different 
amounts of these standard suspensions were then used to inoculate starter cultures or soft-
agars to reach the desired viable cell density appropriate for the assays described below.   
 
2.2.2 Fungi 
Candida albicans Sc 5314 (Table 2.3) was used as a reference strain to rapidly test the 
activity of antifungal agents produced by Burkholderia isolates. Pure cultures were 
maintained in cryogenic storage vials containing 1.5 ml TSB medium supplemented with 
8% DMSO as described above. A C. albicans inoculum culture was prepared as follows: 
one colony of freshly grown bacterial cells was mixed with 9 ml of a sterilized TSB 
medium (contained with a 50 ml tube) and incubated horizontally with shaking (150 rpm) 
at 37ºC for 24 h; the culture was then diluted to an optical density of 0.35 at 530 nm using 
spectrophotometer, 8% DMSO added and stored as 1 ml aliquots which could be thawed 
and used as standard inocula corresponding to a viability of approximately 4.7 x 10
6  
cfu 
ml
-1
.  
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Table 2.3 Wood decay basidiomycetes and ascomycete reference isolates used as an 
indication of Burkholderia antifungal activity. 
 
 
Fungal isolates 
 
Isolate code 
 
Characteristics 
 
Basidiomycete  isolates 
Hypholoma fasciculare HFGTWV2 Late coloniser, forms mycelial cords  
Hypholoma fasciculare HFDD2 Late coloniser,  forms mycelial cords 
Resinicium bicolor  Rbm6A Late coloniser,  forms mycelial cords 
Resinicium bicolor Rb1 Late coloniser,  forms mycelial cords 
Phanerochaete velutina  PV29 Late coloniser,  forms mycelial cords 
Phallus impudicus  PIJHYA Late coloniser,  forms mycelial cords 
Stereum gausapatum  Sa1 Primary coloniser  
Bjerkandera adusta  BK1 Secondary coloniser 
Trametes versicolor  D2 Secondary coloniser 
Heterobasidion annosum  SP313 Tree root pathogen and butt rot  
Ascomycete   isolate 
Candida albicans Sc 5314 Yeast, control strain 
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Ten representative species of cord-forming wood decay basidiomycetes fungi (Table 2.3) 
were provided by Prof. L. Boddy, Bioscience, Cardiff University. These fungi were used in 
this study to detect the activity of antifungal agents produced by Burkholderia isolates. A 
fungal inoculum was aseptically transferred to a tube containing slant of 2% MA medium 
and allowed to grow for 5 d at 20ºC, the stock cultures were then stored at 4ºC. For revival, 
the slant culture was removed from the 4ºC refrigerator and a small portion of fungal 
mycelium transferred with a sterile needle to a fresh 2% MA plate and incubated at 20ºC. 
 
2.3 Sampling and isolation of Bcc and other bacteria 
from natural environments 
Soil samples were collected from mixed deciduous woodland in the Coed Beddick, 
Tintern, U.K (coordinates 51.710690, -2.681351) in August 2009. Maize rhizosphere and 
soil samples were collected with permission from fields around Bridgend, Wales, UK 
(coordinates 51.513837,-3.645841) in July 2010. To remove unwanted materials, such as 
wood litter and big stones, samples were sieved (1.50 and 0.50 mm). 
 
Bacteria were cultivated from soil samples by adding 0.1 g of sieved soil to 700 µl of 
BSM-G media supplemented with cycloheximide (100 mg l
-1
), and polymyxin (400 µg l
-1
) 
(designated as BSM-CP), and gently homogenised by hand with a plunger that fitted the 
1.5 ml microtube in which the sample was placed. After heavy debris had been allowed to 
settle out, 200 µl of soil homogenate was added to 2 ml of BSM-CP in a 14 ml snap top 
tube and incubated horizontally (shaking at 150 rpm) at 30ºC for 24h, then 200 µl of each 
culture were transferred to a sterile micro-tube containing 16 µl DMSO (8%) and stored at 
-80ºC until use. To isolate bacteria from the maize rhizosphere, maize roots were 
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aseptically removed from each plant by cutting about 0.5 to 1 cm portion with a sterilized 
blade and placing them in a microtube. 
 
Each root section was then washed twice by gentle vortex mixing with sterilized distilled 
water (1 ml) to remove any loosely adhering soil particles. The washed root sections were 
placed in 700 µl of BSM-CP and gently homogenised with a plunger. After allowing the 
heavy debris to settle out, 200 µl of the root homogenate was added to 2 ml of BSM-CP 
contained in a 14 ml snap top tube and incubated horizontally with shaking (150 rpm) at 
30ºC for 24 h. After growth, 200 µl of each culture were transferred to a sterile micro-tube, 
DMSO added to 8%, and stored at -80ºC until use. 
 
The soil and root homogenate cultures were screened for antimicrobial phenotypes against 
a wide range of microorganisms as follows. BSM-G plates were inoculated in the center 
with 5 µl of each culture and incubated at 30ºC for 3 d. The microbial growth was killed by 
exposing the plates to chloroform vapour for 2.5 min by placing each plate, agar face down 
on a wire mesh approximately 0.5 cm from chloroform within in a Pyrex dish. After 
chloroform vapour killing, the plates were transferred to a laminar flow cabinet for 10 
minutes to remove residual chloroform by evaporation. Then, plates were overlaid with 
molten SISOA (45
o
C) seeded with approximately 1 x 10
6
 cfu ml
-1
 with a specific 
antimicrobial susceptibility testing micro-organism (C. albicans, B. multivorans or S. 
aureus). 2, 3, 5-triphenyltetrazolium chloride (TTC) was added to a final concentration of 
0.02% to the overlay agar as a metabolic stain to detect growth of the test organisms and 
aid visualisation of antibiotic inhibition zones. Soil or root homogenate cultures which 
showed antimicrobial activity in the above assays were plated to single colonies to enable 
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purification of each antimicrobial producing microorganism. Single colonies were then 
retested for antimicrobial activity using the overlay assay; pure positive isolates were 
identified using 16S rRNA gene sequence analysis (see section 2.8.2) and stored at -80ºC 
until use. 
 
2.4  Identification of isolated bacteria  
2.4.1 Isolation of genomic DNA 
Overnight cultures of Burkholderia and other bacteria used in the study were grown in 
TSB (3 ml cultures) to stationary phase (18 to 48 h dependent on the strain). Bacterial cells 
were harvested by centrifugation and then re-suspended in 100 µl TE buffer (10 mM Tris-
Cl pH 8; 10 mM EDTA, pH 8). The suspension was added to a 2 ml screw-cap micro-
centrifuge tube containing approximately 500 µl of 0.1 mm zirconium beads (Biospec 
products inc., Bartlesville) and 500 µl lysis buffer (50 mM Tris –Cl, pH 8; 70 mM EDTA, 
pH 8; 1% sodium dodecyl sulphate; 0.5 mg ml
-1 
pronase). Bacterial cell lysis was achieved 
by a 10 sec pulse on a bead-beater machine (Biospec Products; Bartlesville, Okla.) and the 
lysate then incubated for 1 h at 37ºC to allow protein digestion. The lysate was centrifuged 
briefly to reduce bubbles, 200 µl of saturated ammonium was added to precipitate protein 
matter, and the lysate was pulsed for 5 sec on the bead-beater machine. Chloroform (600 
µl) was added to the lysate and mixed by a 5 sec pulse on the bead- beater, a high speed 
centrifugation was then used to remove proteins and polysaccharides. Approximately 400 
µl of the cleaned lysate was transferred to a sterile HI-YIELD 1.5 ml microtube containing 
1 ml of 100% ice cold ethanol. After mixing, the tube was centrifuged for 7 min to collect 
the precipitated genomic DNA. The DNA pellet was washed with 500 µl of 70% ethanol 
and subjected to an additional centrifugation step to re-pellet the DNA. After removal of 
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all the ethanol the DNA pellet was dried under vacuum for 10 min and dissolved in TE-low 
EDTA buffer (10 mM Tris-Cl, pH 8; 0.1 mM EDTA, pH8) containing RNase A at 0.5 µg 
ml ml
-1
. After incubation at 37ºC for 1 h to degrade any RNA remaining, the genomic 
DNA was stored frozen at – 20ºC until use. 
 
To examine the quality and roughly estimate the quantity of the isolated DNA, 10 µl was 
loaded onto a 1.25% agarose gel (Bioline Ltd, London, UK) made with Tris-Borate-EDTA 
(TBE) buffer. The molten agarose was supplemented with Safe View dye (NBS 
Biologicals, Huntingdon; 2.5 µl Save View per 100 µl agarose gel) to enable the DNA to 
be subsequently vizualised under UV illumination. A DNA size ladder (10 µl of 1 kb 
molecular ladder; Newengland Biolabs UK.) was also loaded and then, electrophoresis 
performed at 100 volts for about 30 min in 1 x TBE buffer containing Safe View dye (2.5 
µl per 100 ml TBE). Then the agarose gel was viewed under UV light at 245 nm and 
images were taken using a gel documentation camera (Syngene Gene Snap, Cambridge 
UK). 
 
2.4.2 Bacterial 16S rRNA gene amplification and sequence 
analysis 
Pure bacterial cultures isolated from maize or forest soils were identified using 16S rRNA 
gene sequence analysis. Primers 27F (5'- AGA GTT TGA TC TGG CTC AG -3') and 
1492R (5'- GGT TAC CTT GTT ACG ACT T -3') were used to amplify 16S rRNA gene as 
follows: The total volume of each reaction was 25 µl and contained: 10 to 40 ng of 
genomic DNA (2 µl of the concentrated stock solutions that had been diluted tenfold), 13.8 
µl sterile nuclease free H2O, 2.5 µl 10 x Coralload buffer, 5 µl 5 x Q-Solution, 0.5 µl 10 
mM dNTPs, 0.5 µl of each primer (4 pmol µl
 -1
 final concentration) and 0.2 µl (1 unit) Taq  
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DNA polymerase (Qiagen Ltd., Carwley, UK). PCR was carried out in a DNA Engine 
Dyad Thermal cycler gradient block (MJ Research, Boston, MA) for 2.5 h with the thermal 
cycle as described in Table 2.4. PCR products were evaluated by agarose gel 
electrophoresis as described above except that 1.5% agarose was used. Pure 16S rRNA 
gene products were sequenced using primers 27F and 1492R with the Applied Biosystems 
Big Dye Terminator ready reaction mix version 3.1 followed by analysis on an Applied 
Biosystems ABI-Prism 3100 automated sequencer. The identity of each isolate was 
determined by submitting the resultant 16S rRNA gene sequence to the Basic Local 
Alignment Search Tool (BLAST) at the National Centre for Biotechnological Information 
(NCBI; http://www.ncbi.nlm .nih.gov/) and searching for the closest matches. 
 
 
 
Table  2.4 PCR cycles for 16S rRNA gene amplification. 
 
 
Step Temp. Cº Time  Nº cycles 
1. Initial DNA denaturation 95 00.02.00 1 
2. DNA denaturation 94 00.00.30  
35 
3. Primer annealing  52 00.00.30 
4. Primer extension 72 00.01.30 
5. Indefinite hold 72 00.05.00 1 
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2.5  Antimicrobial testing 
2.5.1 Screening of antimicrobial activity using agar overlay 
assay 
To test the ability of Burkholderia isolates to produce antimicrobial agents, a 3 µl drop of 
each Burkholderia frozen inoculum culture (approximately 1 x 10
8
 cfu ml
-1
) was spotted 
onto the centre of two different media (SA or BSM-G) and incubated at 30ºC for 3 d. The 
bacterial growth was chloroform vapour killed as described above (section 2.3) and an 
overlay agar assay was used as a rapid technique to detect which Burkholderia isolates 
were antimicrobial producers (Figure 2.1). To prepare overlay media, 100 ml of molten 
SISOA (45ºC) was aseptically seeded with the susceptibility testing organisms C. albicans 
(500 µl of stock to give approximately 1 x 10
6
 cfu ml
-1 
of SISOA), or S. aureus (500 µl of 
stock to give approximately 1 x 10
6
 cfu ml
-1 
of SISOA), or B. multivorans (100 µl of stock 
to give approximately 2 x 10
5
 cfu ml
-1 
of SISOA). The growth indicator 2,3,5-
triphenyltetrazolium chloride was also added to the SISOA to a final concentration of 
0.02%, to aid visualisation of any resultant zones of clearing. Approximately 15 ml of the 
overlay culture was poured onto the surface of each Burkholderia colony. After allowing 
the soft agar to set at room temperature, the plates were incubated at 37ºC for 18 h. The 
antimicrobial activity was revealed by the presence of a zone of clearing, where the 
susceptibility testing microorganism failed to grow. The diameter of the zone of inhibition 
was measured (mm) and all assays completed in triplicate to allow estimation of the mean 
and standard error of the mean (SEM). 
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Figure 2.1 C. albicans overlay set-up to detect anti-candidal agents produced by B. 
ambifaria BCF. 
Bacterial suspensions was spotted onto the center of BSM-G plate and incubated at 30C for 3 days. The 
Burkholderia strain was killed by exposing to chloroform vapour then the plate was overlaid with Soft 
Isosensitest agar seeded with C. albicans. After incubation at 37C for 24 h, the anti-candidal activity of 
strain BCF is clearly visible as a clear zone on the red background of Candida cells which have grown and 
reduced the tetrazolium chloride metabolic indicator. 
 
 
 
 
 
 
 
 
B. ambifaria BCF 
Inhibition zone  
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2.5.2 Screening of anti-basidiomycete agents  
To test the ability of Burkholderia isolates to produce anti-basidiomycetes agents, two 
different methods were used: the contact antagonism assay and a developed basidiomycete 
overlay assay. 
 
2.5.2.1 Contact antagonism assay 
The agar contact antagonism assay was used to detect the antagonistic ability of 
Burkholderia isolates against the model cord-forming wood decay fungus Bjerkandera 
adusta BK1 (BK1).  A 3 µl drop of each Burkholderia inoculum (see section 2.5.1) was 
spotted onto one of four points on the SA plates as shown in Figure 2.2. The plates were 
incubated at 30ºC for 48 h to allow secretion of secondary metabolites by Burkholderia, 
then the plates were inoculated with a 5 mm agar plug of BK1 grown for 7 d on malt agar 
plates. Control plates of BK1 were also prepared. The plates were incubated for 7 d at 25ºC 
to allow interaction between BK1 and Burkholderia metabolites. The results were scored 
by comparison to BK1 control plates, noting whether there had been the following 
Burkholderia effect on growth of the fungal hyphae: no inhibition (-), weak inhibition (+, 
0.1 cm to 0.5 cm antagonism of BK1 growth), medium inhibition (++, 0.5 cm to 1 cm 
antagonism of BK1 growth) or strong inhibition (+++, 1 cm to 2 cm antagonism of BK1 
growth). 
 
2.5.2.2 Basidiomycete agar overlay assay 
Due to the filamentous nature of fungi it is difficult to obtain separated cells which can be 
used to evenly inoculate basidiomycetes onto media; the following methods involving  
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            (A)                     (B) 
 
 
Figure 2.2  Interaction set-up of Burkholderia isolates and Bjerkandera adusta BK1 
using contact antagonism assay. 
(A) Burkholderia isolates were inoculated, 2 cm from the edge of the SA plate. After incubation at 30C for 2 
days, the plate was centrally inoculated with a 5 mm agar plug of B. adusta BK1 and incubated for 7 d at 
25C. The results were measured by comparison to a B. adusta control plate without any Burkholderia. (B) 
The resulting anti-B. adusta BK1activity is shown for B. ambifaria AMMD, BCF, Kc311 and B. 
vietnamiensis Jw13. 
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mechanical shearing of fungal mycelia to produce an even viable suspension for 
inoculation into an overlay agar was developed. Wood decay basidiomycetes (Table 2.2) 
were grown by inoculating 5 mm agar plugs for 7 d at 25°C on 2% MA plates. Superficial 
growth of fungal mycelia of each species was collected from the agar surface using a 
sterile blade. Approximately, 250 mg of each mycelium scraped and homogenized in a 2 
ml tube, containing 1 ml of sterilized 2% MB and 500 mg of 0.25 mm sterilised zirconium 
beads (Biospec products inc., Bartlesville), using bead-beater machine for 30 sec at 25 
rpm. Aliquots of this homogenised mycelial inoculum were kept at -20ºC until use. Fungal 
inocula were revived by re-culturing fragmented mycelial suspensions in 25 ml of 2% MB 
in 250 ml conical flask, and incubating at 25°C for 2 d at 150 rpm. Then 3 ml of 
fragmented mycelial suspension was mixed with 25 ml of 2% MA and overlaid on the top 
Burkholderia antibiotic production screen plates as described above (section 2.5.1); plates 
were then incubated at 25°C for 4 days to allow basidiomycete growth. The anti-
basidiomycete activity of Burkholderia isolates was determined by measuring the diameter 
(mm) of the mycelial clearing zone.  
 
2.5.3 Determination of antimicrobial activity using broth 
microdilution method 
To determine the minimal inhibitory concentrations (MIC) of crude and semi-purified 
Burkholderia antimicrobial extracts the following was carried out (Sass, et al., 2011). The 
antimicrobial extracts were maintained in methanol, however, to avoid issues with the 
inhibitory effect of the methanol solvent, the extracts were dried using a rotary film 
evaporator, the dry weight of the material was determined and then dissolved in sterilized 
Muller Hinton broth (MHB). A 96-well plastic micro-plate (Sterilin, UK) was then used 
for the microdilution assay as follows. The total volume of culture in each well was 200 µl. 
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Serial dilutions of the antimicrobial extracts were performed in the test set of wells by 
mixing of 50 µl of MHB with 50 µl of the antimicrobial in MHB; control wells without 
antibiotic just contained 100 µl of MHB. The susceptibility testing microorganisms (100 µl 
in MHB; diluted from a fresh overnight culture that was standardized by optical density to 
1.0 at 600 nm) were then added to each well to give a final inoculum of 1 x 10
6
 cfu ml
-1
. 
Then, 96-well plates were incubated with shaking (150 rpm) at 37ºC for 24 h. Microbial 
growth was quantified by measuring optical density at 600 nm using an automatic plate 
reader. The MIC value was identified as the lowest concentration of the antimicrobial 
extract which reduced the optical density to 80% of that of the control cultures; all MIC 
values were confirmed using triplicate wells. 
 
2.6  Selection of suitable media for both growth and 
antifungal production 
The growth of ten wood decay fungi (Table 2.3) was examined on seven different selected 
media (SA, PDA, MA, BSM-G, TSA, ISOA and MHA; Table 2.1). Each agar plate was 
inoculated at the centre by placing a 5 mm fungal colonized agar plug (from a 7 day 
culture grown on 2% MA) upside down in the centre of the plate. The plates were 
incubated at 25ºC and the radial extension (mm) was measured at 3, 5, 7, 9 and 11 d, 
extension rate was determined by linear regression. 
 
Four Bcc isolates, B. ambifaria AMMD, BCF & Kc311 and B. vietnamiensis Jw13 known 
to produce antimicrobial agents were also tested for production of anti-candidal agents on 
the same media used to evaluate optimal growth of the wood decay fungi (SA, PDA, MA, 
BSM-G, CMA and MHA; Table 2.1). An antimicrobial production and overlay assay was 
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performed on each growth medium essentially as described in section 2.5.1. Briefly, a 3 µl 
drop of each isolate inoculum was spotted onto the centre or laterals of each agar plate and 
incubated at 30ºC for 3 d, bacteria were killed by exposure of the plates to chloroform 
vapour. After chloroform killing followed by aeration of the plates in a laminar flow 
cabinet, each plate was overlaid with either C. albicans, S. aureus or B. multivorans and 
incubated at 37ºC for 18 h. The production of anti-microbial agents was determined by the 
presence of a clearing zone surrounding the Burkholderia colony.  
 
2.7 Effects of different factors on anti-candidal activity of 
Burkholderia  
2.7.1 Effects of carbon, nitrogen, phosphate and 
temperature  
To study the effect of carbon sources at different concentrations on anti-candidal activity 
of Burkholderia, the following carbon sources were evaluated in BSM at different 
concentrations (0, 10, 20, 40, 60 & 80 mM): glucose, glycerol, arabinose, fructose, 
galactose, sucrose, lactose, maltose, ribose, succinate and starch. Stock solutions of each 
carbon source were made and sterilised by autoclaving; this was then added aseptically to 
autoclaved, molten BSM agar made without any carbon source. 
 
To determine the optimal conditions for anti-candidal activity of Burkholderia, seven 
different nitrogen sources were tested: beef extract (3g l
-1
), yeast extract (0.5 g l
-1
), peptone 
(2 g l
-1
), urea (2 g l
-1
), ammonium sulphate (4.89 g l
-1
), ammonium chloride (2 g l
-1
) and 
potassium nitrate (3.47 g l
-1
). Three phosphate sources; dibasic potassium phosphate 
sodium phosphate and calcium phosphate at 1, 10, 40 and 80 mM were compared. HEPES 
(C8H18N2O4S) at 20 mM was used as buffer solution to maintain culture pH at 7.20. Seven 
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growth temperatures (10, 15, 20, 25, 30, 35 and 40C) and four points of incubation (24, 
72, 120 and 168 h) were evaluated. 
  
To test all the growth parameter variables a standard antimicrobial production and overlay 
assay was performed (section 2.5.1), except that after growth of the Bcc isolates, the cells 
were harvested by centrifugation and resuspended in 3 ml of sterilised distilled water, prior 
to inoculation of each plate. 
 
2.7.2 Effects of pH on growth rate and production of anti-
candidal agents  
To evaluate the effect of different pH of BSM-G and ISOB media on anti-candidal activity 
of Burkholderia and growth of B. adusta and C. albicans, the pH of the media was 
adjusted using 0.1 M HCl or 0.1 M NaOH as required to produce the following range 3.5, 
4.0, 4.5, 5.0, 5.5, 6.0, 6.5, 7.0, 7.5 and 8.0. TSA, SA agar, TSB and SA broth (all at pH 7) 
were used as control media. For each test a 3 µl drop of B. ambifaria AMMD, BCF, JW13 
and B. vietnamiensis Kc311 was spotted onto the centre of each BSM-G plates and 
incubated at 30ºC for 3 d. The effect of pH was evaluated using a C. albicans agar overlay 
assay as described in section 2.5.1. A control overlay with C. albicans was performed on 
all pH adjusted media to ensure the growth of this test organism was unaffected. 
 
To examine the effect of pH on the secretion of Burkholderia antifungal active metabolites 
on the biosidiomycete, B. adusta BK1, its extension rate on BSM-G medium was 
determined at a range pH (pH 3.5 – 8.00). Each agar plate was inoculated at the centre with 
a 5 mm BK1 colonized agar plug (as described in section 2.6) and the plates incubated in 
the dark at 25ºC. The mycelial radius was measured (mm) after 1, 2, 3, 4, 5 and 6 d. 
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An automated microbial growth analyser, the Bioscreen C Microbiological Growth 
analyser (Lab systems, Finland) was used to monitor effects of different pH (range 3.5 - 8) 
on growth ability of C. albicans in a micro-well growth assay. ISOB medium (100 µl at 
different pH) and 100 l of C. albicans inoculum (1 x 106 cfu ml -1 in ISOB) was added to 
each well of the 100-well Bioscreen plate. Plates were incubated in Bioscreen C 
bioanalyzer at 37C, shaking 10 sec before the optical density was sampled every 5 min for 
up to 24 h, using wide range of fluorescence reader (optical density between 420-580 nm). 
The mean of 5 replicates was determined for each cultivation pH and plotted as a growth 
curve using Excel. 
 
2.7.3 Time course of production and activity of anti-candidal 
agents by B. ambifaria AMMD 
Changes in bacterial growth, culture pH and anti-candidal production over time were 
studied using BSM-G broth medium supplemented with glycerol (4 g l
-1
). The pH was 
adjusted to pH 6 before autoclaving, and confirmed as the same after autoclaving. Each 
250 ml flask contained 100 ml of BSM-G medium plus 50 l of B. ambifaria AMMD as a 
standardised inoculum (Approximately 5 x 10
6
 cfu ml
-1
). The flasks were incubated 
statically and in shaker incubator at 30ºC.  At 6, 14, 26, 38, 50, 74, 98, 122, 146 and 170 h 
mean bacterial growth (turbidity, using spectrophotometer at 630 nm) was determined 
from 3 replicates. Also, at each time point antimicrobial compounds were extracted and 
these activities were determined as follows. The bacterial culture was centrifuged for 10 
min and the pH of the culture was determined by measuring the cleared supernatant. 
Bacterial secondary metabolites were then extracted from the supernatant using XAD16 
resin as described below (see section 2.9.2). The B. ambifaria extracts were run on TLC 
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plates and overlaid with C. albicans to detect their B. ambifaria antifungal profile over 
time (section 2.10). BSM-G medium (without a bacterial inoculum) was used (6, 26 and 74 
h time point) alongside the treatments as a control. 
 
2.8  Transposon mutagenesis 
2.8.1 Screening B. ambifaria AMMD Tn5 transposon mutant 
bank  
A bank of 2500 B. ambifaria AMMD miniTn5-Km2 transposon mutants was created 
(Mahenthiralingam, et al., 2011) and screened for mutants which lack anti-candidal 
activity as follows. BSM-G plates containing the antibiotic kanamycin (50 µg ml
-1
) were 
spotted with AMMD mutants over an eight point grid using a sterile toothpick; they were 
then incubated for 72 h at 30ºC. The bacterial growth was killed using chloroform and 
overlaid with soft Isosensitest agar seeded with C. albicans as described in section 2.5.1. 
The plates were incubated for 24 h at 37ºC and mutants which demonstrated alteration in 
their ability to produce anti-candidal agents noted. Individual mutants of interest were 
replated from the master bank of mutants that had been stored frozen as 96-well plate 
cultures. Each mutant was retested twice to confirm stability of their anti-candidal 
phenotype. Stable mutants were stored as TSB cultures supplemented with 8% DMSO at – 
80ºC until use. 
 
2.8.2 Random amplified polymorphic DNA protocol (RAPD-
PCR) 
A RAPD-PCR fingerprinting protocol was performed as described by Mahenthiralingam, 
et al., (1996) to test whether each of the above transposon mutants was a derivative of B. 
ambifaria AMMD and not a contaminant that may have appeared during screening of the 
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mutant bank. The volume of each PCR was 25 µl and contained: 2 µl of genomic DNA 
(approximately 10 to 40 ng), 10.3 µl sterile nuclease free H2O, 2.5 µl 10X Coralload 
buffer, 5 µl 5X Q-Solution, 1.5 MgCl2, 0.5 µl 10 mM dNTPs, 4 µl primer 270 (5'- TGC 
GCG CGG G -3', 10 pmol µl
 -1
) or primer 272 (5'- AGC GGG CCA A -3', 10 pmol µl
 -1
) 
and Taq DNA polymerase (Qiagen Ltd., Carwley, UK). The PCR was carried out in 0.5 ml 
HI-YIELD micro tubes using a Flexigene thermal cycler (Techne Ltd., Newcastle, UK) as 
described in Table 2.5. 12 µl RAPD-PCR products of each sample were loaded to 2 % gel 
electrophoresis agarose gel, then run alongside 10 µl of 1 kb molecular ladder in 1X TBE 
buffer at 80 volts for 3 h. The gel was then stained with Save view (SYBR safe DNA gel 
stain, Invitrogen, Eugene, Oregon, USA), and visualised under UV light and images were 
taken using Gene Snap system. 
 
2.8.3 Sequencing of Tn5 transposon mutant using PCR to 
detect transposon insertion site 
PCR followed by DNA sequence analysis was used to determine the transposon insertion 
site in B. ambifaria AMMD genome as described by O‟Sullivan, et al., 2007. DNA 
adjacent to the Tn5 insertion was amplified using a two-step of PCR reaction protocol 
(PCR1 and PCR2) and 4 different primers: PCR1: Primer 1: 5'- TTT TTA CAC TGA ATG 
TTC CG-3', Primer 2b: 5'- GGC CAC GCG TCG ACT AGT CAN NNN NNN NNN ACG 
CC-3', PCR2: Primer3: 5'- CGG ATT ACA GCC GGA TCC CCG-3' and Primer 4: 5'- 
GGC CAC GCG TCG ACT AGT AC-3'. 
 
PCR 1 (including primers 1 & 2b) amplified the end of the transposon and adjacent 
chromosomal DNA to give sequences of variable lengths due to the random priming of 
primer 2b at genomic sites flanking the transposon. The volume of PCR1 reaction was 20 
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µl containing 1 µl genomic DNA (10 to 40 ng), 2.9 µl sterile nuclease free H2O, 2 µl 10X 
buffer, 4 µl 5X Q- solution, 1.2 µl MgCl2, 0.4 µl 10 mM dNTPs mixture, 1 µl primer 1 (20 
pmol µl
-1
), 1 µl primer 2b (20 pmol µl
-1
) and 0.2 µl Taq DNA polymerase. PCR was 
carried out in 0.2 ml non-stick micro-tubes using a DNA Engine Dyad Thermal cycler 
gradient block (MJ Research, Boston, MA) as described in Table 2.6.  
 
Table  2.5 PCR cycles for RAPD-PCR. 
 
 
Table  2.6 PCR cycles for PCRI of transposon mutant mapping. 
Step Temp. Cº Time (min.) Nº cycles 
1. DNA denaturation 94 5  
4 
2. Primer annealing  36 5 
3. Primer extension 72 5 
4. DNA denaturation 94 1  
30 
5. Primer annealing 36 1 
6. Primer extension 72 2 
7. Final extension 72 6 1 
8. Indefinite hold 4 0 0 
Step Temp. Cº Time  Nº cycles 
1. Initial DNA denaturation 95 00.05.00 1 
2. DNA denaturation 94 00.00.30  
8 
3. Primer annealing  30 00.00.35 
4. Primer extension 72 00.00.45 
5. Initial DNA denaturation 95 00.05.00 1 
6. DNA denaturation 94 00.00.30  
30 
7. Primer annealing 30 00.00.35 
8. Primer extension 72 00.00.45 
9. Indefinite hold 4 0 0 
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Products of PCR1 were further amplified using primers 3 and 4 in round PCR2 as follows. 
The volume of the PCR2 reaction was 50 µl containing: 2.5 µl PCR1 final product, 5 µl 
10X PCR buffer, 10 µl 5X Q- solution, 3 µl MgCl2, 0.4 µl 10 mM dNTPs mixture, 2.5 µl 
primer 3 (20 pmol µl
-1
), 2.5 µl primer 4 (20 pmol µl
-1
) and 0.5 µl Taq DNA polymerase 
(all PCR reagents from Qiagen Ltd. Carwley, UK). PCR processes were carried out in 0.2 
ml non-stick micro-tubes using a DNA Engine Dyad Thermal cycler gradient block (MJ 
Research, Boston, MA) as described in Table 2.7. PCR2 products were purified using 
QIAquick PCR Purification Kit (Qiagen Ltd), then 10 µl  of purified PCR2 products were 
loaded in 2% agarose gel supplemented with safe view dye (2.5 µl / 100 µl gel) and run 
alongside 10 µl 1-kb molecular ladder. Gel electrophoresis was run at 80 volts in 1X TBE 
buffer containing save view dye (2.5 µl / 100 ml TBE) then the gel was visualised under 
UV light and images were taken using Gene Snap system. PCR2 products (<13 ng µl
-1
) 
and primer 3 (1.6 pmol µl
-1
) were sequenced, and the identities of putative genes that were 
disrupted by transposon insertion were identified using the B. ambifaria AMMD genome 
(http://www.Burkholderia.com) and BLASTN tool. 
 
Table  2.7 PCR cycles for PCRII of transposon mutant mapping 
Step Temp. Cº Time  Nº cycles 
1. Initial DNA denaturation 95 00.02.00 1 
2. DNA denaturation 94 00.00.30  
30 
3. Primer annealing  42 00.00.35 
4. Primer extension 72 00.00.45 
5. Final extension 72 00.05.00 1 
6. Indefinite hold 4 0 0 
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2.9 Extraction of antimicrobial agents, storage and 
maintenance 
Antimicrobial agents of Bcc bacteria were extracted in two different ways: Amberlite 
XAD16 resin extraction and direct extraction. 
 
2.9.1 Maceration (Direct) extraction  
 Burkholderia isolates were inoculated as strips of culture across the agar plates using a 
sterile cotton swab (1 to 3 strips per plate) then incubated at 30C for 72 h and the bacterial 
growth was cut and removed from each plate using a clean scalpel blade. The remaining 
agar was frozen at -80ºC and then placed in a freeze dryer for 72 h until the agar had 
completely dried into thin films. The dried agar was ground to fine particles using a coffee 
grinder. The agar particles were then extracted in 80% methanol (HPLC grade) at ratio 8 g 
agar per 45 ml 80% MeOH; extractions were performed in 50 ml conical tubes and were 
left mixing on a rocking platform at room temperature  (approximately 20 ± 2ºC) for 3 h. 
After extraction the tubes were centrifuged for 10 min, the supernatant was removed and 
the extract was concentrated using a rotary evaporator (Buchi, Flawil, Switzerland) at 30ºC 
until the volume of the extract reduced approximately 10 times. Concentrated extracts were 
stored into micro-tubes at -20ºC until use. 
 
2.9.2 Resin extraction  
Amberlite, a neutral cross-linked polystyrene resin that adsorbs erythromycin from 
solution (Ribeiro & Ribeiro, 2003) was also used as a means to purify secreted antibiotics 
from agar and broth cultures of Burkholderia as follows: strips of Burkholderia growth 
were inoculated onto each plate (3 to 5 strips across the agar) and left to grow for the 
desired length of time at a specific growth temperature (see results 4.3.1 for conditions 
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tested). A total of 12 plates were used for standard extractions. To extract the antifungal 
components from the agar, the bacterial growth was removed by swapping with a spatula 
and the remaining treated with chloroform vapour. The agar was then cut into 0.5 cm 
blocks using a clean scalpel blade and placed into a large beaker. For every 100 g agar, 500 
ml polished water was added and the mixture was stirred for 1 h at room temperature. The 
mixture was then filtered to remove agar blocks and Amberlite XAD16 resin was added to 
the aqueous extract (5 g /100ml) and stirred for 2 h at room temperature to allow 
antibiotics to bind to the resin. The resin was then allowed to settle out and the supernatant 
discarded; the resin was rinsed with 1 l of polished water. A resin column was prepared by 
inserting a loose glass wool plug into the bottom of a glass column (60 mm long x 25 mm 
diameter) and the resin slurry was poured into the column; compressed air was used to 
remove water residues from the resin supernatant mixture. To elute the Burkholderia 
metabolites from resin, 100% methanol was used (3ml methanol/1g of resin). The extracts 
were concentrated by evaporation of the methanol using a rotary evaporator machine at 
30ºC until dry; after weighing of the dried extracts, they were dissolved in methanol 
(normally at concentration of 10 mg ml
-1
) and stored in micro-tubes at -20ºC until use. 
 
To extract Burkholderia antibiotics from liquid cultures, the Amberlite resin procedure was 
modified as follows. Liquid cultures (normally 100 ml) were inoculated and incubated 
under different growth conditions as required. After growth, the bacteria were removed by 
centrifugation (Beckman Coutere centrifuge, Sorvall Avanti J-E). The Amberlite resin was 
then added to the cleared supernatant and processed to extract the antimicrobials exactly as 
described above for the agar plate cultures. 
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2.10 Thin layer chromatography and bioautography assay 
2.10.1 Thin layer chromatography 
Thin layer chromatography (TLC) was carried out to fractionate compound(s) in 
Burkholderia secondary metabolite extracts; a bioautography assay was developed to 
detect any bioactive compounds in this mixture. Two different types of TLC plate were 
used: 20 x 20 cm pre-coated 25 µm Silica Gel 60 plates (Sigma, catalogue no. 5715; 
Merck) and 20 x 20 cm pre-coated 25 µm Silica Gel 60 plates with fluorescent indicator 
UV 254 (Sigma, catalogue no. 5715; Merck); both plate types were activated by heating at 
100°C for 60 min. 5 µl  of Burkholderia extracts (10 mg ml
-1
) were spotted onto the TLC 
plates 2 cm from the base across a horizontal baseline and at least 2 cm apart; a maximum 
of 8 extracts were evaluated on any 20 cm plate and replicate plates were frequently set up 
to enable bioactivity testing with multiple test species. Different solvents (single and 
mixture solvents with different polarities) were tested to generate the best possible 
fractionation profile of Bcc secondary metabolites. The plates were developed vertically in 
a glass chromatography tank containing 200 ml of solvent until the solvent front reached 
the top of the TLC plate, 2 cm from top edge. 
 
Several visualisation techniques were used to monitor developed TLC plates. The 
developed TLC plates were allowed to dry and freeing of solvent. The first visualisation 
technique was iodination. Iodination was carried out by placing a dried developed TLC 
plate in a chamber containing iodine crystals for few minutes, which led to oxidization of 
the substances making their presence visible. The second visualisation technique used a 
different chemical solution (0.1% Anisaldehyde–sulfuric acid, 0.2% Ninhydrin, 0.5% 
Vanillin-Phosphoric acid, or 25% sulphuric acid). In this method the dried developed TLC 
plates were sprayed with a freshly prepared solution for 15 min then placed in a 100ºC 
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oven for 30 min to 1 h, in contact with the substances a visualisation solution exhibited a 
coloured spots of extract constituents. The third visualisation technique used UV radiation 
at two different wave lengths (254 and 366 nm); normal and fluorescent TLC plates were 
visualized under UV light by placing the silica gel side in front of the UV source, which 
provided a rapid and straightforward screen to identify the majority of compounds. Pure 
pyrrolnitrin antibiotic (3-Chloro-4-[3-chloro-2-nitrophenyl]-pyrrole; Sigma, P8861) was 
used as a positive reference compound against new active compounds. Extracts of growth 
media (BSM-G media and SA extracts) incubated without Burkholderia isolates were used 
as a negative controls. The distances travelled by visualized or active compounds relative 
to the solvent front were determined as a retention time (Rf). Developed plates were 
photographed using a digital camera (Sony DSC-W5). 
 
2.10.2 Bioautography 
To reveal the presence of bioactive Burkholderia secondary metabolites, the following test 
organisms were overlaid onto the TLC plates: Gram-negative bacteria (E. coli NCTC 
12241, B. multivorans ATCC17210, B. cenocepacia LMG16656, P. aeruginosa 
NCTC12903, P. putida LMG 2257, P. fluorescens, S. maltophilia, A. baumannii and E. 
faecalis), Gram-positive bacteria (Staphylococcus aureus NCTC12981, other multidrug 
resistance S. aureus Eagles, S. aureus EMRSA15, and S. aureus MRSA Mu50), an 
ascomycete fungus (C. albicans) and basidiomycetes fungi (H. fasciculare, P. impudicus, 
B. adusta, S. gausapatum, T. versicolor, R. bicolor and P. velutina). Burkholderia extracts 
were applied to 20 x 20 cm TLC plates (0.25 mm silica gel–plate) as described above and 
fractionated in a glass chromatography tank containing 200 ml of ethyl acetate-methanol-
water (EtOAc-MeOH- H2O; 20:1:0.5). One set of TLC plates was developed chemically or 
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photographed under UV for use as the reference chromatogram; the remaining replicate 
plates were set aside for the bioassay work as follows.  
 
The TLC plate was placed into a sterile 24 x 24 cm square Bioassay dishes (Sterilin, UK). 
The test organism (Candida and all bacteria) was inoculated into molten SISO agar (cooled 
to 45
o
C) with 2,3,5-triphenyltetrazolium chloride (TTC) added to 0.02% to assist with 
visualisation of microbial growth. After mixing, the molten agar was poured (75 ml/ plate) 
carefully over the TLC plate starting in the centre and then moving evenly across the entire 
plate. After solidification, the TLC-bioautographic plate was incubated for 3 h at room 
temperature to allow metabolites in the TLC plate to diffuse into the agar; the bioassay 
plate was then incubated for 24 h at 37C to allow microbial growth. Clear zones on the 
red background of microbial growth revealed the presence of antimicrobial compounds. 
Growth inhibition areas were compared with the Rf of the related spots on the reference 
TLC plate and all plates were photographed under white light using a digital camera. 
 
In the case of the basidiomycete overlay assay, the developed TLC plate was overlaid with 
soft SA agar (0.75% agar) seeded with the fragmented mycelia of each fungus (see section 
2.5.2.2) and the plates were then incubated at 20C for 4 d. To help visualize fungal growth 
the plates were covered with 2 ml of 2% TTC. Anti-basidiomycete activity was detected as 
a clear zone on the red background of basidiomycete mycelia growth.  
 
2.11 Purification of active metabolites of Burkholderia  
To increase the purity of Burkholderia extracts available for further biological and 
chemical analysis, a wide range of separation techniques including liquid fractionation, 
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silica gel preparative thin layer chromatography and silica gel column chromatography 
were used.  Active fractions obtained from these preparative methods were tested on the 
bioassay as described above with C. albicans used as the main test organism. The 
following extraction methods were used.  
 
2.11.1 Liquid-liquid fractionation  
A liquid-liquid solvent partition method was used to further extract the Burkholderia 
Amberlite resin mixtures. A dry crude methanol extract (approximately 2.5 g) of B. 
ambifaria AMMD was dissolved in 50 ml of distilled water and successively partitioned 
three times with a range of solvents (50 ml of solvent for each extraction). A fractionation 
scheme was employed as shown in Figure 2.3. Each fractionation involved hand-mixing of 
aqueous crude extract in the respective solvent followed by soaking at 25ºC for 15 min. 
  
The aqueous crude extract and the various solvent fractions (diethyl ether fraction [DEF], 
chloroform fraction [CHF], dichloromethane fraction [DHF], acetone fraction [ACF], ethyl 
acetate fraction [EAF] and water fraction [WF]) were filtered through Whitman no.1 filter 
paper. The fractions were dried using a rotary evaporator machine at 30ºC. The dry weight 
yield of each extract and its fractions was measured before storage at -20ºC prior to further 
analysis. 
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Figure 2.3 Scheme for fractionation of B. ambifaria AMMD antimicrobial extracts. 
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2.11.2 Preparative silica gel TLC plates 
Dried extracts of B. ambifaria AMMD, BCF, KW and Mex-5 that had antimicrobial 
activity were re-dissolved separately in methanol and subjected to preparative TLC on 500, 
and 1500 µm Silica Gel 60 plates (Sigma, catalogue no. 5715; Merck). After inoculation of 
the extracts the mixture were fractionated with EtOAc-MeOH-H2O (20:1:0.5). The 
location (Rf) of active constituents of each extract was detected directly on a replica TLC 
plate which was subsequently subjected to bioassay with the C. albicans. The preparative 
TLC plates were divided into 7 to 16 horizontal zones depending on the number of 
detectable active compounds after fractionation. Each zone was scraped off the plate and 
the constituents re-extracted from the silica gel using absolute MeOH. The resulting 
fractions were evaporated to dryness in rotary evaporator at 30ºC and retested for activity 
against C. albicans using agar diffusion assay on TLC plates to confirm their bioactivity 
after fractionation. The semi-purified extracts were kept at -20ºC for further analysis. 
 
2.11.3 Column chromatography 
Dried B. ambifaria AMMD aqueous extract (3 g) was re-dissolved in ethyl acetate and 
applied to a column chromatograph (5 x 50 cm) that had been packed with silica gel (70-
230 mesh, 40 Å)  and previously equilibrated with ethyl acetate methanol: water (EtOAc-
MeOH-H2O) 20:1:0.5v/v. The column was eluted 300 ml of EtOAc-MeOH-H2O to 
produce 59 fractions (5 ml/fractions), then the column was eluted with 50 ml of absolute 
methanol to produce 4 fractions of AMMD extract. The different fractions eluting from the 
column were concentrated by evaporation of the solvent using a rotary evaporator machine 
at 30ºC, and re-tested for activity using pre-coated 25 µm Silica Gel 60 plates and overlaid 
with C. albicans to detect active fractions. Semi pure extracts were merged and kept at      
–20ºC for further analysis. 
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2.12 Identification bioactive compounds of Burkholderia  
2.12.1 Using reversed phase liquid-chromatography-mass 
spectroscopy (RP-LC-MS) 
High performance Liquid Chromatography (LC) coupled with Mass spectrometry (LC-
MS) provides highly detailed information about product ions and is one of the most rapid 
sensitive methods for the detection and putative identification of bioactive organic 
compounds. Active Bcc fractions isolated as described above were chemically analysed 
and identified using Reversed Phase-Liquid chromatography-mass spectroscopy (RP-LC-
MS) that was collaboratively performed by Dr. Lijiang Song (University of Warwick, 
Coventry, UK). LC performed on trial and error challenge was needed to optimize the best 
conditions of extraction, fractionation and visualization. 
 
A Dionex 3000RS with a Sigma Sulpeco Accentis Express column (C18, size: 150 x 
2.1mm, particle size: 2.7um) was used with the following mobile phases: A: H2O with 
0.1% formic acid; B: MeOH with 0.1% formic acid (a gradient from 0 to 20 min was run 
from 20% solvent A to 100% solvent B). The UV spectra of bioactive Burkholderia 
compounds were compared with retention times of UV spectral data library of antibiotics 
and natural products to identify matches to known compounds. To provide further 
information on the structure of the Burkholderia antimicrobials, Nuclear Magnetic 
Resonance (NMR) spectroscopy was performed collaboratively on the RP-LC-MS 
fractions by Dr. Song using a Bruker 700 MHz NMR spectrometer. 
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2.12.2 Detection of the presence of pyrrolnitrin in 
Burkholderia metabolites: a comparative study 
 
Many of the previous studies on Burkholderia sp confirmed that the key role of antifungal 
activity was due to different compounds e.g. pyrrolnitrin. Therefore, in this study pure 
pyrrolnitrin (Sigma) was included as a positive control compounds for Burkholderia anti-
candidal metabolites. Burkhead, et al. (1994) and Schmidt, et al. (2009) recommended 
different conditions to isolation and detection of pyrrolnitrin. 
 
B. ambifaria AMMD fraction no. 7 (Rf 0.98) of the silica gel preparative TLC 
fractionation (see section 4.3.4.1), B. ambifaria AMMD first (G1), third (G3) and fourth 
(G4) fractions of silica gel column chromatography (see section 4.3.4.3), AMMD acetone 
extract which was extracted by liquid extraction using acetone, last fractions of silica gel 
preparative TLC fractionation of BCF, KW and Mex-5 (see section 4.3.4.1; 5 µl of 10 mg 
ml
-1
) and 5µg pure pyrrolnitrin (sigma) were used and run in duplicate and compared side 
by side on the same plate. The first run of these fractions and standard compound were 
carried out on normal 0.25 silica gel TLC plates and chloroform, ethyl acetate and formic 
acid 5:4:1v/v as a solvent system (Burkhead, et al., 1994). The second run was carried out 
on florescence 0.25 silica gel TLC plates and chloroform and acetone 9:1v/v (Schmidt, et 
al., 2009). One set of both was visualized under UV light at 366 nm and the other set was 
overlaid with C. albicans.  
2.13 Statistical analysis 
All data were analysed using MINITAB 16 software. For examining the effect of media 
type on extension rate (mm/h) of cord forming, wood decay basidiomycetes, analysis of 
covariance (General linear model) was used followed by comparisons Tukey tests at the 
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95% confidence level (P ≤ 0.05). To evaluate the effect of media type and media 
composition on production of anti-candidal agents, one way and two way analysis of 
variance (ANOVA) were used followed by comparisons (Tukey test) at the 95% 
confidence level (P ≤ 0.05). Unless otherwise stated, data are presented with means and 
standard errors of the mean. 
CHAPTER THREE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A SYSTEMATIC SCREEN OF ANTIFUNGAL 
ACTIVITY OF Burkholderia cepacia complex AND 
OTHER Burkholderia SPECIES 
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3.1 Introduction  
Burkholderia species inhabit a large array of ecological niches and members of the genus 
are known to be plant, human and animal pathogens. Burkholderia exist in soil, water and 
plant rhizospheres and can be endophytically associated with fungi (Coenye & Vandamme, 
2003). 
 
 Basidiomycetes are major agents of decomposition, which may attack standing and felled 
timber, stumps and other man-made wooden structures. C. albicans is the major 
opportunistic fungal pathogen causing potentially fatal disease in immunosuppressed 
human hosts (Pfaller & Diekema, 2007). In this study, ten representatives of basidiomycete 
and C. albicans were used as target fungi to screen for antifungal compounds. 
 
The interaction between antibiotic producing bacteria and fungi especially phytopathogens, 
has been studied by many researchers for a long time, especially in terms of the 
biopesticidal uses for agriculture, and they attach a particular significance to the 
metabolites produced during interactions, which have potential as antimicrobial agents 
(Kadir, et al., 2008, Rousk, et al., 2008, Sultan, et al., 2008). To date only limited attention 
has been given to interactions between wood decay basidiomycetes and bacteria, especially 
Burkholderia.  
 
There are many Bcc strains known as antimicrobial producers that have been characterized 
as bio-pesticides (Parke & Gurian-Sherman, 2001). Nearly all of Bcc metabolites exhibited 
antimicrobial activities were identified from ˝Burkholderia cepacia˝ isolates which have 
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not been characterized at the species level in terms of the Bcc, and no studies have looked 
at large collections of taxonomically-defined Bcc isolates. 
 
The overall aim of this work was to perform a systematic screen of Burkholderia 
antifungal activity using a large collection of accurately identified Burkholderia species. 
This was performed using different growth media and using both an overlay assay and 
direct antagonism assay to test antimicrobial secretion and inhibition. An initial challenge 
of the work was that the bacterial-fungal interaction media used should support both fungal 
and bacterial growth and aid the production of antimicrobial secondary metabolites. The 
type of media influences the interaction between bacteria and fungi as these organisms 
differ in responses to abiotic factors, such as nutritional requirements, temperature and 
hydrogen ion concentration (Hwang, et al., 2002, Murray  & Woodward, 2003, Li, et al., 
2007, Kadir, et al., 2008). Various media formulations were therefore tested prior to the 
optimal media being selected to examine the diversity of anti-fungal activity across a 
collection of 421 Burkholderia isolates. 
 
An additional challenge of the work was using wood-decay basidiomycete fungi which, 
unlike the ascomycete Candida species, grow as mycelia, and thus are not as 
straightforward to screen in antimicrobial assays. Their interaction with Burkholderia 
species has not been extensively examined. A conventional contact antagonism assay 
applied to many filamentous fungi was used as an initial screen, however, a novel overlay 
assay where homogenised mycelia were used to form an even growth of the basidiomycete 
was also developed. 
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A general hypothesis for this chapter was “all B. cepacia bacteria are capable of 
producing antifungal agents”. The specific aims of this chapter were: 
 To evaluate a range of growth media for their ability to support fungal and bacterial 
growth, and allow the production of antimicrobial metabolites. 
 To systematically screen a collection of Burkholderia cepacia complex species for 
the production of antifungal metabolites. 
  To examine the secretion of antifungal metabolites in Burkholderia species outside 
the complex and compare this to a range of non-Burkholderia species. 
 To develop an overlay-inhibition assay suitable for screening antifungal activity 
against filamentous basidiomycetes. 
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3.2 Materials and Methods  
3.2.1  Growth media and microorganism storage and maintenance   
The media used in the current experiment were as described in section 2.1. A total of 421 
bacterial isolates (section 2.1), including cystic fibrosis, clinical and environmental isolates 
(plant pathogenic and soil isolates), were screened against Candida albicans Sc 5314 and 
B. adusta BK1. C. albicans (1 X 10
-6
 cfu ml
-1
 overlay agar) was used as a reference strain 
to rapidly test the activity of antifungal agents produced by the Burkholderia isolates. Ten 
representative species of wood decay basidiomycete fungi (Table 2.2) were used to detect 
the activity against this class of fungi. A basidiomycete inoculum was aseptically 
transferred onto a slant culture tube containing 2% MA medium as described in section 
2.1. 
 
3.2.2  Selection of suitable media for growth and antifungal 
metabolite production 
Four Bcc isolates (B. ambifaria AMMD, B. ambifaria BCF, B. ambifaria Kc311 and B. 
vietnamiensis JW13) that were known to produce anti-candidal agents were tested for the 
production of anti-candidal agents on six different media, (SA, PDA, MA, BSM-G, CMA 
and MHA), using a C. albicans overlay assay as described in Section 2.4. The production 
of anti-candidal agents was determined by measuring the zone of inhibition in mm. To 
examine the affect of different media on basidiomycete fungi, the growth rates of ten wood 
decay fungi were examined on seven different media (SA, PDA, MA, BSM-G, TSA, ISOA 
and MHA); growth was determined at 3, 5, 7, 9 and 11 d by measuring the hyphal 
extension rates in millimetres (mm; see section 2.6). 
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3.2.3  Interactions between Burkholderia and fungi  
After the selection of appropriate media (3.2.1 & 3.2.2), a total of 421 bacterial isolates 
(section 2.1) were screened against C. albicans and B. adusta BK1 using SA and BSM-G 
media. The interaction between Burkholderia and C. albicans was carried out using an 
overlay agar assay (section 2.5.1) and the results were determined by measuring the zone 
of inhibition in mm. The interaction between Burkholderia and B. adusta were carried out 
using a contact antagonism assay (section 2.5.2.1) and the results scored by comparing to 
the BK1 control plates, noting whether there was: no inhibition (-), weak inhibition [(+); 
0.1 cm to 0.5 cm of no BK1 growth], medium inhibition [(++); 0.5 cm to 1 cm of no BK1 
growth] or strong inhibition [(+++); 1 cm to 2 cm of no BK1 growth] of fungal growth by 
Burkholderia. Eight wood decay basidiomycetes were also tested against four B. 
ambifaria: AMMD, BCF, KW and MEX-5 using a basidiomycete agar overlay assay as 
described in section 2.5.2.2. 
 
Peptone Lactose Agar medium (PLA), which was shown to enhance the production of 
antifungal agents of putative B. multivorans isolates in another study (Dikin, et al., 2007) 
was also used to test 27 isolates of B. multivorans and 18 isolates of B. stabilis. These two 
Bcc species had totally failed to produce antifungal agents when grown on SA or BSM-G 
media, prompting the testing of this alternative medium. 
 
3.2.4  Statistical analysis  
All data were analysed using MINITAB 16 software. To examine the effect of media type 
on growth rate (mm/h) of wood decay basidiomycetes, the results were tested statistically 
using analysis of covariance (General Linear Model) followed by comparisons (Tukey 
Test) at the 95% confidence level (P ≤ 0.05). To evaluate the effect of media type on the 
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production of anti-candidal agents, one-way analysis of variance followed by comparisons 
(Tukey test) at the 95% confidence level (P ≤ 0.05) were used. Chi Square (χ 2 ) at the 95% 
confidence level (P ≤ 0.05)  was used to compare the effect of BSM-G and SA media on 
the production of anti-candidal agents and to test the effect of SA medium on the 
production of antifungal agents of the whole collection and between groups. All data are 
presented with means and standard errors of the mean. 
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3.3  Results 
 
3.3.1 Selection of a suitable medium for growth and production of 
anti-microbial agents 
3.3.1.1  Selection of growth media for wood decay basidiomycetes 
 
In this study, different media (Table 2.1) were used for growing selected wood decay fungi 
(Table 2.3) and Burkholderia isolates (Table 2.2). Seven different media were used to test 
the growth ability of ten different wood decay fungi at 25ºC. Potato Dextrose Agar (PDA) 
was the optimal growth medium supporting the growth of all 8 basidiomycete fungi with 
growth rates ranging from 0.0 to 12.48 mm d
-1
 (Table 3.1, Figure 3.1). Sabouraud Agar 
(SA) and Malt Agar (MA, 2%) also supported the growth of basidiomycetes well, with 
only P. impudicus and R. bicolor failing to grow on each respective medium (Table 3.1). 
The remaining media tested showed weak growth for the wood decay basidiomycetes with 
many species failing to grow (Table 3.1, Figure 3.1). In rank order, the most rapid growing 
basidiomycetes were B. adusta, T. versicolor and S. gausapatum with growth rates of 14.8, 
7.97 and 7.18 mm d
-1
 respectively, seen on Sabouraud agar (Figure 3.2).  
 
The effects of different media on fungal growth were highly variable (Table 3.1, Figure 
3.1). B. adusta showed the best growth rate on MA, SA and PDA media (Table 3.1, Figure 
3.2) with the mycelia reaching the edge of the Petri dishes within 7 days. In contrast, B. 
adusta exhibited the weakest growth on BSM-G (1.37 mm d
-1
) and only grew after 3 days 
of inoculation on ISA and MHA media. The effect of different media on fungal growth 
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Table 3.1 Effects of media type on extension rate of wood decay basidiomycetes. 
a Stereum gausapatum Sa1, Hypholoma fasciculare (HfGTW), Resinicium bicolor (Rbm6A), H. fasciculare (HfDD2), R. bicolor (Rb1), Bjerkandera adusta (BK1), 
Phanerochaete velutina (Pv1), Phallus impudicus (PiJHT4), Trametes versicolor (D2) & Heterobasidion annosum (SP313). 
b Muller Hinton agar (MHA), Tryptone Soya agar (TSA), Isosensitest 0.75agar (ISOA), Basal salts media with glycerol (BSM-G), Potato dextrose agar (PDA),  2% Malt 
agar (MA) & Sabouraud agar (SA). 
 
Extension rate  (mm d
-1 
(SEM)) of wood decay basidiomycetes 
a 
                         Sa1 HfGTW Rbm6A HfDD2 Rb1 BK1 Pv1 PiJHT4 D2 SP313 
M
ed
ia
 b
 
MHA 1.28 (0.07) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 8.47 (0.12) 0.0 (0.0) 0.0 (0.0) 3.72 (0.16) 0.0 (0.0) 
ISO 2.57 (0.06) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 8.18 (0.15) 0.0 (0.0) 0.0 (0.0) 3.72 (0.14) 0.0 (0.0) 
MA 6.68 (0.14) 4.8 (0.17) 3.05 (0.0) 3.03 (0.18) 5.22 (0.09) 15.0 (0.14) 6.05 (0.13) 0.0 (0.0) 5.03 (0.14) 4.77 (0.07) 
SA 7.18 (0.07) 2.5 (0.08) 2.15 (0.09) 2.15(0.05) 3.15 (0.13) 14.8 (0.17) 1.68 (0.1) 3.0 (0.08) 7.97 (0.64) 5.7 (0.13) 
TSA 1.32 (0.07) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 6.37 (0.32) 0.0 (0.0) 0.0 (0.0) 2.28 (0.1) 0.0 (0.0) 
BSM_G 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 1.37 (0.14) 0.0 (0.0) 0.0 (0.0) 1.88 (0.4) 0.0 (0.0) 
PDA 
 
7.33 (0.2) 
 
3.78 (0.02) 
 
3.85 (0.04) 
 
3.85 (0.5) 
 
0.0 (0.0) 
 
12.42 (.08) 
 
9.77 (0.02) 
 
4.25 (0.10) 
 
11.9 (0.22) 
 
3.95 (0.13) 
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Figure 3.1 Effects of media type on extension rate mm d
-1
 (SEM) of wood decay basidiomycetes.  
The growth rate was determined for the following species: Stereum gausapatum Sa1, Hypholoma fasciculare (HfGTW), Resinicium bicolor (Rbm), H. fasciculare 
(HfDD2), R. bicolor (Rb1), Bjerkandera adusta (BK1), Phanerochaete velutina (Pv1), Phallus impudicus (PiJHT4), Trametes versicolor (D2) & Heterobasidion annosum 
(SP313). The following media were examined: Muller Hinton Agar (MHA), Tryptone Soya Agar (TSA), Isosensitest 0.75 Agar (ISOA), Basal Salts Media with glycerol 
(BSM-G), Potato Dextrose Agar (PDA), 2% Malt Agar (MA) and Sabouraud Agar (SA). 
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Figure 3.2 Mean extension rate mm d
-1
 of wood decay basidiomycete across all media. 
Stereum gausapatum (Sa1), Hypholoma fasciculare (HfGTW), Resinicium bicolor (Rbm), H. fasciculare 
(HfDD2), R. bicolor (Rb1), Bjerkandera adusta (BK1), Phanerochaete velutina (Pv1), Phallus impudicus 
(PiJHT4), Trametes versicolor (D2) & Heterobasidion annosum (SP313). The following media were 
examined: MHA, TSA, BSM-G, PDA, MA and SA. Different letters above columns indicate significant 
differences (ANOVA; P ≤ 0.05). Data are presented as the means of three replicates with standard errors of 
the means. 
 
 
was highly significant (P ≤ 0.001, F = 194.26), and all tested isolates showed (Figure 3.2, 
3.3) a significant difference (P ≤ 0.001) in production of anti-candidal agents. 
 
T. versicolor showed the faster extension on PDA and SA media (11.9 and 7.97 mm d
-1 
respectively) and mycelia reached the edge of Petri dishes of PDA medium within 7 days. 
In contrast, T. versicolor showed the weakest growth on BSM-G, TSA, ISA and MHA 
media respectively and grew after 3 days of inoculation. S. gausapatum showed the faster 
extension on PDA, SA and MA (7.33, 7.18 and 6.68 mm d
-1 
respectively; Table 3.1). The 
mycelia reached the edge of PDA Petri dishes within 9 days, and grew after seven days on 
TSA and MHA. However, the fungus failed to grow on BSM-G medium. 
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Figure 3.3 Effects of media type on extension rate mm d
-1
 of wood decay 
basidiomycetes. 
Muller Hinton Agar (MHA), Tryptone Soya Agar (TSA), Isosensitest 0.75 Agar (ISOA), Basal Salts Media 
with glycerol (BSM-G), Potato Dextrose Agar (PDA), 2% Malt Agar (MA) and Sabouraud Agar (SA). 
Different letters above columns indicate significant differences (ANOVA; P ≤ 0.05). Data are presented as 
the means of three replicates with standard errors of the means. 
 
The effect of different media on fungal growth (Figure 3.2) was highly significant (P ≤ 
0.005, F = 98.72). H. fasciculare HFDD2 and HFGTW showed similar behavioural 
patterns on the same growth media, with for example the faster extension on PDA medium 
(3.85 and 3.78 mm d
-1 
respectively). The mycelia of both fungi covered about half of the 
Petri dishes within 11 days. Both H. fasciculare isolates showed weak growth on MA and 
SA media, and failed to grow on MHA, TSA, ISOA and BSM-G media. 
 
The effect of different media on fungal growth was highly significant. Different strains of 
R. bicolor (Rb1 and Rbm6A) behaved differently. Rbm6A showed faster extension on 
PDA, MA and SA media (3.85, 3.05 and 2.15 mm d
-1 
respectively) but failed to grow on 
BSM-G and other media (P ≤ 0.001, F = 3.01), whereas Rb1 extended faster on MA and 
SA media (5.22 and 3.15 mm d
-1 
respectively) and failed to grow on MHA, ISO, TSA, 
BSM-G and PDA media (P ≤ 0.005, F = 154.95). P. velutina and H. annosum showed 
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similar activity, as they failed to grow on MHA, TSA, ISOA and BSM-G media. P. 
velutina grew well on PDA medium and the mycelium covered half of the Petri dish within 
9 days (9.77mm d
-1
; P ≤ 0.001, F = 104.41) and also grew on MA. H. annosum grew on 
three different media: SA, MA and PDA (P ≤ 0.001, F = 12.50). P. impudicus failed to 
grow on most of the tested media (MHA, TSA, ISO and BSM-G) and extended faster on 
PDA (4.25 mm d
-1
; P ≤ 0.001, F = 45.97). 
 
3.3.1.2  Selection of growth media for anti-candidal production by 
Burkholderia  
Six different media were chosen to test the production of anti-candidal agents from four 
Bcc isolates: B. ambifaria AMMD, B. ambifaria BCF, B. ambifaria Kc311 and B. 
vietnamiensis JW13. These strains are known producers of antibacterial agents 
(Mahenthiralingam et al. unpublished data), and production of anti-candidal agents was 
tested using an agar overlay assay. 
 
The effects of Burkholderia metabolites on C. albicans were different from isolate to 
isolate and in additional different classes of interaction were observed. In the first class of 
interaction, no inhibition of C. albicans growth was observed (Figure 3.4 A). In the second 
class of interaction, clear growth inhibition occurred, with Burkholderia metabolites 
stopping the growth of C. albicans, resulting in a visible circular inhibition zone (Figure 
3.4 C). The third class of interaction was one where there was an unclear zone (faint), 
indicating either partial inhibition of C. albicans growth or another form of interaction 
which influenced the growth properties of the ascomycete in the overlay agar (Figure 3.4 
B). In the context of defining the prevalence of antimicrobial activity among Bcc isolates,  
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(A) No inhibition  
 
 
 
 
(B) Faint inhibition zone  
 
 
 
 
 
(C) Clear inhibition zone  
 
 
 
Figure 3.4 The effect of Burkholderia metabolites on C. albicans. 
After incubation at 37C for 24 h, the anti-candidal activity of Burkholderia was visible as; (A) no inhibition 
zone or (B) Faint inhibition zone or (C) clear inhibition zone on the red background of Candida cells which 
have grown and reduced the tetrazolium chloride metabolic indicator. 
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inhibition of C. albicans with a clear zone was considered as a positive effect and faint 
zones of clearing were considered as a negative result. 
 
The ability of the 4 Bcc isolates to produce anti-candidal agents was not consistent and 
increased or decreased under growth different conditions (Table 3.2 and Figures 3.5). All 
four tested Bcc isolates failed to produce anti-candidal agents on MA of the six media 
tested. However, BSM-G, SA and PDA media (Figure 3.5) stimulated the four tested Bcc 
isolates to produce anti-candidal agents as follows. 
 
B. ambifaria AMMD strain (Table 3.2) produced anti-candidal agents when grown on 
BSM-G and SA and the zone of inhibition was 29.6 ± 1.20 and 21.6 ± 0.88 mm 
respectively. The effects of BSM-G and SA media on anti-candidal production was highly 
significant (P ≤ 0.005, F = 151.19). AMMD did not show anti-candidal activity when 
grown on MA, MHA, PDA and CMA.  
 
B. ambifaria BCF isolates (Table 3.2) showed a lack of production of anti-candidal agents 
against all tested microorganisms when grown on MA, SA, PDA and CMA. However, 
anti-candidal agents were greatly enhanced when grown on BSM-G and MHA (59.6 ± 3.28 
and 39.6 ± 1.20 mm respectively) and the effect of different media on anti-candidal 
production was highly significant (P ≤ 0.05, F = 308.29). 
 
B. ambifaria Kc311 isolates (Table 3.2) showed a lack of production of anti-candidal 
agents when grown on MA and MHA. Greatest inhibition by Kc311 was on CMA, BSM-
G, SA and PDA (44.3 ± 1.20, 40.67 ± 0.67, 37.0 ± 1.0 and 29.0 ± 2.08 mm respectively)  
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Table 3.2 Effects of media type on production of anti-Candida albicans Sc5314 agents 
by four different Bcc isolates  
 
a 2% Malt agar (MA), Sabouraud agar (SA), Muller Hinton agar (MHA), Basal salts media   with glycerol 
(BSM_G), Potato dextrose agar (PDA) and Casein meat agar (CMA). b B. ambifaria AMMD, BCF & Kc311 
and B. vietnamiensis JW13. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 Effects of media type on production of anti-Candida albicans Sc 5314 
agents by different Burkholderia strains at 30°C. 
 2% Malt agar (MA), Sabouraud agar (SA), Muller Hinton agar (MHA), Basal salts media   with glycerol 
(BSM-G), Potato dextrose agar (PDA) and Casein meat agar (CAM). Different letters above columns 
indicate significant differences (ANOVA; P ≤ 0.05). Data are presented as the means of three replicates with 
standard errors of the means. 
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and the effect of different media on antifungal production was significant (P ≤ 0.005, F = 
26.06). 
 
 B. vietnamiensis JW13 isolates did not produce anti-candidal activity when grown on MA, 
MHA and CMA. Anti-candidal activity was high when using BSM-G, PDA and SA (50.00 
± 2.88, 41.70 ± 2.02 and 8.7 ± 1.55 mm respectively) and the effect of different media on 
antifungal production was highly significant (P ≤ 0.001, F = 103.73). 
 
3.3.2  Interaction between Burkholderia and fungi 
Examination of antibiotic production on 6 different media by the 4 Bcc isolates known to 
produce anti-candidal agents had shown that BSM-G and SA medium were suitable media 
for the production of these secondary metabolites. Therefore these media were selected to 
perform a systematic antifungal screen of 421 Burkholderia isolates recovered from 
clinical and environmental sources (Appendix A, Table A.1). The collection examined 
included 339 isolates from the B. cepacia complex (representing 11 formally Bcc named 
species and 4 novel groups that represent putatively novel species within the complex; 
Mahenthiralingam et al., 2008), 58 isolates from other Burkholderia species (39 from 
known Burkholderia species and 18 from isolates not identified to the species level), and 
24 other non-Burkholderia bacteria isolates (Table 3.3). Antifungal activity against the 
ascomycete C. albicans Sc5314 (described as anti-candidal activity) and the basidiomycete 
B. adusta (described as anti-basidiomycete) was evaluated. 
 
The raw data for antifungal activity (zone of inhibition for each isolate) is presented in 
Appendix A, Table A.1. Summative data for B. cepacia complex, Burkholderia species 
and non-Burkholderia species is presented in Table 3.3. General trends in the antifungal 
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activity observed were as follows. Growth of the bacteria and subsequently test for 
antifungal activity was most successful on SA medium. After growth on this medium 
45.5% (192) isolates demonstrated anti-candidal and/or anti-basidiomycete activity (Table 
3.3), and in 192 out of 421 cases, both activities were detected for the same isolate. 
Exceptions to this trend are described individually below. SA medium was also superior at 
enhancing the production of anti-candidal metabolites with 45.56% of isolates positive in 
comparison to BSM-G where 33% showed a zone of inhibition (this difference was, 
however, not significant; P > 0.05, Chi-Sq= 0.379). B. stabilis and B. multivorans failed to 
produce anti-fungal agents when grown on two different media: SA and BSM-G. However, 
B. stabilis was significantly successful (18%, P ≤ 0.001, Chi-Sq= 13.8) in producing 
substances which suppressed Candida growth on PLA medium.  
 
3.3.2.1 Interaction between Burkholderia and C. albicans  
The interaction between the whole collection of Burkholderia and the reference strain C. 
albicans was carried out on two different media: SA and BSM-G. The results showed that 
the antagonistic Bcc species against C. albicans when using SA medium were Bcc6, B. 
cepacia, B. cenocepacia and B. ambifaria (100%, 86.6%, 77.1% and 56.8% respectively). 
However, B. anthina showed a poor ability to inhibit the growth of C. albicans (7.1%). 
Other species (B. gladioli, B. glumae, B. oklahomensis and B. plantarii) also produced very 
antagonistic agents (Table 3.3 and Figure 3.6). 
 
The maximum zones of inhibition were recorded against C. albicans due to diffusible 
secondary metabolites of Burkholderia isolates when grown on BSM-G medium compared 
with SA medium and ranged between 82.3 – 7 mm and the maximum inhibition was 
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Table 3.3 Comparison of antifungal activity of Burkholderia and other bacterial 
species using two different media. 
BSM-G; Basal salt medium supplemented with 0.4% glycerol, SA; Sabouraud agar, BKI; B. adusta 
* The full name of species is listed in page 33 and table 2.2. 
 
 
 
 
 
 
No 
 
 
Tested isolates 
Number and 
percentage of 
tested 
isolates 
Number and percentage of active isolates 
producing antifungal agents 
Anti-candidal Anti-BK1 
BSM-G SA SA 
1 
 
B
u
rk
h
o
ld
er
ia
 c
ep
a
ci
a
 c
o
m
p
le
x
 (
B
cc
) 
 
B. ambifaria 101 (23.9%) 45 (44.1%) 58 (56.8%) 69 (67.6%) 
2 
B. cenocepacia 61 (14.5%) 12 (19.6%) 47 (77.1%) 47 (77.1%) 
3 
B. cepacia 30 (7.1%) 15 (50%) 26 (86.6%) 25 (83.3%) 
4 
B. multivorans 27 (6.4%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
5 
B. stabilis 18 (4.2%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
6 
B. vietnamiensis 18 (4.2%) 8 (44.4%) 4 (22.2%) 10 (55.5%) 
7 
B. pyrrocinia 16 (3.8%) 9 (56.2%) 9 (56.2%) 7 (43.7%) 
8 
B. anthina 14 (3.3%) 5 (35.7%) 1 (7.1%) 1 (7.1%) 
9 
B. lata 11 (2.36%) 4 (40%) 0 (0.0%) 1 (10%) 
10 
Bcc 6 10 (2.36%) 8 (80%) 10 (100%) 6 (60%) 
11 
B. dolosa 8 (1.9%) 0 (0.0%) 3 (37.5%) 4 (50%) 
12 
B. contaminans 6 (1.4%) 3 (50%) 5 (83.3%) 4 (66.6%) 
13 
Bcc 5 5 (1.18%) 4 (80%) 4 (80%) 0 (0.0%) 
14 
Bcc 4 3 (0.7%) 3 (100%) 2 (66.6%) 2 (66.6%) 
15 
Bcc kc 2 (0.47%) 1 (50%) 1 (50%) 2 (100%) 
 
                   Total (Bcc) 
 
339 (100%) 
 
 
117 (29.3%) 
 
170 (50.1%) 
 
178 (52.5%) 
16 Other Burkholderia* 58(13.7%) 22 (37.9%) 20 (34.5%) 13 (22.4%) 
 
17 
 
Not Burkholderia
* 
    24 (5.7%) 1 (3.5%)  2 (7.1%) 1 (3.5%) 
 
Total (All 1-17) 
 
421 (100%) 
 
140 (33%) 
 
192 (45.5%) 
 
192 (45.5%) 
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Figure 3.6 Effect of Sabouraud medium (SA) on the production of anti-C. albicans 
and anti-B. adusta BK1 agents. 
339 isolates of B. cepacia complex, 58 isolates of other Burkholderia and 24 isolates of other bacteria (not 
Burkholderia) were tested for their antifungal activity. 
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observed by B. plantarii, B. gladioli, B. phenazinum, B. ambifaria and B. vietnamiensis 
(82.6, 82.2, 60.6, 53.3 and 52 mm respectively).  
 
In general, the results showed that SA medium appeared to be the best at enhancing anti-
candidal production by most tested bacteria with no significant differences between 
bacteria (P > 0.05, Chi-Sq = 0.379). Many of the Bcc isolates, for example, B. 
cenocepacia, B. cepacia B. vietnamiensis and B. anthina, showed highly significant 
differences in their production of anti-candidal agents when grown on two different media: 
SA and BSM-G (P ≤ 0.01, Chi-Sq=34.03, P ≤ 0.05, Chi-Sq= 9.83, P ≤ 0.01, Chi-Sq= 7.4 
and P ≤ 0.01, Chi-Sq= 19.04 respectively). B. ambifaria also showed nearly the same 
results (56.86% and 4.11% respectively) with two different media: SA and BSM-G (P ≤ 
0.2, Chi-Sq = 1.60). In contrast, certain Bcc species preferentially produced anti-candidal 
agents when grown on BSM-G medium compared to SA medium: B. vietnamiensis 
(44.4%, 22.2%), B. lata (40%, 0.0%) and B. anthina (35.7%, 7.1%), (P ≤ 0.5, Chi-Sq = 
0.379; P ≤ 0.5, Chi-Sq = 0.379 and P ≤ 0.5, Chi-Sq = 0.379 respectively). 
 
3.3.2.2 Interaction between Burkholderia and B. adusta BK1 
3.3.2.2.1 Using a contact antagonism assay 
The interaction between a bacterial collection and model wood decay basidiomycete B. 
adusta was carried out on SA medium, using a contact antagonism assay (section 2.5.2.1). 
The effect of Burkholderia metabolites on B. adusta varied considerably from isolate to 
isolate. Three different categories of outcomes were observed. Firstly, a full inhibition of 
B. adusta growth (Figure 3.7 B) was defined when there was no growth at all of B. adusta. 
Secondly, deadlock (Figure 3.7 C) was defined when Burkholderia metabolites stopped the  
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A) BK1 control growth 
 
 
 
 
 
 
 
 
B) Full inhibition 
 
 
 
 
 
 
 
 
 
C) Deadlock 
 
 
 
 
 
 
 
 
 
D) Over growth of BK1 and  
fan-like structure formation  
 
 
 
 
 
Figure 3.7 Outcomes of Burkholderia and B. adusta BK1 interactions. 
After incubation at 25C for 7 d the results were compared to B. adusta control plate without any 
Burkholderia (A). Anti- B. adusta activities were shown as: full inhibition (B) or deadlock (C) or over 
growth of BK1 and fan-like structure formation (D). 
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 BK1 
 BK1 
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 Burkholderia 
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growth of B. adusta and finally, overgrowth of B. adusta on bacterial growth and fan-like 
structure formation (Figure 3.7 D) was defined when no fungal inhibition was observed. 
These findings illustrated a remarkable diversity of interactions between Burkholderia and 
basidiomycetes. 
 
45.5% of tested bacteria (192 out of 421) were able to produce and release active 
metabolites which inhibited the growth of B. adusta. The most aggressive Burkholderia 
species against B. adusta (Table 3.3 and Figure 3.8) were B. cepacia, B. cenocepacia, B. 
ambifaria and Bcc6 (83.3%, 77.1%, 67.6% and 60% respectively). B. gladioli, B. 
oklahomensis and B. plantarii produced very active antifungal agents which inhibited the 
growth of B. adusta. The weakest species was B. anthina (7.1%).  B. stabilis and B. 
multivorans did not inhibit the growth of B. adusta. 
 
Many Burkholderia isolates were able to inhibit and/or change the morphology of B. 
adusta BK1 growth, there being clear variation in mycelial colour and hyphal densities 
compared to the control.  For example B. ambifaria (Bcc0206, Bcc1080), B. cepacia, 
(Bcc0660, LMG 6964), B. cenocepacia (Bcc1014) and B. gladioli (Bcc0238, Bcc0507 and 
Bcc1623) were able to inhibit and deadlock the growth of B. adusta (Figure 3.9).  
 
Burkholderia isolates, particularly B. ambifaria (Bcc0193), B. terricola LMG 20594 
(Bcc0193), B. fungorum LMG 16225 (Bcc0770), B. caribensis LMG 20594 (Bcc0193) and 
other Burkholderia spp (Bcc0435 and Bcc0667) stimulated mycelia of B. adusta BK1 to 
produce fan-like structures (Figure 3.10) at mycelial margins compared to the control, and 
other species were able to grow over Burkholderia colonies and cover it.  
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Figure 3.8 Effect of Basal Salt Medium (BSM) and Sabouraud medium (SA) on 
production of anti-C. albicans agents. 
339 isolates of B. cepacia complex, 58 isolates of other Burkholderia and 24 isolates of other bacteria (not 
Burkholderia) were tested for their anti-candidal activity using two different media. 
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Figure 3.9 Deadlock of B. adusta BK1 growth as outcomes of the interaction with 
Burkholderia isolates. 
(a) B. gladioli Bcc0507, (b) B. cepacias Bcc0660, LMG 6964, (c) B. ambifaria Bcc1080, (d) B. gladioli 
Bcc1620, (e) B. gladioli Bcc1623, (f) B. ambifaria Bcc0206, (g) B. cenocepacia Bcc1014 and (h) B. gladioli 
Bcc0238. 
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Figure 3.10 Overgrowth and fan-like structure formation of B. adusta BK1 as 
outcomes of the interaction with Burkholderia isolates. 
(a) B. terricola Bcc1609, LMG20594, (b) B. ambifaria Bcc0193, (c) B. fungorum Bcc0770, LMG16225, (d) 
Burkholderia sp. Bcc0435, (e) B. caribensis Bcc0768, LMG18531 and (f) Burkholderia sp. Bcc0667. 
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B. adusta BK1 grew completely over many of Burkholderia species on SA medium during 
7 d of incubation, and its mycelia were light or dense. B. lata LMG 22485 (Bcc0803) 
metabolites produced in SA medium decreased the growth of B. adusta, as the mycelium 
of B. adusta stopped just a few micrometers from B. lata’s growth, with formation of a red 
pigment (Figure 3.11). In contrast, no pigmentation was observed when B. lata was 
exposed to other fungi or when grown alone. 
 
3.3.2.2.2 Using basidiomycete overlay assay 
Pouring an overlay of a test microorganism onto agar where a secondary metabolite 
producing microorganism has been grown forms a very simple assay to detect 
antimicrobial compounds. With microorganisms that grow planktonically as single cells or 
small clusters of cells, this overlay assay gives very reproducible and easy to observe 
results, as seen with the anti-Candida inhibition work. However, this classical type of 
overlay-inhibition assay has not been easy to apply to microorganisms which grown in a 
filamentous or clumping manner such as basidiomycete fungi. To develop an overlay assay 
suitable for application to the filamentous basidiomycetes, fragmentation of mycelia was 
evaluated as a means to produce an even inoculation and then subsequent fungal growth 
sufficient to observe the antifungal activity of secreted Burkholderia metabolites. Aliquots 
of homogenized mycelial inoculum were prepared using different size zirconium beads and 
fungal inocula grown under different conditions (see section 2.5.2.2). The best growth was 
observed when 0.25 mm zirconium beads were used to fragment 250 mg of fungal mycelia 
inoculum which had been grown on 2 ml SA medium for 2 days at 25°C under shaking 
conditions. Subsequent re-growth of 1 ml of fragmented fungal mycelia in the 25 ml soft 
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agar overlay medium was good and showed no bacterial contamination under experimental 
conditions. 
 
 
 
       
 
 
 
 
 
 
 
 
 
 
 
 
         
Figure 3.11 Production of red pigment from B. lata during interaction with B. adusta 
BK1. 
B. lata suspension was spotted onto SA plate and incubated at 30C for 3 d, and then the plate was centrally 
inoculated with B. adusta BK1. After incubation at 30C for 5 d, the red pigment of B. lata was secreted. 
 
 
 
 
 
Table  3.4 Zone of inhibition (mm ± SEM) of B. adusta and T. versicolor due to B. 
ambifaria AMMD, BCF, KW and MEX-5 diffusible metabolites using the 
basidiomycetes overlay assay 
 
 
 
  AMMD BCF KW MEX-5 
B. adusta 51.75 ± 0.85 47.50 ± 1.19 37.75 ± 4.19 32.25 ± 1.11 
T. versicolor 59.75 ± 0.63 58.00 ± 1.22 51.75 ± 1.18 41.00 ± 1.35 
Red pigment  
BK1  
B. lata 
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Five of the seven tested basidiomycetes were hard to optimize for overlay growth using the 
zirconium bead fragmentation assay. H. fasciculare, P. impudicus and R. bicolor did not 
grow reproducibly using this method. P. velutina produced weak growth that was barely 
visible. S. gausapatum produced a scattered variable growth that was unacceptable in the 
context of an even overlay assay. However, B. adusta BK1 and T. versicolor D2 showed 
an even layer of good growth covering the entire surface of SA plates within 3 and 4 d, 
respectively. 
 
The ability to measure a zone of clearing using a basidiomycete-overlay assay enabled a 
more quantitative evaluation of antifungal activity compared to the contact-antagonism 
assay. It was also more comparable to the anti-candidal overlay assay since the 
Burkholderia strain could be left to secrete metabolites in the absence of the fungi, and 
then inactivated by chloroform vapour followed by assay of the anti-basidiomycete 
activity. The basidiomycete overlay assay was only applied to the 4 control B. ambifaria 
isolates since it had taken a while to develop. The inhibition zone due to B. ambifaria 
metabolites (Table 3.4 and Figure 3.12) ranged from 32.25 to 51.75 mm for B. adusta and 
41 to 59.75 mm for T. versicolor.  
 
The interaction of B. ambifaria AMMB, BCF, KW and Mex-5 against B. adusta BK1 and 
T. versicolor D2 was carried out on SA medium. The results showed that the antagonistic 
Burkholderia species against B. adusta BK1 were B. ambifaria AMMD and BCF (51 and 
49 mm respectively). However, B. ambifaria Mex-5 and KW showed less ability to inhibit 
the growth of BK1 (40 and 32.25 mm respectively). The maximum zones of inhibition  
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Figure 3.12 Zone of inhibition of B. adusta (BK1) and T. versicolor (D2) due to B. 
ambifaria AMMD, BCF, KW and MEX-5 metabolites using the overlay assay.  
Burkholderia suspensions were spotted onto the center of SA plate and incubated at 30C for 3 d. The plate 
was then overlaid with soft SA (1% Agar) seeded with fragmented BK1 or D2 inoculum. After incubation at 
20C for 3 d, the anti-basidiomycete activities of Burkholderia isolates were clearly visible as a clear zone of 
inhibition. 
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were recorded in interaction between B. ambifaria AMMD, KW and BCF and T. 
versicolor D2 on SA medium were 59.75, 58 and 56 mm respectively. Furthermore, B. 
adusta showed more regular growth after overlaying onto the secreted Burkholderia 
secondary metabolites than T. versicolor. 
 
3.4 Discussion 
Burkholderia (Tago, et al., 2006) and basidiomycetes (A'Bear, et al., 2012) are two of the 
dominant organisms in soil. Interactions between bacteria and fungi are affected by 
diffusible secondary metabolites including toxins, antibiotics and other metabolites or via 
bacteria-fungi interference or parasitism (Palumbo, et al., 2007, Vial, et al., 2008). To 
study the relationship between these organisms, growth conditions of both must be 
optimized. Bacterial-fungal interaction media should maintain both fungal and bacterial 
growth and support the production of secondary metabolites, especially those exhibiting 
antimicrobial activities, since microorganisms growing on different media can produce 
different metabolites and show different behavioural growth (Hwang, et al., 2002, Li, et 
al., 2007, Kadir, et al., 2008). In this study, there was a need to search for suitable media 
which allow an equal opportunity for interaction between Burkholderia isolates and wood 
decay basidiomycetes, and thus explore new anti-fungal agents.  
 
The ability of Burkholderia to use a broad spectrum of compounds as carbon sources is a 
known phenomenon and many of them are well known for the production of a variety of 
antifungal compounds (Parke & Gurian-Sherman, 2001). Studies have just begun to 
examine the antifungal ability of systematically identified Bcc species, with 
Mahenthiralingam et al., (2011) specifically examining the anti-bacterial activity of 268 
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isolates. The work presented in this chapter has considerably expanded the latter study, 
looking at 339 Bcc and also 58 other Burkholderia species. In addition, the antagonism 
towards 10 representative wood decay basidiomycetes has been examined for the first 
time. 
 
B. cepacia complex and other Burkholderia spp had varied capability to produce antifungal 
agents when grown on the same basal media. Four known antimicrobial producing Bcc 
bacteria were used to evaluate different growth media and our results showed that the best 
media to support production and activity of anti-candidal agents by B. ambifaria AMMD, 
BCF and Kc311 and B. multivorans JW13 were SA and BSM-G. However, rich media like 
TSA did not show activity. Murray and Woodward (2003) demonstrated a similar result 
with un-identified environmental bacteria as they confirmed that the best media to enhance 
antimicrobial production against wood decay fungi were SA and YPDA (Yeast Peptone 
Dextrose Agar) media. However, unlike this study they did not examine a minimal 
medium like BSM-G we have successfully used. 
 
C. albicans has been used as a target microorganism to discover new antifungal 
substances. During its interaction with 421 bacterial isolates on BSM-G and SA media, the 
results revealed that SA medium was superior for screening, as 45.5% of isolates produced 
anti-candidal agents. The enhanced production may have occurred for a number of reasons. 
Firstly, this medium may contain precursors for anti-candidal metabolic activity, as Ismet 
et al., (2004) showed an increase in antifungal production when using peptone as a 
nitrogen source. Secondly, the anti-candidal activity might be due to the effect of the pH of 
the medium (pH 6), as many Burkholderia are isolated from acidic soils (Roitman, et al., 
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1990). Similar enhancement of the production of antimicrobial agents at low pH has been 
seen in other studies (Roitman, et al., 1990, El-Banna & Winkelmann, 1998). Overall, this 
may reflect the fact that Burkholderia bacteria are found at the highest densities in soils 
which are acidic, and hence their secondary metabolism and enzymic pathways are 
optimised towards this. 
 
The production of anti-Candida and anti-B. adusta agents by Bcc isolates varied from one 
Bcc species to another, and also within the species. The differences in anti-fungal agent 
production reflect the considerable genetic variation seen between and within Burkholderia 
species. Of the basidiomycetes screened B. adusta showed the best ability to grow on all 
tested media and was therefore selected for use as an antagonistic model of wood decay 
fungi. The same overall number of isolates was active against B. adusta as were also active 
against C. albicans (Table 3.3). However, there were several groups of B. cepacia complex 
such as B. ambifaria, B. vietnamiensis and Bcc6 showed differential antagonism towards 
either the ascomycete or basidiomycetes. These similarities regarding the effects of 
Burkholderia isolates on both C. albicans and on B. adusta seem to be as a result of the 
ability of Burkholderia to produce many active substances with antifungal activity or due 
to the presence of active compound(s) that affect the growth of both C. albicans and B. 
adusta, or that different compounds might have the same mode of action. Li, et al., (2008) 
showed that the anti-candidal activity of some Burkholderia metabolites was as a result of 
losing the cell wall and altering the lipid and sterol contents of the cell.   
 
The most active Bcc species were B. ambifaria, B. cepacia and B. cenocepacia; however, 
these species were all represented by 30 isolates or more (Table 3.3) and hence it could not 
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be ruled out that if more isolates in other species had been screened greater activity would 
have been seen. These Bcc species have been seen to be highly antifungal in previous 
studies (Vial, et al., 2008). Quan, et al., (2006) showed that B. cepacia isolates produced 
strong anti-candidal agents and Li, et al., (2008) reported that strong anti-candidal activity 
of a CF66I compound was produced by B. cepacia. It is noteworthy that previous studies 
indicated that the most active Burkholderia producing antifungal compounds were B. 
cepacia and B. ambifaria AMMD, however, none of these studies examined large number 
of isolates. 
 
B. stabilis and B. multivorans failed completely to produce anti-candidal and anti-B. adusta 
BK1 agents when grown on selected media SA and BSM-G. This might be due to the 
absence of those genes responsible for antifungal production, or due to the lack of specific 
ingredients in these media which are responsible for the activation of antifungal 
production. Using different media leads to the production of different metabolites and 
shows different behavioural growth (Hwang, et al., 2002, Li, et al., 2007). B. multivorans 
was unsuccessful in producing anti-candidal agents when grown on neo peptone and 
Lactose medium (PLA). Dikin, et al., (2007) demonstrated that PLA medium was able to 
induce antifungal production by a putative B. multivorans isolate (one isolate); this 
contrasts with the data from the present study, but we have screened many more isolates 
(27 isolates) than they did. Reflecting that B. multivorans was unable to produce anti-
candidal agents under the tested conditions.   
   
B. stabilis significantly (18 %, P ≤ 0.001, Chi-Sq= 13.8) produced anti-candidal agents 
when grown on peptone lactose agar (PLA) medium. The importance of peptone in 
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enhancing the production of antifungal metabolites was previously reported (Schmidt, et 
al., 2001). Furthermore, Dikin, et al., (2007) found that peptone and lactose were important 
supplements to enhance the production of antifungal metabolites by B. cepacia and B. 
multivorans. The effect of nutrients on antifungal production might be due to the effect of 
such compounds on the production and the efficiency of particular enzymes involved in 
this process or on the availability of important compounds needed to activate silent genes 
responsible for antifungal production. 
 
Interactions between Burkholderia species and 10 different basidiomycetes on SA agar 
showed outcomes ranging from stimulation to inhibition. Some Burkholderia species on 
SA medium produced secondary antifungal metabolites which diffused to the surrounding 
agar and stopped or reduced the growth of tested fungi. In general B. ambifaria, B. cepacia 
and B. cenocepacia showed the strongest antagonistic activity against B. adusta. However, 
other Burkholderia isolates tended to stimulate the growth of B. adusta by producing 
stimulant metabolites that were presumably used as food or by using Burkholderia cells, 
after making contact (overgrowth) as an alternative source of protein and other important 
nutrients. Alternatively, the success of B. adusta might be as a result of defence 
mechanisms induced before direct contact. 
 
The current results of Burkholderia, particularly B. cepacia complex (45% antifungal 
producers in Bcc collection) have provided a starting point for further experiments after the 
current study, to explore the ecology of Burkholderia and as an initial source for 
comparisons. It may also answer some essential questions about: the production 
conditions; the diversity of antifungal agents within B. cepacia complex, especially the 
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large collection of B. ambifaria and to determine the nature of these antifungal agents and 
the genetic basis of genes responsible for antifungal production. 
 
Additional to antimicrobial activity of Burkholderia, other effects were seen for example, 
red pigment production and mycelial morphological changes. Red pigment produced by B. 
lata 383 was only observed during the interaction against B. adusta. This might be due to 
the effect of B. adusta metabolites which interfere with B. lata metabolism and reflect a 
highly species-specific interaction, or might be due to the quorum sensing (QS) effect. QS 
regulated the pigmentation and production of many other important metabolites, as 
Schmidt et al., 2009 confirmed that the pigmentation in B. lata 383 was QS-controlled.     
 
The fragmentation of mycelia of certain basidiomycetes was found to be a useful method 
to provide good growth that covered the Petri dishes in a short time (3 d) compared with 
the period of growth using the antagonism assay (7 d). This provided a regular distribution 
of fungal growth to determine the zone of inhibition due to diffusible bacterial metabolites. 
In general, the species which grew faster using fragmentation assays were B. adusta and T. 
versicolor. These species also showed high growth ability on different media (Table 3.1) 
after inoculation with a 5 mm agar plug of each fungus that was grown for 7 d on malt agar 
plates. However, the growth ability of basidiomycetes using the fragmentation assay was 
different from species to species and that might be caused by the nature of the fungal 
mycelium and the growth ability of each species. Alternatively, the method by which 
fragmentation is achieved might lead to damaged fungal mycelia which may in turn lead to 
a loss in or affect their ability to grow again. 
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3.5 Conclusions 
Overall the following conclusions were reached: 
 BSM-G and SA were the best media of those tested to screen for the production of 
antifungal agents by Burkholderia; with SA also highly suitable for subsequent 
antagonism assays with the basidiomycete fungi. 
 B. ambifaria, B. cepacia and B. cenocepacia were the most antagonistic Burkholderia 
species against both C. albicans and B. adusta. However B. multivorans and B. 
stabilis appear to be species with a limited ability to produce antifungal agents. 
 A basidiomycete overlay assay was developed and B. adusta BK1 and T. versicolor D2 
were shown to be the most suitable species to screen in this way. 
 The overall hypothesis for the chapter was rejected, in that not all Bcc species were 
found to be active in the secretion of antifungal agents under the conditions 
screened. However, the screen succeeded in identifying several potent anti-fungal 
Burkholderia isolates which can now be characterized. 
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CHAPTER FOUR  
 
 
 
 
THE CHEMISTRAY AND ACTIVTY OF 
Burkholderia ANTIMICROBIAL AGENTS  
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4.1 Introduction 
In comparison to bacteria such as Streptomyces, Burkholderia are relatively unexploited in 
the antibiotic discovery field. By screening for antifungal activity in a large collection of 
Burkholderia species and strains we have demonstrated that 45.5 % of isolates have 
antimicrobial activity (Chapter 3). To further explore the diversity of the anti-fungal 
activity within Burkholderia, methods for production, extraction and chemical analysis of 
the antimicrobial compounds need to be developed and evaluated. In addition, the activity 
of pure Burkholderia antibiotics on their target organism will need to be tested. New 
antibiotics and their producing organisms are in great demand at the present time, and if 
the characterization of Burkholderia can be brought forward they may provide a new 
resource for antibiotic discovery. 
 
A profile of secondary metabolites of each organism consists of compounds produced 
under special growth conditions and includes enzymes, toxins, antibiotics and other 
unusual compounds. An advantage of using microorganisms to study secondary 
metabolites is that they can be grown under controlled conditions in the laboratory, which 
can be altered to mimic natural and un-natural conditions. For comparative purposes, 
microorganisms considered for chemical analysis must be grown on the same medium and 
under the same conditions of incubation to control the production of secondary 
metabolites. If the same antimicrobial extraction method is then applied, the metabolite 
profile obtained will primarily result from microbial diversity differences rather than due to 
the effect of environmental conditions (Sarker, et al., 2006). To date no work has studied 
the diversity of anti-candidal compounds produced by a wide range of Burkholderia. 
 
After the identification of antimicrobial activity in a pure culture, the extraction of 
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biologically active compounds is the next crucial step in the characterization of the 
antimicrobials. The development of suitable sample preparation techniques with significant 
advantages for the extraction and analysis of natural products plays an important role in 
providing a high quality and quantity of active natural products. Many studies have 
established various methods of extraction, characterization and identification of 
antimicrobial agents produced by Burkholderia. Different extraction techniques: 
maceration, liquid partition and adsorption (resin extraction) methods were used to extract 
biologically active constituents of Burkholderia metabolites in Mahenthiralingam lab, and 
were also conducted with a wide range of solvents with different polarities.  
 
Thin layer chromatography (TLC) is a simple, rapid and economical procedure. The 
extract profile can be visualized, depending on the nature of these compounds. The degree 
of the fractionation depends on the nature of the compound mixtures under investigation, 
the type of adsorption layer and the power (polarity) of the mobile phase (Fritz & Schenk, 
1987). The retention or retardation factor (Rf) is commonly used to describe the 
chromatographic structure of any TLC profile. The Rf value is the ratio of the distance the 
solvent travels to the distance the compound travels, and the center of each spot is the point 
at which the measurement is taken. Rf values and other characteristics, such as the colour 
of metabolites make it possible to study complex mixtures qualitatively. TLC together with 
various visualization reagents offers the ability to obtain a nearly complete picture of 
microbial secondary metabolite patterns. TLC combined with a bioassay is a rapid and 
simple method that was developed in this current project to study the presence and the 
diversity of antifungal agents in Burkholderia secondary metabolites.  
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A number of methods can be used to begin to clarify the structure of active compounds 
including liquid-liquid chromatography (LC), mass spectrometry (MS), nuclear magnetic 
resonance (NMR), infrared spectrometry (IR) and ultra-violet (UV) absorption. A 
combination of LC-MS is used to study multi component mixtures for the presence of 
specific compounds. This method can be used to help identify known classes of 
compounds when searching for novel bioactive compounds. Molecular weight and UV 
absorbance data of bioactive natural products in a database allows rapid identification of 
compounds. These data can then be compared to a database of compounds that have 
already been tested. NMR is ultimately the method used to confirm the structural identity 
of a compound (Petr, 2008). 
 
The general hypotheses for this chapter were: “Burkholderia bacteria produce more than 
one antimicrobial compound” and “TLC-Bioautography can be used to examine 
Burkholderia antimicrobial activity.” The aims of this chapter were: 
 To develop extraction techniques of active metabolites of Burkholderia.  
 To optimize conditions of thin layer chromatography to enhance fractionation and 
visualization of Burkholderia active metabolites.  
 To optimize the bioautography assay to detect active agents in each extract. 
  To study the diversity of antimicrobial agents within Burkholderia.  
 To purify and identify Burkholderia active metabolites. 
 To determination the minimal inhibitory concentrations of crude and semi-purified 
Burkholderia active metabolites. 
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4.2 Materials and Methods  
 
This present work was done to select the best conditions for the isolation, fractionation and 
identification of Burkholderia crude extracts and to determine the best conditions required 
to detect the active compounds of each extract. It also enabled detection of synergistic and 
antagonistic activity between compounds in each extract to show any antimicrobial activity 
effects. 
 
4.2.1 Extraction techniques 
Burkholderia antimicrobial metabolites were extracted using three methods of extraction 
(section 2.9): maceration, liquid-liquid and resin extraction. These fractions were then 
concentrated using a rotary evaporator at 30°C, and then kept at -20°C until use. The solid-
phase extraction technique, resin extraction, was also used for the first time on 
Burkholderia anti-fungals in this study. Amberlite XAD16 resin, a neutral cross-linked 
polystyrene resin was used to extract secreted antibiotics from agar and broth cultures of 
Burkholderia (section 2.9). Extract was stored in microtubes at -20ºC until used. 
 
4.2.2 Thin layer chromatography and bioautography assay (TLC) 
As described in Section 2.10, TLC and different solvents with different polarities were 
used as a mobile phase to achieve the best fractionation of Burkholderia crude extracts. 
The developed TLC plates were observed under suitable visualizing reagents and the 
position of each spot was marked. The distance from the center of the spot to the point of 
the solvent front was then measured and the values of retention factor (Rf) were obtained. 
A bioautography assay enabled rapid screening of natural extracts for antimicrobial 
activity. Many factors (section 2.10.1) were tested to detect the best conditions of 
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microbial growth on TLC plates such as: the affect of residual solvents, microbial 
inoculum size, pre-incubation and incubation conditions. The photos of developed TLC 
plates after the bioassay were taken under normal day light using a fixed digital camera 
(Sony, Cyber-shot, Japan).  
   
4.2.3  Diversity of antimicrobial agents within Burkholderia 
Eighteen Burkholderia isolates (Table 4.1) were chosen to investigate the diversity of anti-
candidal activity within Burkholderia. The selection of a small panel of Burkholderia 
isolates was based on different criteria including superior activity against C. albicans and 
B. adusta. The diversity of anti-candidal activity within these Burkholderia extracts was 
investigated using a TLC-bioautography assay. 
 
Four Burkholderia isolates B. ambifaria AMMD, BCF, KW and Mex-5 were chosen to 
further investigate the diversity of anti-basidiomycete activity within Burkholderia. These 
isolates were selected because they showed superior activity against C. albicans. The 
diversity of active metabolites produced by these B. ambifaria isolates against the 
following three basidiomycetes B. adusta, T. versicolor and S. gausaptum was investigated 
using a TLC-bioautography assay (section 2.10.2) and a basidiomycete agar overlay assay 
(section 2.5.2.2). 
 
Six Burkholderia isolates B. ambifaria AMMD, BCF, KW and Mex-5, B. vietnamiensis 
Bcc1409 and B. lata Bcc0233 were selected to investigate the diversity of anti-bacterial 
activity against 10 different species of Gram-positive and Gram-negative bacteria (Table 
4.2).  
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The TLC conditions used to separate pyrrolnitrin were adapted from previous studies as 
follows in order to compare the B. ambifaria active metabolites to this known antifungal. 
Pure pyrrolnitrin and eight of partially pure extracts of B. ambifaria AMMD were included 
in this comparison (section 4.3.4.1). Metabolite fractions were run in duplicate and 
compared side by side with pure pyrrolnitrin on the TLC plates under fixed conditions.  
The first run of these fractions and standard compounds were carried out on normal 0.25 
silica gel TLC plates and treated with chloroform, ethyl acetate and formic acid 5:4:1 v/v 
as a solvent system (Burkhead, et al., 1994). The second run was carried out on 
fluorescence 0.25 silica gel TLC plates and treated with chloroform and acetone 9:1v/v 
(Schmidt, et al., 2009). One set of TLC plates was visualized under UV light at 366 nm 
and the other set was overlaid with C. albicans. 
 
4.2.4 Purification and identification of Burkholderia active 
metabolites  
Based on the results of the initial preliminary anti-candidal screening tests using TLC-
bioautography assays, the crude extracts of B. ambifaria AMMD (Bcc0207), BCF 
(Bcc0203), KW (Bcc1256) and Mex-5 (Bcc1599) showed broad spectrums of activity 
against C. albicans, B. adusta and some bacteria. The attempt to isolate pure antimicrobials 
from Burkholderia metabolite extracts, three fractionation strategies were investigated to 
separate the B. ambifaria crude extracts into constituent active fractions, liquid 
fractionation (section 2.11.1), silica gel preparative thin layer chromatography (Section 
2.11.2) and silica gel column chromatography (section 2.11.3). Burkholderia fractions 
were separately applied onto silica gel TLC plates to confirm purity and anti-candidal 
activity for further analysis. These extracts were subjected to further investigation using 
fractionation, isolation and identification by MS. 
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The information obtained from MS is important for the identification of certain types of 
organic compounds. Recently the advanced liquid chromatography conducted with mass 
spectrometry (LC-MS) has provided important information about product ions, and it is 
one of the most rapid and sensitive methods for detection and identification. Active B. 
ambifaria fractions of crude and semi-purified extracts from strains AMMD, BCF, KW 
and Mex-5 were sent to Prof. Gregory Challis‟s laboratory at Warwick University for 
further chemical analysis, performed by Dr. Lijiang Song.  
 
4.2.5 Burkholderia antimicrobial activity  
Crude and semi-pure antimicrobial extracts of Burkholderia were dried and then dissolved 
to set concentrations in Muller Hinton broth (MHB). A 96-well plastic micro-plate 
(Sterilin, UK) was used to perform a microdilution antimicrobial susceptibility assay 
following the Clinical Laboratory and Standards Institute (CSLI) guidelines (Sass, et al., 
2011). Serial dilutions of the antimicrobial extracts were made in the test set of wells. 
Standardised cultures of the susceptibility testing microorganisms (approximately 1 x 10
5 
cfu ml
-1
) were then added to each well. The plates were incubated at 37ºC for 24 h and the 
resulting microbial growth was quantified by measuring optical density at 600 nm using an 
automatic plate reader. The MIC value was identified as the lowest concentration of the 
antimicrobial extract which reduced the optical density to 80% of that of the control 
cultures (section 2.5.3). 
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4.3 Results  
4.3.1 Extraction 
Both maceration of growth agar and solid-phase resin extraction were able to isolate active 
Burkholderia metabolites. However, the extraction efficiency of the Amberlite XAD-16 
resin followed by methanol elution proved to be the most robust method to extract the 
bioactive compounds from Burkholderia. 
   
4.3.2 Optimization of TLC and bioautography assay 
The solvents producing best fractionation of Burkholderia crude resin extracts were 
methanol, ethyl acetate, acetone and chloroform respectively. To improve the fractionation 
process of the crude resin extracts, these solvents were then mixed at different percentages 
to achieve suitable polarity. Ethyl acetate, methanol and water (EtOHc: MeOH: H2O) at a 
20:1:0.5 ratio was the best solvent system for separation of metabolites (Figures 4.1and 
4.2).  Methanol and water (8:2) was also capable of separating metabolites, but lacked the 
resolution of the EtOHc: MeOH: H2O (Figure 4.3). 
 
Most of the Burkholderia metabolites were not visible under day light before treatments 
with different chemical reagents.  Long-wave length (366 nm) of UV radiation and iodine 
vapour (period of exposure 15 min) were the best means to visualize Burkholderia 
metabolites profiles on normal silica gel TLC glass plates.  
 
Normal silica gel showed good separation of Burkholderia crude resin extracts (Figure 
4.4). UV at 366 nm was easier to apply than iodine vapour development, and under UV 
light each single metabolite appeared as different colour. In contrast, florescence silica gel  
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Figure 4.1 Fractionation of Burkholderia crude resin extracts using silica gel TLC. 
Crude resin extracts of B. ambifaria isolates, pyrrolnitrin (Pyr) and Basal salts agar (BSM) were spotted onto 
TLC plates in duplicate then fractionated using ethyl acetate:methanol:water (20:1:0.5). One set of developed 
TLC plates was visualized using UV at 366 nm (Panel N).The other set was used for bioautography assay, 
the plate was overlaid with soft Isosensitest agar seeded with C. albicans, after incubation of plates at room 
temperature for 3 h and then 24 h at 37C. The anti-candidal activity of different compounds is clearly visible 
as a clear zone on the red background of Candida cells which have grown and reduced the tetrazolium 
chloride metabolic indicator (Panel T). AMMD, B. ambifaria Bcc0207; BCF, B. ambifaria Bcc0250; KW, B. 
ambifaria Bcc1256; MEX-5, B. ambifaria Bcc1599. 
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Figure 4.2 Fractionation of B. ambifaria crude resin extracts using silica gel TLC. 
Crude resin extracts of 8 B. ambifaria isolates, pyrrolnitrin (Pyr) and Basal salts agar (BSM) were spotted 
onto TLC plates in duplicate then fractionated using ethyl acetate:methanol:water (20:1:0.5). One set of 
developed TLC plates was visualized using UV at 366 nm (Panel N).The other set was used for 
bioautography assay, the plate was overlaid with soft Isosensitest agar seeded with C. albicans, after 
incubation of plates at room temperature for 3 h and then 24 h at 37C. The anti-candidal activity of different 
compounds is clearly visible as a clear zone on the red background of Candida cells which have grown and 
reduced the tetrazolium chloride metabolic indicator (Panel T). A, Sabouraud Agar; B, Basal Salt Agar; C1, 
Pyrrolnitrin; 1, B. ambifaria Bcc0207; 2, B. ambifaria Bcc410; 3, B. ambifaria Bcc1599; 4, B. ambifaria 
Bcc0267; 5, B. ambifaria Bcc0193; 6, B. ambifaria Bcc1265; 7, B. ambifaria Bcc0478; 8, B. ambifaria 
Bcc0203. 
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Figure 4.3 Fractionation of Burkholderia crude resin extracts using silica gel TLC and methanol: water (8:2). 
Crude resin extracts of 10 B. ambifaria and B. lata, Sabouraud agar (C1) and Basal salts agar (C2) were spotted onto TLC plates in duplicate then fractionated in 
methanol:water (8:2). One set of developed TLC plates was visualized using iodine vapour (Panel N). The other set was used for bioautography assay, the plate was 
overlaid with soft Isosensitest agar seeded with C. albicans, after incubation of plates at room temperature for 3 h and then 24 h at 37C. The anti-candidal activity of 
different compounds are clearly visible as a clear zone on the red background of Candida cells which have grown and reduced the tetrazolium chloride metabolic indicator 
(Panel T). 1, B. ambifaria Bcc0478; 2, B. ambifaria Bcc0267; 3, B. ambifaria Bcc0250; 4, B. ambifaria Bcc0193; 5, B. lata Bcc0193; 6, B. ambifaria Bcc1256; 7, B. 
ambifaria Bcc0410; 8, B. ambifaria Bcc0372; 9, B. ambifaria Bcc1241; 10, B. ambifaria Bcc1222; 11, B. ambifaria Bcc0207. 
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was not able to discriminate many of these metabolites using UV (Figure 4.4 N1). 
Furthermore, the visualising of Burkholderia metabolites separated on reversed phase C18 
TLC plate was also un-successful (data not shown). The MeOH solvent showed extra 
capacity to extract many active metabolites compared with the acetone solvent which only 
extracted a fraction of the same compounds as MeOH.  
 
Once the basic solvent conditions had been optimised, the microbial overlay system was 
then optimised. After development, it was found that the TLC plates needed to be aired for 
at least 15 min in a laminar flow cabinet before use. The inoculum size of the 
microorganisms for bioautography assay varied between the species used. The best 
inoculum size of C. albicans and gram-positive bacteria was 5 ml of 1 x 10
-6
 cfu per 100 
ml of overlay agar. 1 ml of 1 x 10
-6
 cfu per 100 ml of overlay agar was optimal for gram-
negative bacteria B. multivorans. Pre-incubation of overlaid TLC plates for at least 3 h at 
room temperature (20 ± 2°C) improved the detection of bioactivity, prior to the 24 h 
incubation at 37°C to allow the overlay organisms to grow. Many of the inhibition zones 
were associated with distinct compound spots and could be detected under the UV light as 
round areas of quenching.  
 
4.3.3 Diversity of antimicrobial agents within Burkholderia 
Eighteen Burkholderia isolates were chosen to investigate the diversity of anti-candidal 
activity within Burkholderia. This panel included 9 isolates of B. ambifaria and an isolate 
from each category of B. cepacia complex. B. lata (Bcc0308) was used as a positive 
control. Two Burkholderia isolates B. ambifaria Bcc0193 and Bcc0372 were included as 
negative controls. Extracts of the un-inoculated BSM and SA media were included as  
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Figure 4.4 Fractionation of Burkholderia crude resin extracts using fluorescent and 
normal silica gel thin layer chromatography. 
Crude resin extracts of Burkholderia were spotted onto fluorescent (N) and normal (T) TLC plates in 
duplicate then fractionated using ethyl acetate: methanol: water (20:1:0.5). One set of developed TLC plates 
was visualized using UV at 366 nm (Panel N1 & N2).The other set was used for bioautography assays (T1 & 
T2), the plate was overlaid with soft Isosensitest agar seeded with C. albicans, after incubation of plates at 
room temperature for 3 h and then 24 h at 37C .  The anti-candidal activities of different compounds are 
clearly visible as a clear zone on the red background of Candida cells which have grown and reduced the 
tetrazolium chloride metabolic indicator. AMMD, B. ambifaria Bcc0207; BCF, B. ambifaria Bcc0250; KW, 
B. ambifaria Bcc1256; MEX-5, B. ambifaria Bcc1599. 
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negative controls. Pure pyrrolnitrin (Sigma) and gladiolin were also included as positive 
controls (Table 4.1). 
 
4.3.3.1 Diversity of anti-candidal agents  
The TLC-bioautography profile obtained from control extracts made from un-inoculated 
BSM and SA media showed no antimicrobial activity (Table 4.1). Pure pyrrolnitrin 
migrated to the end of the TLC solvent front with Rf value 0.97 ± 0.02 and showed anti-
candidal activity with an inhibition zone of 17 mm (Appendix B, Figure B.1). From the 
screening of Burkholderia isolates for anti-candidal activity (section 3.3.2), several isolates 
produced very faint bioactivity zones in the candidal overlay; they were scored as inactive 
isolates because no clear zone of inhibition was seen. Crude resin extracts were prepared 
from representatives of these relatively inactive isolates to determine if the anti-candidal 
agents could be extracted and act more potently. For example, B. ambifaria Bcc0193 was 
previously shown to have no major inhibitory effect on candidal growth (section 3.3.2.1); 
the TLC-bioautography demonstrated that this isolate did produce metabolites with Rfs 
0.42, and 0.74 had a very limited “faint” affect on the candidal overlay (Table 4.1 and 
Appendix B, Figure B.1). 
 
 
All sixteen active Burkholderia isolates examined were able to produce anti-candidal 
agents; they produced between 1 and 7 bioactive metabolites (Table 4.1). A total of 12 of 
the 18 Burkholderia isolates (66.6%) were able to produce active metabolites with similar 
Rf of pure pyrrolnitrin (Rf 0.97±0.02). The number and migration of active metabolites 
seen after growth on BSM-G and SA media were roughly the same (Table 4.1), with two 
major exceptions. B. cepacia Bcc0233 produced 5 active metabolites at Rfs 0.0, 
(T) A 
17 
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Table 4.1 TLC-bioautography assay of anti-candidal agents produced by 18 B. cepacia complex isolates. 
 
Bcc isolates 
 
Media  
Rf  of active metabolites (inhibition zone mm)    Active 
spots 
0.0 0.1 0.3 0.4 0.5 0.6 0.7 0.8 0.9 
B. ambifaria     Bcc0267 
BSM 0.02(2.5) 0.13 (20) - - - - - - - 2 
SA 0.01(2) 0.14(27) - - - - - - 0.916(20) 3 
B. ambifaria     Bcc0410 
BSM 0.01(16) 0.13(34) - - - - - - 0.916(20) 3 
SA - 0.13(32) - - - - - - 0.90(21) 2 
B. ambifaria     Bcc0478 
BSM - 0.13 (36) - - - 0.67(5F) - - 0.916(13) 2 
SA NT         - 
B. ambifaria     Mex-5 
BSM 0.01(10) 0.14(35) 0.35(14) - 0.51(19) 0.65(30) - 0.82(10) 0.95(17) 7 
SA 0.02(5) 0.12(30) 0.33(10) - 0.50(22) 0.62(14) - - 0.96(11) 6 
B. ambifaria     Bcc0193 
BSM - - - 0.42(3f) - - - - - 0 
SA - - - - - - 0.74(3f) - - 0 
B. ambifaria     Bcc0372 
BSM - - - - - - - 0.86(3f) - 0 
SA - - - - - - - 0.86(2f) - 0 
B. ambifaria     KW 
BSM 0.09(25) - - - 0.5(16) 0.63(20) - 0.82(10) 0.95 (22) 5 
SA - 0.16(14) - - 0.52(19) 0.67(5f) - 0.85(8) - 4 
B. ambifaria     AMMD 
BSM 0.01(6)     0.10(5) - 0.45(17) - 0.67(20) - 0.81(21) 0.97(8) 6 
SA 0.02(5) 0.11(4) - 0.42(10) - 0.64(11) 0.77(14) - 0.93(20) 6 
B. ambifaria     BCF 
BSM - 0.122(30) - - - 0.64(23) - - 0.97(8) 3 
SA 0.08 (23) - - - - 0.61(17) - - 0.93(20) 3 
B. vietnamiensis  Bcc1409 
BSM - - - - - 0.65(14) 0.73(5) - 0.92(26) 3 
SA NT         - 
B. contaminans  Bcc1315 
BSM - - - - - - - - 0.906(18) 1 
SA 0(1) - - - - - - - 0.906(18), 
0.98(8) 
3 
B. anthina             Bcc1350 
BSM - 0.107(20) - - - - - - 0.903(14) 2 
SA - 0.107(15) - - - - - - 0.9(18) 2 
B. cepacia             Bcc0233 
BSM - - - - - - - - 0.98(f) 0 
SA 0(2) - 0.35(4) 0.46(2) - - 0.75(4) - 0.98(22) 5 
B. cepacia             Bcc0004  
BSM NT          
SA - - - 0.48(f) 0.58(f) - 0.786(f) - 0.978(f) 0 
B. cenocepacia    Bcc0019 
BSM - - - - - - - - 0.90(13) 0 
SA - - - - - - - - - 1 
B. cenocepacia    Bcc0165 
BSM - - - - - - - - 0.90(11) 1 
SA - - - - - - - - 0.92(7) 1 
B. lata                   Bcc0803 
BSM - - - - - - 0.73(3) - - 1 
SA - - - 0.48(4) - - 0.72(2) - - 2 
B. pyrrocinia       Bcc0171 
BSM - - - 0.48(2) - - - - - 1 
SA - - - 0.49(2) 0.58(2) - 0.72(2) - - 3 
Pyrrolnitrin  (positive control) - - - - - - - - 0.978(17) 1 
BSM              (negative control) - - - - - - - - - 0 
SA                 (negative control) - - - - - - - - - 0 
Rf, Retention factor; values in brackets show the mean of inhibition zone in mm; f, faint effect;  NT, not tested; BSM,  basal salt medium; SA, Sabouraud medium.  
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0.35, 0.46, 0.75 and 0.98 when grown on BSM medium and produced only 1 compound 
with a faint affect at Rf 0.9 when grown on SA (Table 4.1). B. cenocepacia Bcc0019 
produced only one anti-candidal compound when grown on BSM-G medium at Rf 0.98 
and it did not produce any active agents when grown on SA medium (Table 4.1 and 
Appendix B, Figure B.1: 13A, 13B). 
 
B. ambifaria Mex-5, AMMD and BCF were the most active isolates when both the size of 
the inhibition zones and the number of active anti-candidal metabolites were considered 
(Table 4.2). B. ambifaria Mex-5 produced at least 7 active metabolites when grown on 
BSM-G medium at Rfs 0.01, 0.14, 0.35, 0.51, 0.65, 0.82 and 0.95 with different inhibition 
zones ranging from 10 mm to 35 mm. A slight difference in the production of anti-candidal 
agents was observed between BSM-G and SA media, as one of anti-candidal agents with 
Rf 0.82 was absent. C. parapsilosis showed nearly the same sensitivity against 
Burkholderia metabolites as C. albicans (Table 4.1 and Appendix B, Figure B.2). 
 
4.3.3.2 Diversity of anti-basidiomycetes agents  
As had been done with the anti-candidal assays, the Burkholderia crude resin extracts were 
fractionated on silica gel TLC plates using ethyl acetate, methanol and water (20:1:0.5) 
prior to analysis of anti-basidiomycete activity (Figure 4.5, B). The subsequent 
bioautography testing involved using the novel fragmented mycelial overlay assay for 
basidiomycetes B. adusta, T. versicolor and S. gausapatum, that had been successfully 
developed previously (section 2.5.2.2). 
 
According to the TLC-bioautography profile (Figure 4.5, A and Table 2), the results  
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Figure 4.5 Fractionation of 4 different B. ambifaria extracts (AMMD, BCF, KW and MEX-5) on TLC and detection of 
anti-basidiomycetes agents using bioautography assay.
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Figure 4.5 Detection of anti-basidiomycete agents of B. ambifaria crude 
resin extracts. 
Crude resin extracts of 4 different B. ambifaria isolates (AMMD, BCF, KW and MEX-5) were 
spotted onto TLC plates in duplicate then fractionated using ethyl acetate:methanol:water 
(20:1:0.5). One set of developed TLC plates was visualized by UV light at 365 nm (Panel B). 
The other set was used for bioautography assay; the plate was overlaid with soft Sabouraud agar 
seeded with Bjerkandera adusta (BK1), Trametes versicolor (D2), Stereum gausapatum (Sa1). 
After incubation of plates at 20C for 3d, the plates covered with 2 ml 2% triphenyl tetrazolium 
chloride (TTC). The anti-basidiomycete activity of different compounds is clearly visible as a 
clear zone on the red background of basidiomycete cells which have grown and reduced the TTC 
metabolic indicator (Panel A). Arrows indicated the location of active metabolites. 
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showed that all B. ambifaria isolates were able to produce anti-basidiomycete metabolites 
which inhibited the growth of the 3 tested fungi. B. ambifaria AMMD, BCF, KW and 
Mex-5 produced 2 active anti-T. versicolor and anti-S. gausaptum metabolites at Rfs 0.02 
and 0.98 (Figure 4.5, panel A: D2 and Sa1). B. ambifaria AMMD and Mex-5 produced 3 
active anti-B. adusta metabolites at Rfs 0.02, 0.70 and 0.98. In addition, B. ambifaria BCF 
and KW produced 2 active anti-B. adusta metabolites at Rfs 0.02 and 0.98 (Figure 4.5, 
panel A; BK1). 
 
4.3.3.3 Diversity of anti-bacterial agents  
Pure pyrrolnitrin migrated up to the end of the TLC solvent front with Rf values 0.97 ± 
0.02, and showed anti-bacterial activity against all tested bacteria, except S. maltophilia 
LGM958 and A. baumannii (Table 4.2 and Appendix B; Figure B.2). All tested 
Burkholderia produced active antibacterial metabolites with Rf values 0.97 ± 0.03 which 
corresponded to that of pure pyrrolnitrin (Table 4.2). 
 
B. ambifaria AMMD, BCF, KW and Mex-5 produced a wide range of active antibacterial 
metabolites. They produced up to six active metabolites which exhibited greater effect 
against Gram positive than Gram negative bacteria (Figure 4.6). The profile of active anti-
Gram positive compounds largely matched those of the anti-candidal metabolites (Figure 
4.1) for the Burkholderia screened. 
 
Active metabolites of B. ambifaria AMMD (Rf 0.45 ± 0.05) with yellow colour, inhibited 
all Gram-positive and Gram-negative bacteria tested. However, B. ambifaria BCF 
metabolites (Rf 0.01 ± 0.01) with a brown colour were most active against Gram-positive 
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bacteria (Figure 4.6 for S. aureus; Table 4.2), but also showed good activity against P. 
fluorescens (Table 4.2 and Figure 4.6) and weaker activity on E. coli (Table 4.2 and 
Appendix B, Figure B.2). Other BCF metabolites migrating at Rf 0.45 ± 0.05 with a yellow 
colour also showed good anti-Gram positive activity, and some activity against P. 
fluorescens (Table 4.2 and Figure 4.6). 
 
B. ambifaria KW Metabolites (Rf 0.41 ± 0.01, 0.70 ± 0.01, 84 ± 0.02 and 0.99 ± 0.01) 
were able to inhibit the growth of E. faecalis ATCC51299 (Figure 4.6, A) and P. 
fluorescens LMG1974 (Figure 4.6, D). Furthermore, other KW metabolites (Rf 0.69 ± 
0.02, 0.83 ± 0.01 and 0.99 ± 0.01) inhibited the growth of all Gram-positive bacteria 
(Table 4.2). 
 
In B. ambifaria Mex-5 only one metabolite (Rf 0.01 ± 0.01) was able to inhibit the growth 
of all tested bacteria (Figure 4.6 and Appendix B, Figure B2) except Gram-negative S. 
maltophilia LMG958 (Appendix B, Figure B2) and A. baumannii (Figure 4.6, C) and the 
metabolites detected at Rfs 0.83 ± 0.02 and 0.98 ± 0.02 inhibited the growth of all tested 
bacteria except S. maltophilia LGM958, A. baumannii, E. coli NCTC1224 and B. 
cenocepacia LMG16656 (Table 4.2, Figure 4.6 and Appendix B, Figure B2). 
 
B. vietnamiensis Bcc1409 produced a range of antibacterial metabolites which mainly 
affected the growth of the Gram-positive bacteria (Table 4.2). In contrast, B. lata Bcc233 
metabolites  (Rfs 0.02, 0.08, 0.16, 0.42, 0.53, 0.66, 0.81 and 0.99), inhibited the growth of 
Gram-positive S. aureus strains, except NCTC12981 (Appendix B, Figure B2). However, 
this extract was inactive against other gram negative bacteria (Appendix B, Figure B2).  
2 3 
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Figure 4.6 Detection of antibacterial agents of Burkholderia crud resin extracts. 
Crude resin extracts of 6 Burkholderia, pyrrolnitrin and pure gladiolin were spotted onto TLC plates in 
duplicate then fractionated using ethylacetate:methanol:water (20:1:0.5). One set of developed TLC plates 
was visualized using UV at 366 nm. The other set was used for bioautography assays, the plate was overlaid 
with soft Isosensitest agar seeded with gram positive bacteria, after incubation of plates at room temperature 
for 3 h and then 24 h at 37C. The anti bacterial activity of different compounds are visible as a clear zone on 
the red background of gram positive bacteria cells which have grown and reduced the tetrazolium chloride 
metabolic indicator. AMMD, B. ambifaria Bcc0207; BCF, B. ambifaria Bcc0250; KW, B. ambifaria 
Bcc1256; MEX-5, B. ambifaria Bcc1599; 233, B. lata Bcc0233; 1409, B. vietnamiensis Bcc1409; Pyr, pure 
pyrrolnitrin; Gla, pure gladiolin. The overlaid bacteria were: A, E. faecalis; B, S. aureus Egales; C, A. 
baumannii; D, P. fluorescens. 
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Table 4.2 Spectrum of inhibition of the Burkholderia crude resin extracts. 
                                       Rf values of Burkholderia active metabolites            Controls 
 Tested microorganisms AMMD BCF KW Mex-5 1409 233 Pyr Gla 
A
s
c
o
m
y
c
e
te
  
 
C. albicans  
(6)/ 0.0 
0.09 
0.44  
0.65 
0.85 
0.98 
(3)  
0.03 
 
0.61 
 
0.98 
(5) 
 0.09 
0.52 
0.65 
0.84 
0.98 
(6)/ 0.00 
0.35 
0.53 
 0.62 
0.84 
0.98 
(3) 
 0.00 
0.05f 
0.66  
 
0.99 
(5) 
0.01 
0.35 
0.46 
0.75 
0.98 
 
 
 
 
 
0.99 
 
 
0.36 
C.  parapsilosis  
(6) 
 0.00 0.05 
0.43  
0.65 
 0.8 
 0.99 
(2) 
 0.00 
 
0.52f 
 
 
0.98 
(5) 
 0.10 
0.45 
0.70f 
0.87 
0.95 
1.00 
(7)/ 0.00 
0.10 
0.49 
 0.64 
0.86 
 0.94 
1.00 
(4) 
0.00 
0.04 
0.50f 
0.72  
 
0.98 
(5) 
0.10 
0.33 
0.46 
0.76 
 
0.96 
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0.40 
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 B. adusta (3)/ 0.02 
0.70 
0.9 
(2) 
 0.02 
0.98 
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 0.02 
0.98 
(3)/ 0.02 
0.47 
0.98 
N N  
 
0.98 
N 
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 0.02 
0.98 
(2)  
0.02 
0.98 
(2)  
0.02 
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(2)  
0.02 
0.98 
N N  
 
0.98 
N 
S. gausapatum  (2) 
 0.02 
0.98 
(2) 
 0.02 
0.98 
(2) 
0.02 
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(2) 
0.02 
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 0.85 
0.98 
(2) 
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0.08f  
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E. coli   0.4 0.0 
0.5 f 
- 0.0 0.0 -  
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E. faecalis  
(3)  
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0.07 
0.48 
(2)  
0.00 
0.42 
(4) 
 0.40 
0.71 
0.82 
0.98 
(5)/ 0.0 
0.45 
 0.74 
0.82 
0.97 
- (2) 
 0.00 
0.5 
 
0.98 
0.35 
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0.44 
 0.66 
0.0 
0.45 f 
(4) 
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0.45 
0.82 
 0.95 
1.00 
0.08 (7)0.02 
0.08 
0.16 
0.53 
0.66 
0.81 
0.99 
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0.37 
S. aureus MRSA15 
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 0.49 0.73 
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 1.00 
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0.08 
 
 
 
0.99 
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0.42 
0.53 
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0.81 
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0.44 
S. aureus MRSAMu50.0 
(4) 
0.0 
0.43 
 0.68 
 
1.00 
(2) 
0.0 
0.41 
(4) 
0.49 
0.64 
0.83 
 
0.98 
(6) 
 0.0 
0.45 
 0.60 
0.81 
 0.90 
0.98 
(2) 
0.02 
 
0.99 
(7)0.02 
0.08 
0.16 
0.53 
0.66 
0.81 
0.99 
 
 
 
 
 
0.99 
 
0.35 
S. aureus  NCTC12981 
 
0.44 
0.0 (3)/  
0.71 
0.83 
1.00 
(3)/ 0.00  
 
0.81 
1.00 
- -  
 
 
0.98 
 
0.37 
Results are shown for B. ambifaria AMMD; BCF; KW and Mex-5; B. vietnamiensis 1409; B. lata 
Bcc0233; Pyr, pyrrolnitrin; Gla, Gladiolin; N, not tested; f, faint activity; Rf, retention factor; 
numbers between bracts ( ) are the number of active metabolites were detected.  
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In addition to screening the anti-bacterial nature of the Bcc isolates, a novel pure antibiotic, 
designated gladiolin, was also investigated for the first time using TLC-bioautography 
(Figure 4.6, Gla). Gladiolin is a novel macrolide antibiotic produced by Burkholderia 
gladioli Bcc 0238 and is characterization has just begun (Mahenthiralingam et al., 
unpublished data). Gladiolin showed broad spectrum anti-bacterial activity against both 
Gram-positive and Gram-negative bacteria (Figure 4.5, Table 4.2).  
 
4.3.4 Purification of Burkholderia active metabolites 
The Burkholderia crude resin extracts of secreted metabolites contained large amounts of 
inactive materials, in addition the active antimicrobial compounds which were often 
present at low concentrations. To obtain large quantities of Burkholderia active 
metabolites, three purification strategies were evaluated: liquid-liquid extractions, column 
chromatography and silica gel preparative TLC. After multiple attempts at purification 
using these different methodologies, preparative TLC was judged as the most simple and 
productive method to purify bioactive metabolites within Burkholderia crude resin 
extracts. A preparative TLC purification scheme was developed and specifically applied to 
characterize the anti-candidal components of the Amberlite XAD-16 Burkholderia extracts 
(crude resin extracts). Semi-purified active Burkholderia fractions were subsequently sent 
to Warwick University for mass measurement and putative chemical identification. 
 
4.3.4.1  Preparative TLC plates 
Silica gel preparative TLC plates with two different thicknesses, 500 and 1500 µm, were 
used to fractionate Burkholderia metabolites. The thickness of the silica gel of preparative 
TLC had a clear affect on the fractionation of crude extracts (Figure 4.7). The 1500 µm 
plates showed better separation than the 500 µm plates. For example, the crude resin 
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extracts of B. ambifaria AMMD, which contained 2 major active metabolite spots on both 
plates, showed much greater separation on the 1500 µm plate (Figure 4.7). The crude resin 
extracts of B. ambifaria KW and Mex-5 gave, respectively, 5 and 6 active metabolites, 
well separated anti-candidal metabolites on plates of 1500 µm thickness; in comparison, 
these strains gave, respectively, just 3 and 4 active anti-candidal metabolites on plates of 
500 µm which showed a reduced ability to separate active components within the same 
crude extracts (Figure 4.7). Additionally, the 1500 µm preparative TLC plates also 
possessed about four times the loading capacity, and larger quantities of the crude resin 
extracts could be inoculated to provide better yields of the active fractions.  
 
Once the anti-candidal components of the preparative TLC fractions had been identified 
using the TLC-bioautography assays, replicate separations were set up where a single 
strain extract was fractionated on a single TLC plate. Using the Rf values observed in the 
bioassays (Figure 4.7), area of silica gel sorbent containing the active metabolites was 
scraped and collected. Absolute methanol was then used to re-extract semi-pure 
Burkholderia metabolites bound to silica gel; after filtration to remove the gel, the extract 
was concentrated and stored at -20ºC for further analysis.  
 
From the analytical and preparative TLC it was clear that B. ambifaria BCF and Mex-5 
produced metabolites associated with highly active zones that did not migrate under the 
TLC conditions applied. These spots were dark brown in colour and their anti-candidal 
activity was considerable (Figure 4.7). Fractionation of these basal fractions was therefore 
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Figure 4.7 Fractionation and purification of anti-candidal agents of Burkholderia using preparative silica gel TLC. 
Crude resin extracts of 6 Burkholderia, were spotted onto preparative TLC plates with different thickness 500 µm and 1500 µm and developed with ethyl acetate: 
methanol: water (20:1:0.5). The developed plates were then overlaid with soft Isosensitest agar seeded with C. albicans. After incubation of plates at room temperature for 
3 h and then 24 h at 37C. The anti-candidal activity of different compounds was visible as a clear zone on the red background of Candida cells which have grown and 
reduced the tetrazolium chloride metabolic indicator. AMMD, B. ambifaria Bcc0207; BCF, B. ambifaria Bcc0250; KW, B. ambifaria Bcc1256; MEX-5, B. ambifaria 
Bcc1599; 233, B. lata Bcc0233 and 1409, B. vietnamiensis Bcc1409. 
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attempted using different solvents with different polarities to see if they could be separated 
further. A mixture of ethylacetate:methanol:water (4:1:0.25) was able to fractionate these 
non-migrating spots into roughly 3 different fractions with anti-candidal activity (Rfs 0.05, 
0.30 and 0.65; Figure 4.8). 
 
The separations were not as clear as seen under previous conditions (Figure 4.7), with 
active metabolites running as more of a smear, however, a non-migrating zone and two 
inhibitions zones above this could be seen.  Moreover, these results also confirmed that the 
single inhibition zones seen in the TLC fractionation of Burkholderia extracts may 
sometimes be due to the presence of multiple active metabolites. 
 
 Semi-pure fractions of Burkholderia crude resin extracts were evaluated against C. 
albicans using TLC-Bioautography assays, to detect the activity and purity of each 
fraction. The fractionation progression using 1500 µm preparative TLC plates was able to 
separate reasonable amounts of semi-pure compounds for further investigations. The crude 
extract of B. ambifaria AMMD provided 3 semi pure active fractions which separated at 
different Rfs 0.66, 0.85 and 0.98 (Figure 4.9). The B. ambifaria BCF extract provided 4 
semi pure active fractions that were located at Rfs 0.00, 0.20, 0.60 and 0.98 (Appendix B: 
Figure B3; N1, T1). The B. ambifaria KW extract provided 5 semi pure active fractions 
(Appendix B: Figure B3; N2, T2) separating Rfs 0.00, 0.50, 0.60, 0.84 and 0.98. B. 
ambifaria Mex-5 extract provided 6 semi pure active fractions which were located at Rfs 
0.00, 0.25, 0.50, 0.74, 0.84 and 0.98 (Appendix B: Figure B4). The activity of these 
fractions was retested against C. albicans and the activity was confirmed. 
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Figure 4.8 Fractionation and detection of anti-candidal activity of the previously non-migrating active metabolites (Rf 0.01) of B. 
ambifaria BCF and Mex-5. 
Non-migrating fractions (Rf 0.01) of B. ambifaria BCF and Mex-5, were spotted onto TLC plates in duplicate. One set of TLC plates was developed with ethyl acetate: 
methanol (1:1) (panel N1) and the other set was developed with ethyl acetate:methanol:water (20:1:0.5) (panel N2). The developed TLC plates were then overlaid with 
soft Isosensitest agar seeded with C. albicans. After incubation of plates at room temperature for 3 h and then 24 h at 37C, the anti-candidal activity of different 
compounds was visible as a clear zone on the red background of Candida cells which have grown and reduced the tetrazolium chloride metabolic indicator (panel T1 and 
T2). Arrows indicated the location of active semi-pure metabolites. 
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Figure 4.9 Profile of B. ambifaria AMMD metabolites fractionated using silica gel preparative TLC. 
Semi-pure fractions (Fraction 1 to fraction 7) fractionated from crude resin extract and cured resin extract of B. ambifaria AMMD were spotted onto TLC plates in 
duplicate. One set of TLC plates was developed with ethyl acetate: methanol: water (20:1:0.5) (panel N). The other set was overlaid with soft Isosensitest agar seeded with 
C. albicans. After incubation of plates at room temperature for 3 h and then 24 h at 37C, the anti-candidal activity of different compounds was visible as a clear zone on 
the red background of Candida cells which had grown and reduced the tetrazolium chloride metabolic indicator (panel T). Arrows indicate the location of active semi-pure 
metabolites.  
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4.3.4.2  Liquid-liquid extraction  
The liquid-liquid method of fractionation was also evaluated for use on B. ambifaria 
AMMD crude extracts using different solvents with different polarities in an attempt to 
purify component antimicrobials (section 2.11.1). Anti-candidal activity was found in just 
one fraction of B. ambifaria AMMD extract, a yellow fraction extracted using the non-
polar solvent di ethyl ether. TLC-bioautography indicated that the activity of the ether 
fraction was due to just one yellow compound which lay at Rf 0.65 (data not shown). In 
contrast, the results of the TLC-bioautography assay of AMMD crude extract revealed that 
the anti-candidal activity located to at least 6 inhibition zones seen at different Rfs (Table 
4.2).  
 
4.3.4.3 Column chromatography  
The B. ambifaria AMMD crude resin extract was also fractionated using silica gel column 
chromatography into 4 fractions with 3 active anti-candidal metabolites using ethyl acetate 
:methanol:water 20:1:0.5 (Figure 4.10). The first active metabolite collected from the 
beginning of the eluting process within the first 10 ml of solvent and deposited at Rf 0.98, 
was colourless under day light and black under UV at 366 nm (Figure 4.10, G1). The 
second active metabolite collected after 15 ml until 25 ml from the beginning of the 
fractionation process and deposited at Rf 0.73 ± 0.01, was colourless under day light and 
light blue under UV at 366 nm (Figure 4.10, G2). The third active metabolite detected at 
30 ml of eluted solvent and collected as a pure compound after 100 ml until 475 ml from 
the beginning of the fractionation process and deposited at Rf 0.54 ± 0.02, was yellow 
under day light and black under UV at 366 nm (Figure 4.10, G3). 
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Figure 4.10 Profile of B. ambifaria AMMD metabolites fractionated using silica gel 
column chromatography. 
B. ambifaria AMMD crude resin extract was fractionated by ethyl acetate, methanol and water 20:1:0.5 using 
silica gel chromatography column. The fractions were collected and then analysed using TLC-bioautography 
as shown. Semi-pure fractions (Fraction 1 to fraction 63) fractionated from cured resin extract of B. 
ambifaria AMMD were spotted onto TLC plates in duplicate. One set of TLC plates was developed with 
ethyl acetate: methanol: water (20:1:0.5) (panel A). The other set was overlaid with soft Isosensitest agar 
seeded with C. albicans. After incubation of plates at room temperature for 3 h and then 24 h at 37C, the 
anti-candidal activity of different compounds was visible as a clear zone on the red background of Candida 
cells which have grown and reduced the tetrazolium chloride metabolic indicator (panel B). G1, first active 
semi-pure metabolites (Rf 0.99); G2, second active semi-pure metabolites (Rf 0.70); G3, third active semi-
pure metabolites (Rf 0.52); G4, forth in active semi-pure metabolites; crude, crude risen extract. 
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4.3.5 Identification of anti-candidal compounds produced 
by B. ambifaria isolates 
 
Semi-pure fractions of B. ambifaria isolates AMMD, BCF, KW and Mex-5 (section 
2.11.2) were sent to Warwick University for characterisation and identification.  
 
4.3.5.1 Anti-candidal compounds produced by B. ambifaria 
AMMD 
B. ambifaria AMMD produced 6 active fractions (Figure 4.4).  The basal fraction (Rf 0.01) 
provided 3 ions with m/z of 758.3905, 776.4010, 790.3182 with molecular formulas of 
C45 H52 N5 O6, C45 H52 N5 O7 and C25 H48 N11 O18, respectively (Appendix B; 
Figure B5). It was proposed that these ions correspond to polyethylene glycol (PEG), 
unknown peptides and plasticizer respectively. Fraction 2 which had Rf 0.65 provided 
(Figure 4.11, a) an ion with m/z = 724.2270 with molecular formulas (C33 H45 Cl 2 N Na 
O11). It was deduced that these ions correspond to enacyloxin II a.  
 
Fraction 3 which had Rf 0.86 provided 3 ions with m/z 256.1705, 256.1693 and 256.1693 
with molecular formulas C17 H22 N O, C19 H26 N O and C21 H30 N O3, respectively 
(Figure 4.11, b). It was deduced that these ions correspond to a group of quinolinones: 4-
hydroxyl-3-methyl-2-alkyl-4-quinolinone (HMAQ-256), 4-hydroxyl-3-ethyl-4-quinolinone 
(HAQ-284) and one other derivative of 4-hydroxyl-3-methyl-2-alkyl-4-quinolinone 
(HMAQ-344). Fraction 4, which deposited at Rf 0.98, provided ions with m/z = 301.1409 
and 413.2664 and molecular formulas of C16 H22 Na O4 and C24 H38 Na O4, 
respectively (Figure 4.11). It was deduced that these ions correspond to different 
plasticizers. 
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Figure 4.11 Mass spectra of B. ambifaria AMMD fraction 3 (Rf 0.65) and fraction 4 (Rf 0.48). 
Data indicated that these fractions were dominated by (a) enacyloxin IIa (724 m/z) and other putative enacyloxin isomer (b) 4-hydroxyl-3-methyl-2-alkyl-quinoline 
(HMAQ-256), 4-hydroxyl-3-ethyl-quinoline (HAQ-284); and derivative of 4-hydroxyl-3-methyl-2-alkyl-quinoline (HMAQ-344).The chemical structure shown on lift 
panel (a) is enacyloxin IIa, and the chemical structure shown on right panel (b) is HMAQ respectively. 
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4.3.5.2 Anti-candidal compounds produced by B. ambifaria 
BCF 
 
B. ambifaria BCF provided 3 active fractions with anti-candidal activity. The BCF basal 
fraction was deposited at Rf 0.01 and provided 4 ions with m/z 454.1164, 438.1211, 
383.0755 and 494.1466, with molecular formulas C19 H28 Cl 2 O8, C19 H28 Cl 2 O7, 
C15 H17 Cl 2 N6 O2 and C20 H30 Cl 2 N3 O7, respectively (Figure 4.12). It was 
proposed that these ions correspond to different bactobolins: A, B, D and a new bactobolin 
containing Cl2 (Figure 4.12, d). Fraction 2 was deposited at Rf 0.61 and provided an ion 
with m/z = 724.2270 and with a molecular formula of C33 H45 Cl 2 N Na O11. It was 
deduced that these ions corresponded to enacyloxin II a. Fraction 3 was deposited at Rf 
0.98 and provided ions with m/z = 301.1409 and 413.2664,  and molecular formulas C16 
H22 Na O4 and C24 H38 Na O4. It was deduced for these ions that they correspond to 
different plasticizers as had been seen with the AMMD fraction 7 analysis. 
 
4.3.5.3 Anti-candidal compounds produced by B. ambifaria 
KW and Mex-5 
The crude extract of B. ambifaria KW and Mex-5 provided 5 and 6 active anti-candidal 
fractions respectively. The mass spectra of these fractions indicated the presence of at least 
10 potentially novel anti-candidal metabolites (Appendix B; Figures B7 and B8). The basal 
fraction of B. ambifaria Mex-5 was deposited at Rf 0.01 and provided many ions with m/z 
383.0770, 367.0824 and 395.0780 with molecular formulas C14 H21 Cl2 N2 O6, C14 H21 
Cl2 N2 O5 and C15 H21 Cl2 N2 O6, respectively (Figure 4.13). As had been observed 
with strain BCF, these were putatively identified as derivatives of bactobolin. 
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Figure 4.12  Mass spectra of B. ambifaria BCF fraction 1 (Rf 0.01). 
Data indicated that this fraction is dominated by different of Bactobolins. (a) Bactobolin A; (b) Bactobolin B; 
(c) Bactobolin D; and (d) new Bactobolin containing Cl2. The chemical structure shown on the middle of the 
panel is bactobolin A. 
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Figure 4.13  Mass spectra of B. ambifaria Mex-5 fraction 1 (Rf 0.01). 
Results indicated that, fraction 1 was dominated by many of Bactobolins. (a), Bactobolin A (383.077 m/z); 
(b), Bactobolin c (367.08 m/z) and (c), new Bactobolin (395.078 and 397.07 m/z). 
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It was proposed that these ions correspond to bactobolin A, C and a new bactobolin 
containing Cl2 (Figure 4.13, c). The Mex-5 bactobolins were different in mass to those 
produced by strain BCF, except for the BCF bactobolin D and Mex-5 bactobolin A which 
shared very similar ion mass. The results also indicated that bactobolin C was the major 
bactobolin fraction detected in the Mex-5 metabolites. Mass spectra data indicated that B. 
ambifaria KW and Mex-5 produced many compounds but database search indicated these 
belong to new chemicals. Overall, the mass spectra data indicated that both B. ambifaria 
KW and Mex-5 produced a wide range of known bioactive metabolites such as the 
bactobolins as well as novel compounds with mass that did not match to those within the 
database of antimicrobials examined at Warwick University. 
 
4.3.6  Detection of pyrrolnitrin in B. ambifaria and 
comparison of extraction procedures 
Several previous studies on Burkholderia sp have shown that pyrrolnitrin was one of the 
compounds they produce that contribute to their antifungal activity (Schimdt, et al., 2009). 
Therefore, in the current study pure pyrrolnitrin (5 µg) was included as a known control for 
comparison with Burkholderia anti-candidal metabolites and incorporated into the TLC 
and other purification schemes used to isolate novel metabolites. 
 
TLC fractionation of pyrrolnitrin using the ethyl acetate: methanol: water (20:1:0.5) 
solvent system results in the compound migrating with the solvent front at Rf values of 
greater than 0.95. Therefore, other solvent systems were evaluated based on those that had 
been previously applied to pyrrolnitrin (Burkhead, et al., 1994). Silica gel TLC-
bioautography assay using a chloroform-ethyl acetate-formic acid 5:4:1 v/v solvent system 
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was successful for fractionation of pyrrolnitrin. The pure compound located as a single 
dark spot at Rf 0.77 (Figure 4.14, N1 pyr), produced a large clear inhibition zone (12mm) 
against C. albicans (Figure 4.14, T1 pyr). In addition using fluorescence TLC plates and 
chloroform:acetone (9:1) as the solvent system, pure pyrrolnitrin gave a single dark spot at 
Rf 0.685 (Figure 4.14, N2 pyr) and a large (18 mm) inhibition zone (Figure 4.14, T2 pyr). 
Both systems were, therefore, applied to screen the Burkholderia extracts for the presence 
of pyrrolnitrin-like metabolites. 
 
Several fractions from the metabolite isolation and purification work were suspected to 
contain pyrrolnitrin as one of the active antifungal metabolites. The last fraction of 
preparative TLC plates of B. ambifaria AMMD crude extract, which was deposited at Rf 
0.98 (Table 4.2), co-located adjacent to pure pyrrolnitrin (Figure 4.14). The first fraction of 
column chromatography, the ethyl acetate fraction (Figure 4.10), also ran at the same Rf as 
pure pyrrolnitrin (Figure 4.14). Finally, an acetone extract from the liquid-liquid 
extractions also showed the same results as pure pyrrolnitrin (Figure 4.14). All these 
AMMD fractions also produced the anti-candidal activity characteristic of pyrrolnitrin 
under both conditions of TLC fractionation (Figure 4.14: T1 and T2). The same separation 
scheme was also applied to the last preparative TLC fraction (Rf 0.98) of B. ambifaria 
Mex-5, and the isolated active compound showed the same Rf and anti-candidal activity as 
pure pyrrolnitrin under both conditions of the preparative TLC plate. Overall, these results 
demonstrated that both B. ambifaria AMMD and Mex-5 produced an antifungal compound 
that was most likely pyrrolnitrin, a well characterized and highly bioactive Burkholderia 
metabolite. 
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Figure 4.14 Characterisation of pure pyrrolnitrin and semi-purified antifungal 
extracts of B. ambifaria using two different systems of TLC and solvents. 
The first system was normal silica gel (0.25 µm) and chloroform-ethyl acetate-formic acid 5:4:1 v/v as 
solvent system (N1) and the second system was fluorescens silica gel (0.25 µm) and chloroform: acetone 9:1 
v/v as solvent system (N2). One set of TLC plates was visualised using UV at 366 nm (N1 & N2) and the 
other set was overlaid with C. albicans (T1 & T2). Pyr, pure pyrrolnitrin (Sigma); 1, B. ambifaria AMMD 
semi-pure fraction of preparative TLC (Rf 0.98); 2, B. ambifaria AMMD first fraction of column 
chromatography called ethyl acetate fraction; 3, acetone extract of liquid extraction; 4, B. ambifaria BCF 
semi-pure fraction of preparative TLC (Rf 0.98); 5, B. ambifaria KW semi-pure fraction of preparative TLC 
(Rf 0.98); 6, B. ambifaria Mex-5 semi-pure fraction of preparative TLC (Rf 0.98); 7, B. ambifaria AMMD 
second fraction of column chromatography called the ethyl acetate: methanol (1:1) fraction; 8, B. ambifaria 
AMMD third fraction of column chromatography called methanol fraction. Arrows indicate the location of 
pure pyrrolnitrin and similar metabolites (Rf) of other extracts.   
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4.3.7  Determination of antimicrobial activity of crude and 
semi purified extracts of Burkholderia sp 
 
The antimicrobial activity of Burkholderia crude and semi purified extracts were further 
evaluated using broth dilution assay against a range of microorganisms. A minimal 
inhibitory concentration (MIC) was calculated for each Burkholderia extract against each 
respective susceptibility testing organism (Table 4.3). The MICs ranged from 15.6 to 5000 
µg/ml and demonstrated a wide spectrum of activities against C. albicans, Gram-positive 
and Gram-negative bacteria; extracts which were active on all three test groups were 
considered as broad spectrum. Both the crude resin extract and acetone extract of B. 
ambifaria AMMD were active against C. albicans, Gram-positive and Gram-negative 
bacteria. Crude resin extracts of B. ambifaria AMMD and Mex-5 were more active against 
Gram-negative bacteria than the comparable acetone extracts. In particular, the crude resin 
extracts of B. ambifaria AMMD were 20 times more potent than acetone extracts against 
B. multivorans and E. coli (Table 4.3 and Appendix B; Figure B9). 
 
The presumptive enacyloxin IIa of B. ambifaria AMMD (Fraction 2) was very active 
against all tested microorganisms: B. multivorans, E. coli, S. aureus, C. albicans and P. 
aeruginosa and MIC values were 15.6, 15.6, 62.5, 125 and 250 µg ml
-1
 respectively. The 
active concentrations of AMMD crude resin extract were 187.5, 375, 1500, 1500 and 5000 
µg ml
-1 
respectively for the same test organisms. The B. ambifaria BCF crude resin extract 
was also very active against the gram-negative B. multivorans and E. coli, with MIC values 
were 46.8 µg ml
-1
. BCF crude resin extract was more active than the equivalent extracts 
from B. ambifaria AMMD for all tested organisms except P. aeruginosa (Table 4.3). 
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Table 4.3 Minimum inhibitory concentrations of Burkholderia antimicrobial extracts 
MIC values are giving as µg/ml for crude and semi-pure extracts of Burkholderia ambifaria AMMD, BCF, KW and Mex_5, and B. gladioli BCC0238. a; The 
susceptibility testing organisms were C. albicans (Sc5314), Staphylococcus aureus (NCTC12981), B. multivorans (ATCC17210), Escherichia coli (NCTC12241) and 
Pseudomonas aeruginosa (NCTC12903). b; The semi-pure fraction F6 extracted from the AMMD extract using silica gel column chromatography had been shown to 
contain enacyloxin IIa. *; Semi pure fraction of B. ambifaria AMMD crude resin extract which was fractionated using preparative silica gel TLC. 
 
 
 
       Extracts 
b b
             
(µg ml
-1
)  
 
 
Microbes 
a
   
B. ambifaria AMMD extracts Mex_5 BCF 
Crude resin 
extracts 
KW 
Crude resin 
extracts 
B. gladioli 
Crude resin 
extracts 
Crude resin 
extracts 
Acetone  
extract 
Semi-pure 
fraction (F6*) 
Crude resin 
extracts 
Acetone  
extract 
C. albicans 1500 > 5000 125 3000 >5000 3000 1500 46.8 
S. aureus 1500 1500 62.5 1500 >5000 750 3000 750 
B. multivorans 375 1500 15.6 187.5 >5000 46.8 1500 187.5 
E. coli 187.5 >5000 15.6 187.5 >5000 46.8 375 187.5 
P. aeruginosa >5000 >5000 250 < 5000 >5000 >5000 >5000 >5000 
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4.4 Discussion  
 
 
The TLC-Bioautography assay under the current experimental conditions showed that 
Burkholderia produced a large variety of active secondary metabolites which exhibited a 
broad spectrum of activity against Gram-positive and Gram-negative bacteria, yeasts and 
basidiomycetes. This result was unpredicted and could not be achieved using other 
antimicrobial assays. We have performed an Amberlite XAD 16 resin extraction procedure 
for the first time on Burkholderia antimicrobials, using methanol as the elution solvent; 
this method was selected as the best to use because of its simplicity and the extract purity 
obtained.  
 
Several different TLC visualization methods were used in this study; UV light was the 
simplest to apply and allowed multiple metabolites to be located. This corroborates the 
findings of the previous work in this field (Kadir, et al., 2008) recommending UV light as 
a visualization method. UV light at 366 nm was the superior visualization method for 
Burkholderia resin extracts which were separated on standard silica gel TLC plates. To 
obtain the best results, visualization was performed with the silica gel side of the TLC plate 
face down on the source of the UV light. Under these conditions the resin extracts of 
Burkholderia produced highly distinctive profiles of Burkholderia metabolites. Care must 
be taken when obtaining these photographs to avoid excessive exposure to UV radiation.   
 
Ethyl acetate, methanol and water (EtOH:MeOH:H2O), with both ratios 10:1:0.5 and 
20:1:0.5, was one of the best solvent systems identified to resolve Burkholderia 
metabolites. Chloroform and acetone (1:1), and methanol and water (8:2), were also able to 
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partition the extracts under investigation, but neither performed quite as well as the Ethyl 
acetate, methanol and water mixture. This could be because the solvent system was a 
mixture of three different solvents with different polarities. Ethyl acetate, methanol and 
water combination had a strong ability to partition metabolites and the active anti-
microbials within the crude Burkholderia extracts that were polar and semi-polar 
compounds.  
 
Two other steps in the development of the TLC-bioautography assay which were found to 
be critical for successful analysis were as follows. The fractionated TLC plates had to be 
exposed for at least 15 min of aeration within a chemical fume cupboard before the agar 
overlay was added. If the residual solvents were not removed in this way they often 
inhibited microbial growth in the overlay. Another critical finding was that the pre-
incubation of the overlaid TLC plates for at least 3 hours at room temperature was optimal 
to allow diffusion of Burkholderia metabolites from the silica gel into the seeded agar 
layer. This pre-incubation allowed very clear inhibition zones to be observed for 
antimicrobial agents present on the developed TLC plates. This finding corroborates the 
ideas of Rojas et al., (2008), who suggested that the pre-incubation of plates for up to 12 h 
was necessary to achieve clear results from an antimicrobial suitability test. Consistency of 
these simple steps in performing bioautography assay were important, especially if the 
assay was going to be used as a preliminary screening technique to detect antimicrobial 
components of novel Burkholderia extracts. 
 
The TLC-bioautography assay was able to provide data which helped with the 
interpretation of findings from the simple overlay assay used to screen for antimicrobial 
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activity (see chapter 3). For example, B. ambifaria Bcc0193 demonstrated no anti-candidal 
activity in the overlay screens and hence was selected as a negative control for the 
metabolite extraction analysis; the TLC-bioautography assay also confirmed that this Bcc 
isolate did not produce highly active metabolites, with only very a faint affect on C. 
albicans seen after TLC analysis of concentrated metabolite extracts from Bcc0193 (Figure 
4.5). B. cenocepacia Bcc0019 was able to inhibit the growth of C. albicans when grown on 
SA medium but did not produce this affect when grown on BSM-G medium. The TLC-
bioautography assay was able to explain the effect of different media on anti-candidal 
production, locating the presence of one active metabolite produced by B. cenocepacia 
Bcc0019 when it was grown on SA medium (Figure 4.5). This could be because this 
compound was induced after growth on SA remains to be determined.  
 
The TLC-bioautography, LC-MS data and comparative analysis of B. ambifaria resin 
extracts showed that Burkholderia are potentially a very large reservoir of known and 
novel antimicrobial agents, especially with those exhibiting anti-fungal activity. Many of 
these compounds were discovered for the first time in this group of bacteria. The B. 
ambifaria AMMD resin extract comprised five main compounds. The following were 
detected previously in other Burkholderia sp. (1) polyethylene glycol, (2) quinolines group 
(4-hydroxyl-3-methyl-2-alkyl-4-quinoline, 4-hydroxyl-3-ethyl-4-quinoline and other 
HMAQ) and (3) pyrrolnitrin. Enacyloxin II a, a known antibiotic previously found in a 
Frateuria species bacterium, was identified for the first time to be also produced by B. 
ambifaria (Mahenthiralingam, et al., 2011). The presence of novel unknown peptide 
antibiotics in strain AMMD also shows further antimicrobials may be discovered in this 
strain. 
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B. ambifaria BCF produced 4 active bands which exhibited nearly the same profile as B. 
ambifaria AMMD, except B. ambifaria BCF produced a highly polar basal fraction (Rf 
0.05) which was identified as a mixture of bactobolins: bactobolin A, B and D (Kondo, et 
al., 1979, Seyedsayamdost, et al., 2010) and a new bactobolin containing Cl2.  B. ambifaria 
KW and Mex-5 produced more than 6 active bands containing at least 10 detectable active 
compounds. Most of these potent compounds could not be fully identified and were 
presumed to be unknown antifungal agents. The basal fraction of B. ambifaria Mex-5 (Rf 
0.05), that was identified as a mixture of new bactobolins, was different compared with the 
BCF strain. Bactobolin C was the major compound detected in Mex-5, but bactobolin D 
and B were not detected, while a new bactobolin was observed.  
 
The detection of pyrrolnitrin within the resin extracts of Burkholderia using LC-MS failed. 
This might be due to the limited amount of pyrrolnitrin produced by Burkholderia under 
these growth and extraction conditions. Also a large amount of plasticizer was identified in 
some extracts and this fractionated in a very similar way to pyrrolnitrin running with the 
solvent front; after this was discovered use of plastics was avoided in the extraction. A 
method using pure pyrrolnitrin as a control and previous conditions for its detection by 
TLC-bioautography was able to indicate that pyrrolnitrin-like metabolites were present in 
several Burkholderia strains. Ethyl acetate, methanol and water (20:1:0.5) produced the 
best overall fractionation of Burkholderia crude extracts, however, pyrrolnitrin travelled 
with the solvent system until the top of solvent front (Rf around 0.97 ± 0.02) and hence it 
was not useful to isolate this antifungal. Therefore, different solvent systems and different 
TLC sorbents were used, as recommended by Burkhead, et al., (1994) and Schmidt, et al., 
(2009), to detect and improve the isolation of pyrrolnitrin by TLC. The findings of the 
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current study support the previous studies that reported that Burkholderia were considered 
well known for their ability to produce pyrrolnitrin (Arima, et al., 1964, Cartwright, et al., 
1995). Pyrrolnitrin showed a strong effect on C. albicans and basidiomycetes; it was also 
active against Gram-positive bacteria, but did not show inhibitory effect on many of the 
Gram-negative bacteria. The findings were similar to the results of previous studies (El-
Banna & Winkelmann, 1998, Loper & Gross, 2007). 
 
One of the most interesting findings was that semi-purified extracts of B. ambifaria 
AMMD containing enacyloxin produced an inhibitory affect at low concentrations (15.6 
µg ml
-1
) on Gram-negative bacteria such as E. coli, B. multivorans and A. baumanni. 
Enacyloxin IΙa isolated from B. ambifaria AMMD and BCF inhibited C. albicans. 
However, this does not support the previous studies of Watanabe, et al., (1982, 1994) as 
they reported that Enacyloxin IΙa did inhibit both Gram-positive and Gram-negative 
bacteria but could not inhibit C. albicans. This might be because of the concentration that 
they used was lower. Mahenthiralingam, et al., (2011) found that Enacyloxin IΙa at high 
concentration was active against C. albicans, but that below 100 µg ml
-1 
it was not 
significantly anti-candidal. 
 
 Bactobolin isolated from B. ambifaria BCF and Mex-5 showed a strong ability to inhibit 
C. albicans and other fungi belonging to basidiomycetes. However, this result has not 
previously been described. 
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4.3 Conclusion 
 
The following conclusions were reached: 
 Extraction efficiency of the Amberlite XAD-16 resin followed by methanol elution 
proved to be the most robust and simplest method for extracting the bioactive 
compounds at high purity from Burkholderia. 
 TLC combined with a bioautography assay is a rapid and accurate method for 
localization of antimicrobial activity on a chromatogram. It offers the ability to 
obtain a profile of Burkholderia antimicrobial secondary metabolite patterns to study 
the presence and the diversity of antimicrobial agents of natural products. 
 Ethyl acetate, methanol and water (20:1:0.5), Normal silica gel TLC plates, UV light 
(366 nm) and 15 min of aeration were the best conditions to separate and visualise 
Burkholderia secondary metabolites. 
 The inoculum size of the microorganisms for bioautography must be specifically 
adapted for use with different test organisms. 
 Pre-incubation of overlaid TLC plates for at least 3 h at room temperature was 
critical for improving the detection of bioactivity to allow an active metabolite to 
diffuse.  
 The TLC-bioautography and GC-MS data showed that Burkholderia are potentially 
a very large reservoir of known and novel antimicrobial agents, especially with those 
exhibiting antifungal activity. Many of these compounds were discovered for the 
first time in this group of bacteria. 
 The B. ambifaria AMMD crude resin extract comprised five main antimicrobial 
compounds. The following were detected previously in other Burkholderia sp: (1) 
polyethylene glycol (2) quinolines group (4-hydroxyl-3-methyl-2-alkyl-4-quinoline, 
4-hydroxyl-3-ethyl-4-quinoline and other HMAQ) and (3) pyrrolnitrin.  
 B. ambifaria BCF produced 4 active bands which exhibited nearly the same profile 
as B. ambifaria AMMD. The following were detected: (1) quinolines group; (2) 
pyrrolnitrin; and (3) Enacyloxin IIa. B. ambifaria BCF produced highly active 
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metabolites which were identified as a mixture of bactobolin A, B, D and a new 
bactobolin containing Cl2.  
 B. ambifaria KW and Mex-5 produced more than 6 active bands containing at least 
10 detectable but unknown active compounds and were presumed to be unknown 
antifungal agents. 
 B. ambifaria Mex-5 produced highly active metabolites which were identified as a 
mixture of new bactobolin and were different to those obtained from the BCF strain. 
Bactobolin C was the major compound detected in Mex-5, but bactobolin D and B 
were not detected.  
 Pyrrolnitrin, a known antibiotic previously found in Burkholderia and Pseudomonas 
was detected in 60% of tested Burkholderia, using classic comparative TLC and 
pure pyrrolnitrin (Sigma). Pyrrolnitrin showed a strong effect on C. albicans and 
basidiomycetes. It was also active against Gram-positive bacteria. 
 Novel unknown peptide antibiotics were detected in B. ambifaria AMMD, BCF, 
KW and Mex-5. 
 Semi-purified extracts of B. ambifaria AMMD (Rf 0.60 ± 0.03) containing 
enacyloxin IIa produced an inhibitory affect at a low concentration (15.6 µg ml
-1
) 
against E. coli, B. multivorans and A. baumannii. 
 Bactobolin isolated from B. ambifaria BCF and Mex-5 showed a strong ability to 
inhibit C. albicans and other fungi belonging to basidiomycetes. 
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CHAPTER FIVE 
 
 
 
 
 
 
 
 
OPTIMIZATION OF GROWTH CONDITIONS TO 
IMPROVE ANTIFUNGAL ACTIVITY OF Burkholderia  
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5.1 Introduction  
 
The biosynthesis of natural products by organisms is affected by biotic and abiotic factors. 
In the laboratory, the components of synthetic media and different factors such as pH, 
temperature and incubation period alter antibiotic biosynthesis in many producer strains. 
Understanding these production conditions in the laboratory will provide an insight into 
when antimicrobial agents are produced in nature. 
 
Carbon, nitrogen and phosphate are the major requirements for the growth and metabolic 
activities of microorganisms. Nitrogen is one of the major requirements because it is 
required for the synthesis of cell components and functional proteins. It is well-known that 
the different kinds of nitrogen source greatly influence microbial secondary metabolite 
production. It is interesting that inorganic phosphate controls the synthesis of a large 
number of antibiotics that belong to different classes (Martin, 2004). However, most of the 
antibiotics were repressed
 
by high concentrations of inorganic phosphate (Kishimoto, et 
al., 1996). The pH of growth media also exerts an effect on the production of antimicrobial 
agents. The pH may change the ionizing state of important vital molecules such as proteins 
and enzymes. The production of antimicrobial agents is dependent on many enzyme 
catalysed reactions, so pH is one of the most important physical factors affecting anti-
candidal production and activity.  
 
Previous research in our laboratory had shown that Burkholderia bacteria grew well on a 
chemically-defined minimal medium, named Basal Salts Medium (BSM; section 2.1). The 
production of antifungal agents by Burkholderia was shown to occur when they were 
grown on BSM with glycerol as a carbon source (Chapter 3 and 4). The objective of this 
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chapter was to improve the composition of BSM to enhance antimicrobial production by 
Burkholderia. Since BSM was a defined minimal salts medium it was possible to change 
the composition of its ingredients and its pH, and detect the effects of a target nutrient on 
antimicrobial production. A general hypothesis for this chapter was ‘‘chemical and 
physical factors can influence anti-candidal production and activity of Burkholderia’’, 
and the specific objectives of this chapter were: 
(i) To examine the effects of six different factors: carbon, nitrogen, phosphate, pH, 
incubation time and temperature on the activity of anti-candidal agents of Burkholderia. 
(ii)  To create an optimal medium to increase anti-candidal activity of Burkholderia 
metabolite.  
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5.2 Materials and Methods 
 
5.2.1 Bacterial and fungal strain maintenance and revival 
The well defined antifungal control strains examined in previous chapters, B. ambifaria 
AMMD, BCF, KC311, B. vietnamiensis JW13 and two reference fungi, C. albicans 
Sc5314 and B. adusta BK1, were used to assess physical and chemical conditions affecting 
the growth and production of antifungal agents. The effect of various factors on the 
production of anti-candidal metabolites was compared to the standard Basal Salts Medium 
(BSM; see sections 2.1). The maintenance and storage conditions of these isolates were as 
described previously (sections 2.2.1 and 2.2.2). 
 
5.2.2 Effects of different growth factors on anti-candidal 
activity of Burkholderia  
To determine the best conditions for both fungal growth and anti-candidal activity of 
Burkholderia metabolites (section 2.7), different concentrations and combinations of 
chemical factors such as carbon, nitrogen and phosphate were altered in the BSM growth 
medium. In addition, the three physical factors: hydrogen ion concentration, temperature 
and period of incubation were also examined. The effect of hydrogen ion concentration on 
the growth abilities of B. adusta and C. albicans was also examined. All experiments were 
carried out at 30°C for three days unless stated, with three replicates of each treatment.  
 
5.2.3 Statistics 
One and two-way analysis of variance and the General Linear Model were used to test for 
differences between treatments and strains.  
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5.3 Results 
 
 
 
5.3.1 The effect of carbon source on anti-candidal activity 
of Burkholderia  
 
5.3.1.1 Effect of carbon sources  
All tested isolates showed a significant difference (P ≤ 0.001) in production of anti-
candidal agents (Figure 5.1). Glycerol, fructose, galactose, glucose and succinate 
significantly (P ≤ 0.001) increased the activity of Burkholderia anti-candidal agents . B. 
ambifaria Kc311was the strongest producer among tested isolates (36.8 mm). However, 
there was very low anti-candidal activity on lactose, starch and maltose. B. ambifaria BCF, 
KC311 and B. vietnamiensis JW13, showed similar responses to the carbon sources tested. 
Their anti-candidal activity was greatest after growth on glycerol followed by fructose and 
succinate (Figure 5.1). However, no anti-candidal activity of B. ambifaria BCF was seen 
with sucrose as a sole carbon source; B. vietnamiensis JW13 did not produce any activity 
when grown on lactose as a sole of carbon source. The anti-candidal activity of B. 
ambifaria AMMD was greatest when grown on succinate, glycerol, and ribose. However, 
there was a weak affect of AMMD metabolites on candidal growth when grown on 
arabinose, lactose and maltose, and there was no anti-candidal activity when starch was 
used as a sole carbon source (Figure 5.1).  
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Figure 5.1 Effect of 12 carbon sources on anti-candidal activity of B. ambifaria AMMD, BCF, KC311 and B. vietnamiensis JW13. 
Error bars are not visible in some cases where values approach 0; when no error bars are shown they fall within the size of the symbol. Data are presented as the means 
of three replicates with standard errors of the means. 
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5.3.1.2 The effect of different concentrations of glycerol and 
succinate on antifungal activity  
All four control strains B. ambifaria AMMD, BCF, KC311 and B. vietnamiensis JW13 that 
were tested, could grow well on either carbon source (glycerol or succinate) with or 
without supplements such as CAS amino acids or yeast extracts (Figure 5.4 a, b, c, d). 
However, they lost the ability to grow and produce active anti-candidal agents when the 
medium was not supplemented with CAS amino acids and yeast extract. 
 
 In general, there were significant differences between different carbon source 
concentrations (P ≤ 0.05).  The optimum carbon concentrations (Figure 5.5) were 40 mM 
and 20 mM (30.7 and 29.13 mm respectively). In terms of media supplementation for 
either a glycerol or succinate carbon source, BSM with CAS amino acids and complete 
BSM medium with both CAS amino acids and yeast extract produced the largest zones of 
inhibition against C. albicans (Figure 5.6). Overall, production of anti-candidal agents on 
glycerol was better than using succinate (Figure 5.2). 
 
B. ambifaria BCF and B. vietnamiensis JW13 showed the greatest activity against C. 
albicans with complete BSM medium supplemented with glycerol at 40 mM (63.37 and 
49.7 mm respectively; Figure 5.2: b, d). B. ambifaria Kc311 exhibited the greatest activity 
with BSM supplemented with CAS amino acids and glycerol at 40 mM (51.30 mm, Figure 
5.2, c). B. ambifaria AMMD showed significantly (P ≤ 0.05) anti-candidal activity when 
glycerol was used as a sole carbon source at 40 and 20 mM (41.3 and 40.5 mm 
respectively; Figure 5.2, a). The optimal media combinations were BSM supplemented 
with CAS amino acids and glycerol (44.3 mm) and complete BSM medium supplemented 
with glycerol (41.3 mm). 
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Figure 5.2 Effect of glycerol and succinate at different concentrations (0 - 60 mM) on 
anti-candidal activity of B. ambifaria AMMD, BCF, KC311 and B. vietnamiensis 
JW13, using BSM medium with different combinations. 
Error bars are not visible in some cases where values approach 0; when no error bars are shown they fall 
within the size of the symbol. Data are presented as the means of three replicates with standard errors of the 
means. 
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5.3.2 The effect of nitrogen 
5.3.2.1 The effect of nitrogen sources on activity of anti-
candidal agents  
B. ambifaria Kc311 and BCF showed the greatest effect (44.5 and 42 mm, respectively) 
against C. albicans (Figure 5.3). B. ambifaria BCF and AMMD showed similar responses 
with different nitrogen sources used; the production of active anti-candidal agents by these 
strains was greatest with yeast extract (55.3 and 27.3 mm, respectively), followed by 
ammonium phosphate (52.3 and 24.67 mm, respectively). The anti-candidal activity of B. 
ambifaria KC311 was optimum with ammonium phosphate (55.3 mm) and ammonium 
chloride (51.3 mm). However, B. vietnamiensis JW13 showed the most anti-candidal 
activity with ammonium chloride (55.3 mm) and CAS amino acids (52.67 mm). However, 
JW13 did not grow on BSM-G supplemented with sodium nitrite, potassium nitrate or 
ammonium nitrate as sole nitrogen sources (Figure 5.3). 
 
Sodium nitrate totally suppressed the production of anti-candidal agents by all tested 
Burkholderia. Ammonium nitrate and potassium nitrate were significantly (P ≤ 0.01) 
poorer at stimulating anti-candidal activity than the other nitrogen sources tested. There 
was good anti-candidal activity when ammonium phosphate, CAS amino acids, ammonium 
chloride, peptone and yeast extract were added to the medium (45.5, 44, 43.5, 43 and 41 
mm respectively). However, there were no significant differences between these nitrogen 
sources (Figure 5.3).  
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Figure 5.3 Effect of different nitrogen sources on anti-candidal activity of B. ambifaria AMMD, BCF, KC311 and B. vietnamiensis 
JW13. 
Error bars are not visible in some cases where values approach 0; when no error bars are shown they fall within the size of the symbol. Data are presented as the mean 
of three replicates with standard errors of the mean. 
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5.3.2.2 The effect of ammonium phosphate in different 
combinations with BSM-G on anti-candidal activity of 
Burkholderia  
 
Anti-candidal activity was influenced by different combinations of BSM-G (Figure 5.4). 
The optimal combinations were ammonium phosphate, yeast extract and CAS amino acids, 
and ammonium chloride, yeast extract and CAS amino acids (43, 41.6 mm respectively). 
Moreover, there were highly significant differences between Burkholderia isolates (P ≤ 
0.001). B. ambifaria Jw13 and BCF were the best in the production of active anti-candidal 
agents under different conditions (Figure 5.4). 
 
5.3.2.3 The effect of different concentrations of yeast extract at 
different pHs on anti-candidal activity  
 
The effect of different concentrations of yeast extract at two different pHs (6 and 7) on 
anti-candidal activity was assessed on BSM-G medium. No significant difference in the 
effect of yeast extract at different pHs was observed for the production of anti-candidal 
agents (P > 0.05). 2 g of yeast extract at pH 6 was the optimal concentration to increase the 
production of anti-candidal agents (Figure 5.5). B. vietnamiensis JW13 produced good 
anti-candidal activity at different concentrations of yeast extract: 0.5, 1.0 and 2.0 gl
-1
 at pH 
6 (53, 50.67 and 50.67 mm respectively). The highest anti-candidal activity for B. 
ambifaria AMMD was obtained by addition of 2 gl
-1
 yeast extract at pH 6 (29.67 mm). B. 
ambifaria BCF showed greatest activity (51.00 mm) at 2 gl
-1
 yeast extract at pH 7. The 
maximum anti-candidal activity of B. ambifaria KC311 was obtained by addition of either 
1 or 2 gl
-1
 yeast extract at pH 6 (70.0 and 68.67 mm respectively). However, there were 
significant differences (P ≤ 0.05) between Burkholderia isolates (Figure 5.5). 
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Figure 5.4 Effect of ammonium phosphate alone and with different combinations of BSM-G on anti-candidal activity of B. 
ambifaria AMMD, BCF, KC311 and B. vietnamiensis JW13. 
C, normal BSM-G; 1, BSM-G supplemented with ammonium phosphate (NH4H2PO4) without yeast extract (YE) and CAS amino acids (CAS); 2, BSM-G 
supplemented with ammonium phosphate and yeast extract; 3, BSM-G supplemented with ammonium phosphate and CAS amino acids; 4, BSM-G supplemented with 
ammonium phosphate, yeast extract and CAS amino acids. Data are presented as the mean of three replicates with standard error of the mean. 
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Figure 5.5 Effect of yeast extract at different concentrations (g l
-1
) and different pHs (6 and 7) in BSM-G on anti-candidal activity 
of B. ambifaria AMMD, BCF, KC311 and B. vietnamiensis JW13.  
When no error bars are shown they fall within the size of the symbol. Data are presented as the means of three replicates with standard errors of the means. 
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5.3.3 The effect of different phosphate sources and 
concentration on the anti-candidal activity of 
Burkholderia 
 
Different phosphate sources at different concentrations did not significantly (P > 0.05) 
affect anti-candidal activity of the four Burkholderia strains. In general, lower 
concentrations of phosphate (10 mM or less) gave better anti-candidal activity than higher 
concentrations (40 mM or greater). In general, sodium phosphate at 10 mM enhanced the 
production of anti-candidal agents for all strains (Figure 5.6). 
 
The results showed that there were highly significant differences (P ≤ 0.05) between 
Burkholderia isolates on anti-candidal activity and the best producer was B. ambifaria 
BCF. B. ambifaria BCF produced the greatest anti-candidal activity at 80 mM sodium 
phosphate (45.00 mm), which was only slightly above that seen at 10 mM sodium 
phosphate. The activity of anti-candidal activity of B. ambifaria AMMD and KC311 was 
best with sodium phosphate at 10 mM, producing inhibition zones of 29.3 and 48.3 mm 
respectively. Anti-candidal activity of B. vietnamiensis was greatest with the addition of 
calcium phosphate at 80 mM, producing an inhibition zone of 45.0 mm (Figure 5.6). 
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Figure 5.6 Effect of different phosphate sources at different concentrations of BSM-G on anti-candidal activity of B. ambifaria 
AMMD, BCF, KC311 and B. vietnamiensis JW13. 
(K); Potassium phosphate, (Na); sodium phosphate and (Ca); calcium phosphate. When no error bars are shown they fall within the size of the symbol. Data are 
presented as the means of three replicates with standard errors of the means. 
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5.3.4 The effect of hydrogen ion concentration (pH) 
 
5.3.4.1 The effect of pH on C. albicans and B. adusta BK1 
growth rate 
Prior to testing the production of antifungal metabolites by the Burkholderia strains, the 
growth of the C. albicans was tested at a range of pHs to ensure that it would grow 
normally in the overlay and hence still be able to act as a readout for antimicrobial activity. 
C. albicans was able to grow over a wide range of pHs (5 to 8); the best growth occurred 
when the pH ranged from 6.5–7.5 (Figure 5.7).  
 
B. adusta BK1 was capable of growing on BSM-G over a wide range of pH (Figure 5.21), 
with the best growth occurring at pH 6 and 6.50 (extension rate 10.53 and 9.70 mm d
-1
 
respectively). For all pHs tested, the B. adusta growth was sufficient to allow the mycelia 
to cover a 90 mm Petri dish of BSM-G medium within 6 days. The weakest growth of B. 
adusta where mycelial dense occurred was seen at the extremes of the pH range tested, 3 
and 8, respectively (Figure 5.8). 
 
Overall, both fungal species used to detect antifungal activity, C. albicans and B. adusta 
BK1, were capable at growth over a wide range of pH, demonstrating that bioassay 
detection of Burkholderia metabolites could be assayed at multiple the hydrogen ion 
levels. 
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Figure 5.7 Effect of pHs (3.5-8) of BSM-G medium on C. albicans growth rate. 
Data are presented as the means of three replicates with standard errors of the means. When there are no error bars are shown they fall within the size of the symbol. 
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Figure 5.8 Effect of pHs (3-8) of BSM-G medium on B. adusta BK1 extension rate (mm d
-1
).  
SA: Sabouraud Agar at pH 5.8 was used as a control medium. BSM-G: Basal Salt Medium supplemented with glycerol. When there are no error bars are shown they 
fall within the size of the symbol. The same letter above bars indicates no significant difference (ANOVA; P > 0.05).  
0
2
4
6
8
10
12
14
16
SA5.8 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.05.8
a
b
b
b
bc
b b b
c
c
c
d
SA 
medium
BSM-G medium
Hydrogen ion concentrations (pH)
 
E
x
te
n
si
o
n
 r
a
te
 m
m
 d
-1
 
E
x
te
n
si
o
n
 r
a
te
 m
m
 d
-1
 
    
 169 
5.3.4.2 The effect of pH on anti-candidal activity of B. 
ambifaria AMMD, BCF, KC311 and B. vietnamiensis 
JW13  
Three Burkholderia isolates, B. ambifaria AMMD, KC311 and B. vietnamiensis Jw13 
preferred acidic conditions, around pH 6.0 to 6.5 where anti-candidal activity was greatest 
(Figure 5.22). The activity of Burkholderia anti-candidal agents was significantly affected 
depending on initial concentrations of hydrogen ion (Figure 5.9; P ≤ 0.001). For example, 
at pH 6 the anti-candidal inhibition zones were 34.33, 58.67 and 60.67 mm, respectively, 
for these three strains. In contrast B. ambifaria BCF maintained a high level of anti-
candidal activity after growth at pH 6.5 through to pH 8, while below pH 6.5 the activity of 
this strain was greatly diminished (Figure 5.9). 
 
B. ambifaria AMMD grew and produced active anti-candidal agents at all tested pHs (3.5 - 
8), although at the acidic pH of 4.5 and below this activity was less than 50% of that seen 
at the optimal pH of 6 for this strain. In contrast, no activity was seen for B. ambifaria BCF 
and KC311 below pH 4.5, and B. vietnamiensis did not produce anti-candidal agents below 
pH 4 (Figure 5.9).   
 
5.3.5 The effect of temperature on anti-candidal activity of B. 
ambifaria AMMD, BCF, KC311 and B. vietnamiensis 
JW13 
 
The results showed that the activity of anti-candidal agents steadily increased with an 
increase in temperature from 10
o
C
 
through to 35
o
C, then decreased above this temperature. 
There were highly significant differences in anti-candidal activity between different 
temperatures (P ≤ 0.001) and between Burkholderia isolates (P ≤ 0.05) (Figure 5.10).
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Figure 5.9 Effect of hydrogen ion concentration (3.5-8) of BSM-G on anti-candidal activity of B. ambifaria AMMD, BCF, KC311 
and B. vietnamiensis JW13. 
When there are no error bars are shown they fall within the size of the symbol. Data are presented as the mean of three replicates with standard error of the mean. 
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Figure 5.10 Effect of temperatures (10-40˚C) on anti-candidal activity of B. ambifaria AMMD, BCF, KC311 and B. vietnamiensis 
JW13. 
When there are no error bars are shown they fall within the size of the symbol. Data are presented as the means of three replicates with standard errors of the means. 
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The anti-candidal activity of B. ambifaria AMMD and KC311 increased over time and 
reached maximum activity at 25°C (41.3 and 70.67 mm, respectively; Figure 5.27). B. 
ambifaria BCF and B. vietnamiensis JW13 metabolites reached their maximum activities at 
30°C (43.3 and 73.3 mm respectively). B. ambifaria AMMD, BCF, and B. vietnamiensis 
JW13 metabolites did not show anti-candidal activity at 10C, and B. vietnamiensis JW13 
lost the ability to produce active anti-candidal agents above 40C (Figure 5.10). 
 
5.3.5 The effect of time of incubation on anti-candidal activity 
of B. ambifaria AMMD, BCF, KC311 and B. 
vietnamiensis JW13 
 
 
The activity of anti-candidal agents steadily increased over time (Figure 5.11). Typically, 
168 h was the best length of time, producing the maximum anti-candidal activity with 
highly significant differences (P ≤ 0.001). Moreover, all isolates showed significant 
differences (P ≤ 0.05) in the production of active anti-candidal agents at different times of 
incubation. Anti-candidal activity after growth on BSM-G medium was demonstrated by 
all four tested strains within 24 h (Figure 5.11). The anti-candidal activity of B. ambifaria 
BCF and B. vietnamiensis JW13 metabolites increased over time and achieved the 
maximum by 120 h of incubation (46.0 and 80.0 mm respectively). However, B. ambifaria 
AMMD and KC311 reached the maximum capacity of activity at 168 h of incubation (46.0 
and 80.0 mm respectively). 
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Figure 5.11 Effect of time of incubation (24-168 h) on anti-candidal activity of B. ambifaria AMMD, BCF, KC311 and B. 
vietnamiensis JW13. 
When there are no error bars are shown they fall within the size of the symbol. Data are presented as the means of three replicates with standard errors of the means. 
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5.3.6 The effect of different formulae of basal salts medium 
(BSM) on anti-candidal activity of B. ambifaria AMMD 
metabolites 
 
 
The main purpose of the investigations described above was to enable the best media 
combinations and conditions to be selected for optimized production of anti-candidal 
activity in the Burkholderia strains. Using the data of current study, combinations of 12 
different media were tested on B. ambifaria AMMD, all using glycerol as the carbon 
source (Figure 5.12). Medium composition influenced the activity of anti-candidal agents 
produced by B. ambifaria AMMD (P ≤ 0.001). The BSM4.6 medium (BSM supplemented 
with ammonium phosphate at 0.037 M and 0.05 g yeast extract as nitrogen sources and 20 
mM HEPES to maintain the pH at 6) was superior in supporting the production of anti-
candidal agents (38.67 mm). The next best medium was BSM5.6 (BSM supplemented with 
ammonium phosphate at 0.037 mM and 0.05 g yeast extract as nitrogen source and 0.02 
mM phosphate buffer to maintain the pH at 6). The third best medium was BSM0.6 
(normal BSM with 0.02 mM phosphate buffer to maintain the pH at 6; 36.33 mm). For 
these three anti-candidal activity promoting media there were no significant differences in 
the zones of inhibition observed. The BSM2.7 (BSM supplemented with 2 g yeast extract 
as nitrogen source and 0.02 mM HEPES to maintain the pH at 7) showed the lowest anti-
candidal activity (24.67 mm) compared with all the other treatments (Figure 5.12).  
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Figure 5.12 Effect of different formulae of BSM medium on anti-candidal activity of B. ambifaria AMMD. 
BSM0.6, Normal BSM with 0.020 mM phosphate buffer to maintain the pH at 6; BSM0.7, Normal BSM with phosphate buffer to maintain the pH at 7; BSM1.6, BSM 
supplemented with 2 g yeast extract as nitrogen source and 0.020 mM phosphate buffer to maintain the pH at 6; BSM1.7, BSM supplemented with 2 g yeast extract as 
nitrogen source and 0.020 mM phosphate buffer to maintain the pH at 7; BSM2.6, BSM supplemented with 2 g yeast extract as nitrogen source and 20 mM HEPES to 
maintain the pH at 6; BSM2.7, BSM supplemented with 2 g yeast extract as nitrogen source and 20 mM HEPES to maintain the pH at 7; BSM3.6, BSM supplemented 
with 2 g yeast extract as nitrogen source and 0.025 mM of sodium phosphate to maintain the pH at 6; BSM3.7, BSM supplemented with 2 g yeast extract as nitrogen 
source and 0.025 mM of sodium phosphate to maintain the pH at 7; BSM4.6, BSM supplemented with ammonium phosphate at 0.037 mM and 0.05 g yeast as nitrogen 
source and 20 mM HEPES to maintain the pH at 6; BSM4.7, BSM supplemented with ammonium phosphate at 0.037 mM and 0.05 g yeast as nitrogen source and 20 
mM HEPES to maintain the pH at 7; BSM5.6, BSM supplemented with ammonium phosphate at 0.037 mM and 0.05g yeast as nitrogen source and 0.020 mM 
phosphate buffer to maintain the pH at 6; BSM5.7, BSM supplemented with ammonium phosphate at 0.037 mM and 0.05 g yeast as nitrogen source and 0.020 mM 
phosphate buffer to maintain the pH at 7. The same letter above bars indicates no significant difference (ANOVA; P > 0.05). 
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5.4 Discussion  
 
The present study set out with the aim of assessing the importance of nutrients, including 
carbon, nitrogen and phosphate, as well as physical factors such as hydrogen ion 
concentration (pH) and temperature on the production and activity of Burkholderia anti-
candidal metabolites. The production of antimicrobial metabolites is known to be 
influenced by media components and culture conditions, such as carbon, nitrogen, pH and 
temperature, each of which may vary from organism to organism in terms of the most 
optimal conditions (Iwai & Omura, 1982). Culture conditions such as carbon, nitrogen and 
hydrogen ion concentration were found to affect the production of antifungal metabolites 
by Burkholderia (Kadir, et al., 2008). El-Banna and Winkelmann (1998) reported that by 
varying the conditions under which B. cepacia is grown, the activity of the pyrrolnitrin 
antibiotic could be changed. 
 
The current study found that the production of anti-candidal substances of B. ambifaria 
AMMD, BCF and KC311 and B. vietnamiensis JW13 were strongly influenced by several 
chemical and physical factors. The effect of different carbon sources: glucose, glycerol, 
arabinose, fructose, galactose, sucrose, lactose, maltose, ribose, succinate and starch on the 
anti-candidal activity of Burkholderia metabolites, were examined. The production of anti-
candidal agents of B. ambifaria AMMD, BCF and KC311 and B. vietnamiensis JW13 were 
acutely changed by the carbon source. The carbon source required for maximal anti-
candidal activity was different among Burkholderia strains. 
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Glycerol strongly enhanced the anti-candidal activity of strains BCF, AMMD and KC311; 
whereas succinate and glycerol increased the anti-candidal activity of AMMD. This 
finding was consistent with that found by El-Banna and Winkelmann, (1998), and 
Bhattacharyya et al. (1998), who found glycerol was superior for antifungal production by 
B. cepacia NB-1 and Streptomyces hygroscopicus D1.5 respectively. In contrast, the 
maximum anti-candidal activity of B. vietnamiensis JW13 was achieved after growth on 
galactose. 
 
Arabinose, maltose and starch repressed the anti-candidal activity of AMMD. Moreover, 
Lactose stopped the anti-candidal activity of JW13 and AMMD. These findings suggest 
that each strain preferred a specific source of carbon to produce active anti-candidal agents. 
BSM medium without a carbon source showed minimal anti-candidal activity for all tested 
isolates. AMMD, BCF and JW13 were not able to grow on BSM medium without a carbon 
source, CAS amino acids and yeast extract. They were able to grow and produce anti-
candidal agents on BSM medium without a carbon source but supplemented with at least 
one organic nitrogen source such as CAS amino acids, peptone or yeast extract, where both 
nitrogen and carbon were provided. This finding was expected and reflects the ability of 
these isolates to use organic nitrogen resources as a source of energy instead of carbon 
compounds. This finding was similar to results obtained by Gebreel et al. (2008), who 
reported that bacterial isolates belonging to Bacillus, Corynebacterium and 
Cellulosimicrobium were able to grow and produce antimicrobial agents with no carbon 
source. 
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One unanticipated finding was that KC311 was able to grow and produce anti-candidal 
agents on BSM medium without a carbon source or nitrogen source. This agreed with 
Duffy and Défago (1999), who found that P. fluorescens was able to grow and produce 
antibiotics and other metabolites even in the absence of a carbon source.  This could be due 
to two reasons: firstly, the agar used in this study was a bacteriological grade which is 
quite pure, but might contain contaminating materials having enough nutrients to support 
minimal growth sufficient for some production of metabolites. The second reason might be 
that Kc311 was able to use dead cells of Kc311 inoculum as a nutrient to support minimal 
growth and production of anti-candidal agents. 
 
A significant correlation was found between anti-candidal activity and concentrations of 
carbon sources. The anti-candidal activity increased when the concentration of succinate 
and glycerol increased up to 20 mM and 40 mM respectively. However, above these 
concentrations the activity decreased. Gupta and Kulkarni (2002) tested the effect of 
different concentrations of sugar (2, 5 and 7.5%) on the production of antifungal agents of 
Thermomonospora sp MTCC 3340 and they found that 2 % of glucose was the optimum 
concentration for the maximum yield. 
  
Dikin et al. (2007) reported that the quantity of lactose affected the production of 
antifungal substances of B. cepacia and B. multivorans. This could be due to the feedback 
effect on the host cells, which might enhance carbon metabolism and consequently lead to 
the fast accumulation of the carbon. Burkholderia isolates had different capabilities to 
produce anti-candidal substances in the same medium. The varied capability of each strain 
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to hydrolyze and utilise different carbon sources may depend on active enzymatic systems 
of each strain.  
 
Nitrogen is one of the key requirements for the growth and synthesis of cell component 
and functional proteins, and greatly influences microbial growth. Nitrogenous compounds 
may influence the biosynthesis of antibiotics at the level of secondary metabolism, as 
substrates for antibiotic biosynthesis, or through modulation of biosynthesis and activity of 
the enzymes. Aharanowitz, (1980) reported that amino acids can serve as a carbon source 
in the absence of any other carbon source in a defined medium.  Both inorganic and 
organic nitrogen were tested in this study, and they both exhibited a significant effect on 
the anti-candidal activity. In comparison with inorganic nitrogen sources, organic nitrogen 
(yeast extract, urea, peptone and CAS amino acids) gave relatively higher anti-candidal 
activity. This corroborates the findings of Vahidi et al., (2004) and Saurav and Kannabiran 
(2010) who reported that organic nitrogen improved the production of antifungal agents by 
actinomycetes. Yeast extract, CAS amino acids and ammonium phosphate were selected as 
a nitrogen sources for the optimized anti-candidal production medium that was developed. 
 
The combination between yeast extract, CAS amino acids and ammonium phosphate 
improved anti-candidal activity above the level obtained these nitrogen sources alone or in 
other combinations that did not include all three. The stimulatory effect of complex 
nitrogen sources such as yeast extract, CAS amino acids and peptone, on production and 
activity of anti-candidal agents might be due to the presence of the amino acids, peptides, 
vitamins, numerous trace elements in these complex organic mixtures. Such supplementary 
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compounds might exhibit a stimulatory effect or act as inducers of enzymatic systems 
which are responsible for anti-candidal production and activity.  
 
The pH value has a marked effect on the production of anti-candidal agents. The current 
study found that the maximum activity of anti-candidal agents by Burkholderia was 
achieved when the initial pH was adjusted to 6 in BSM medium. The finding was 
consistent with Chin-A-Woeng et al., (1998) who found that pyrrolnitrin increased below 
pH 6. Quan et al., (2009) and Li et al., (2007) reported that the production and activity of 
CF66I from B. cepacia was influenced by the level of pH and the best production and 
activity was at pH 6. Moreover, different studies reported that Burkholderia tend to be 
found at highest numbers in acidic soils. Therefore, it was not unexpected to see the 
optimal active anti-candidal metabolite production at acidic pHs (Dalmastri, et al., 2003, 
Ramette, et al., 2005 , Li, et al., 2007). 
 
Bacterial growth and production of effective metabolites were dependent on temperature 
and how temperature affects the activity of enzymes. The growth of Burkholderia and the 
synthesis of anti-candidal agents need a series of enzyme catalysed reactions which are 
affected by temperature. However, lower and higher temperatures can reduce the activity 
of the enzymes, reduce the growth rates and hence production rate of metabolites. The 
optimum temperature for maximum anti-candidal production and activity of tested 
Burkholderia lay in the range of 15 to 25 ºC. B. vietnamiensis JW13 lost the ability to 
produce active anti-candidal agents at 40C; this could be because temperate temperatures 
are suitable for growth of such bacteria and consequently for the activity of enzymes 
responsible for anti-candidal biosynthesis and activity. This corroborates the findings of 
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previous studies in this field. Quan et al. (2009) reported that the most suitable temperature 
of the production of CF66I from B. cepacia was 25°C. At this temperature activity of 
CF66I increased rapidly and was greater than at other temperatures used.  
 
It is well known that Burkholderia can grow and utilise a variety of organic compounds 
under different physical conditions through different metabolic pathways (Chain, et al., 
2006). However, it is very useful to identify the optimal medium, temperature and pH 
preferences of Burkholderia to produce active anti-candidal agents. The regulatory 
mechanism of the production of anti-candidal agents in Burkholderia is poorly understood. 
The interpretation of the results obtained herein was complicated because of the potential 
for overlapping affects with the different factors tested. In addition to gene activation 
/repression by the growth conditions, the growth substrates tested may also enter different 
metabolic pathways which lead to intermediate compounds needed to produce the 
antifungal metabolites.  
 
The main purpose of this work was to select the best medium composition and conditions 
to improve the activity of anti-candidal agents of B. ambifaria AMMD. The media 
optimization studies revealed that different media compositions and culture conditions 
have significant impacts on the activity of anti-candidal agents, and the most interesting 
finding was that Burkholderia exhibited promising activity on the culture media BSM4.6, 
BSM5.6 and BSM0.6 and the common effective factor for all these media was the pH of 6.  
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5.5 Conclusions 
 
 The production of anti-candidal agents from B. ambifaria AMMB, BCF and Kc311 and 
B. vietnamiensis JW13 were reported for the first time. 
 Glycerol and succinate at lower concentrations were the carbon sources that resulted in 
largest activity of anti-candidal agents of Burkholderia. 
 Hydrogen ion concentration (pH) was also one of the most important growth 
conditions.  It influenced Burkholderia anti-candidal antibiotic production with pH 
6.0 being optimal. pH also effected the growth of the basidiomycete with BSM-G 
at pH 6.0 being one of the best growth media for B. adusta BK1.  
 Increased anti-candidal activity occurred with the addition of ammonium phosphate, 
CAS amino acids, ammonium chloride, peptone or yeast extract as a sole nitrogen 
source.  
 Sodium nitrate totally suppressed the activity of anti-candidal agents of Burkholderia. 
 Lower concentrations of phosphate (10 mM) increased the activity of anti-candidal 
agents more than higher concentrations. 
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CHAPTER SIX 
 
 
 
 
 
ISOLATION AND IDENTIFICATION OF BACTERIA 
THAT PRODUCE ANTIFUNGAL COMPOUNDS  
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6.1 Introduction   
 
 
A variety of microbes can be found growing in rhizosphere habitats. Soil-borne 
microorganisms interact with plant roots and soil constituents at the root–soil interface 
(Barea, et al., 2005). There are several beneficial soil-borne microorganisms in the 
rhizosphere, which can improve soil quality and enhance crop production and protection. 
The release of root exudates and decaying plant material provide sources of nutrients for 
the soil microorganisms as growth substrates; the root surface also forms a structural 
platform on which root-associated microbiota develops (Werner, 1998). The Burkholderia 
are a large group of Gram-negative bacteria present in both natural and clinical 
environments.  B. cepacia complex are opportunistic human pathogens responsible for lung 
infections in cystic fibrosis patients and various infections in immune-compromised 
patients (Mahenthiralingam & Vandamme, 2005). Moreover, they are present in the 
rhizosphere of many crop plants, particularly maize (Di Cello, et al., 1997, Bevivino, et al., 
2005, Dalmastri, et al., 2007), rice plants (Estrada, et al., 2001), woodlands (Richardson, et 
al., 2002) and agricultural and urban soils (Miller, et al., 2002). 
 
Previous work has shown that B. cepacia complex bacteria produce a wide range of 
antimicrobial substances (Chapter 3 and 4). A successful screening approach using a 
classical overlay assay to detect antimicrobial activity was developed (Chapter 2) and 
optimized in terms of substrate and physiological parameters (Chapter 5) to enhance 
secondary metabolite production. In addition, TLC-bioautography has been developed as a 
rapid and useful means to fractionate and purify Burkholderia antibiotic compounds 
(Chapters 4 and 5). Using these optimized approaches, a range of soil and rhizosphere 
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habitats were screened for the presence of antibiotic producing bacteria. A general 
hypothesis for this chapter was “all soil and rhizosphere bacterial isolates are capable of 
producing one or more antifungal agents.” The specific aims of this chapter were: 
 To isolate antifungal producing bacteria from different soil and rhizosphere 
environments, with a view to isolate antifungal Burkholderia species. 
 Identify the antifungal producing bacteria using 16S rRNA gene sequence.  
 Extract antifungal agents synthesised by these producing isolates. 
 Study the presence and diversity of antifungal agents in antifungal producing 
bacteria using TLC-bioautography assay. 
 To examine other non-B. cepacia complex such as Burkholderia gladioli as 
antifungal producing species. 
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6.2 Materials and Methods 
 
 
6.2.1 Sample collection  
 
Multiple environmental samples were examined as follows: 
i. Soil samples were collected from mixed deciduous woodland in the Coed Beddick, 
Tintern, UK (coordinates 51.710690, -2.681351).  A total of 10 soil samples were 
examined. Bacteria were cultivated from soil samples by adding of sieved soil to BSM-
G medium supplemented with cycloheximide, and polymxin, and gently homogenised, 
and incubated horizontally at 30ºC for 24h, then 200 µl of each culture were transferred 
to a sterile micro-tube containing DMSO and stored until use. 
 
ii. Maize rhizosphere and soil samples were collected from Hargrove Farm, Bridgend, 
Wales, UK (coordinates 51.515393,-3.646903), with permission from the land owner. 
A total of 14 soil samples were examined. To isolate bacteria from the maize 
rhizosphere, maize roots were aseptically removed, 200 µl of the root homogenate was 
added to 2 ml of BSM-G medium and then incubated at 30ºC for 24 h. After growth, 
200 µl of each culture was transferred to a sterile micro-tube, DMSO was then added to 
8%, and it was then stored at -80ºC until use. 
 
iii. Bacteria associated with rhizosphere of tropical rainforest plants were obtained from 
multiple sites at the Danau Girang Field Centre, Sabah, Malaysia (coordinates 
5.414000, 118.037317; all samples were obtained by E. Mahenthiralingam, Cardiff 
University). A total of 96, 1 cm root samples were aseptically cut from a range of 
plants growing on the rainforest floor and homogenised (using a disposable micro tube 
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pestle) in 1 ml of BSM-G (pH 5.5) containing 0.1 mg ml
-1
 of cycloheximide to prevent 
fungal growth. The samples were shipped to the UK immediately and the growth of 
bacteria allowed to proceed during this period (8 days). Upon arrival in Cardiff, DMSO 
was added to a final concentration of 8% v/v and the samples stored at -80
o
C prior to 
screening. Anti-candidal activity of these mixed rhizosphere cultures was tested using 
growth on BSM-G followed by overlaying with C. albicans; pure cultures of the anti-
candidal bacteria within these mixtures were then obtained by plating to single colonies 
and re-screening the isolates (performed by Ewa Karpinska, Cardiff University).  
 
iv. Four isolates of B. gladioli from cystic fibrosis (CF) patients were obtained from the 
Cardiff University Collection (Mahenthiralingam, et al., 2011) and included in this 
study since they had shown evidence of antifungal activity in previous work. 
 
6.2.2 Antifungal activity of bacterial isolates 
The soil, root and CF isolates were screened for antifungal phenotypes against C. albicans 
using an agar overlay assay (section 2.5.1), and against B. adusta using an agar antagonism 
assay (section 2.5.2). Active isolates which showed antifungal activity in the above assays 
were plated to obtain single colonies to enable purification of each antifungal producing 
microorganism. Single colonies were then retested for antagonistic activity using the 
overlay assay. 
 
6.2.3 Identification of isolated bacteria 
Antifungal producers were putatively identified to the species level using 16S rRNA gene 
sequence analysis (section 2.4). All pure isolates were stored at -80ºC until use. All of 
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isolated antifungal producing bacteria were subjected to qualitative analysis using TLC-
bioautography assay (section 2.10). 
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6.3 Results  
 
6.3.1 Isolation of antifungal producing bacteria  
 
In total, 120 samples of rhizosphere soil and plant root samples were collected from 
different locations and screened for antifungal activity. This resulted in the isolation of 84 
pure bacterial isolates, of which 16 had anti-candidal activity in an initial pre-screen using 
the overlay assay. These 16 environmental isolates were combined with 4 B. gladioli 
strains isolated from CF patients and subjected to detailed antimicrobial activity analysis. 
 
All 20 isolates inhibited growth of C. albicans, with different inhibition zones ranging 
from 9 to 60 mm (Table 6.1). The maximum inhibition was caused by B. gladioli (Bcc1671 
and Bcc1668) and B. cepacia Bcc1640 (60.0, 40.0 and 33.5 mm respectively) (Table 6.1). 
All four isolates of B. gladioli obtained from CF infection demonstrated both anti-candidal 
and anti-basidiomycete activity (Figure 6.1 and Table 6.1). 
 
The effect of bacterial metabolites on B. adusta varied considerably. Three different 
classes of outcomes were observed between the bacteria and B. adusta (as described in 
chapter 3). Firstly, a full inhibition of B. adusta growth (Figure 3.4 A) was defined when 
there was no growth at all of B. adusta. Secondly, deadlock (Figure 3.4 B) was defined 
when the bacterial metabolites stopped the growth of B. adusta and finally B. adusta 
sometimes overgrowth the bacteria (Figure 3.4 C).  
 Table 6.1 Antifungal activity of active bacterial species isolated from different environments 
CA, C. albicans; BK1, B. adusta; CF, cystic fibrosis; ENV, environmental; * Nearest relative by 16S rRNA sequence analysis. 
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ENV 29 + 0.0 0.1 - - - - - - - - 
2 BCC1631 10TC2 B. cenocepacia ENV 11.5 - 0.0 0.12 - - - - - 0.7 - - 
3 BCC1632 45TC1 B. cenocepacia ENV 15 + 0.0 0.12 - - - - - 0.7 - - 
4 BCC1635 7PMX2 Burkholderia sp. ENV 8.5 - - 0.12 - - - - - - - - 
5 BCC1638 5PMX3 B. ambifaria ENV 51 - - - - - - - - - - 0.92 
6 BCC1640 10PMX2 B. cepacia ENV 33.5 - - - - - - - - 0.7 - - 
7 BCC1641 10PMX3 B. cenocepacia ENV 9 + - - - - - - - - - 0.92 
8 BCC1667 64952 B. gladioli  
Cardiff UK 
 
CF 25 + 0.0 - 0.28 - - 0.56 - - - - 
9 BCC1668 5567 B. gladioli CF 40 ++ 0.0 0.12 - 0.37 - 0.5 - 0.71 0.75 - 
10 BCC1671 COL 1090 B. gladioli CF 60 + 0.0 0.13 0.23 - - - - - 0.75 - 
11 BCC1672 Manchester B. gladioli Manchester 
UK 
CF 30 + - 0.12 - 0.37 0.49 - - 0.7, 
0.76 
- 0.99 
12 ESH736 Chep.1.cord Bacillus sp.* Coed 
Beddick, 
Tintern  U.K 
ENV 26 ++ 0.0 0.12 - - - - - 0.74 - - 
13 ESH737 Chep.2.soil Bacillus altitudinis* ENV 22 
- 
0.0 0.11 - - - - 0.68 - - - 
14 ESH738 S2.3 Bacillus pumilus * 
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ENV 11 + - - - - - - - - - - 
15 ESH739 S2.5 Paenibacillus polymyxa * ENV 14 ++ - 0.10 - - - - - - 0.8 0.98 
16 ESH740 R3.2 Bacillus licheniformis * ENV 12 + - 0.10 - - - - - - - - 
17 ESH741 S4.4 Bacillus altitudinis * ENV 16 + - - - - - - - - - - 
18 ESH742 S4.7 Bacillus safensis * ENV 15 - 0.0 - - - - - - - - - 
19 ESH743 R6.6 Bacillus subtilis * ENV 11.5 - - - - - - - - - - - 
20 ESH744 R7.7 Bacillus sonorensis * ENV 12 + - - - - - - - - - - 
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Figure 6.1 The outcomes (inhibition, deadlock and overgrowth) of the interaction 
between B. adusta BK1 and active bacterial isolates. 
1630 (B. ambifaria, BCC1630), 1631 (B. cenocepacia Bcc1631), 1632 (B. cenocepacia Bcc1632), 1635 
(Burkholderia sp. Bcc1635), 1638 (B. ambifaria Bcc1638), 1640 (B. cepacia Bcc1640), 1641 (B. 
cenocepacia Bcc1641), 1667 (B. gladioli Bcc1667), 1668 (B. gladioli Bcc1668), 1671 (B. gladioli Bcc1671), 
1672 (B. gladioli Bcc1672), S23 (Bacillus pumilus ESH738 ), S25 (Paenibacillus polymyxa ESH739), R32 
(Bacillus licheniformis ESH740), R44 (Bacillus altitudinis ESH741), S47 (Bacillus safensis ESH742), R66 
(Bacillus subtilis ESH743 ), R77 (Bacillus sonorensis ESH744 ), SOIL (Bacillus altitudinis ESH737) , 
CORD (Bacillus sp ESH736). 
 
 
 
 
 
 
 
 
 
CORDSOIL
1640 1641 1667 1671
1632 163816351630 1631
1668
R66R32
S23 S47S441672 S25
R77
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These findings illustrate a remarkable diversity of interactions between bacteria and 
basidiomycetes. 65% of tested bacteria were able to produce and release active metabolites 
which inhibited the growth of B. adusta. The most aggressive Burkholderia isolate against 
B. adusta (Table 6.1 and Figure 6.1) was B. gladioli Bcc1668. Isolates of B. gladioli 
Bcc1667, isolate ESH739 and ESH736 produced very active antifungal agents which 
inhibited the growth of B. adusta. The weakest isolates were Bcc1630, Bcc1631, Bcc1632, 
Bcc1641, Bcc1671, Bcc1672, ESH739 and ESH740. Isolates Bcc1635, Bcc1638, Bcc1640, 
ESH742 and ESH743 were unsuccessful to inhibiting the growth of B. adusta. The results 
showed that many isolates were able to change the morphology of B. adusta growth, as 
there was clear variation in mycelial colour and hyphal density compared to the control.  
For example, Bcc1635, Bcc1640 and ESH737 isolates stimulated mycelia of B. adusta to 
produce fan-like structures at mycelial margins compared to the control, and other species 
were able to grow over Burkholderia colonies and cover it. B. adusta grew completely over 
ESH742 isolate (Figure 6.1). 
 
The bacterial soil and rhizosphere isolates are listed in Table 6.1 with their classification 
based on the nearest match to their 16S rRNA genes. Seven antifungal isolates were 
obtained from the Malaysian rainforest rhizospheres, and six were members of the 
Burkholderia cepacia complex as follows: B. ambifaria (2 isolates), B. cenocepacia (3 
isolates) and B. cepacia (1 isolate) (Table 6.1). The remaining rainforest isolate was a 
member of the genus Burkholderia but could not be identified to the species level based on 
16S rRNA gene analysis (Bcc1635, Table 6.1). In contrast, no Burkholderia species were 
isolated from the maize rhizospheres in Bridgend, Wales, UK. Bacillus and Paenibacillus 
species isolates comprised the antifungal producers obtained. Four isolates were obtained 
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from loose soil around maize roots and included isolates putatively identified from their 
16S rRNA sequences as Bacillus sp (ESH738, ESH739, ESH741 and ESH742). Three 
other isolates ESH740, ESH743 and ESH744 were recovered from the maize root-
homogenates (as more tightly adhered rhizosphere bacteria) and were putatively identified 
as Bacillus sp. (Table 6.1). Two antifungal producer isolates, ESH736 and ESH737 
(isolated from loose soil), were obtained from the forest rhizosphere of deciduous 
woodland in Tintern, UK and identified from their 16S rRNA gene sequences as Bacillus 
sp (Table 6.1). 
 
6.3.2 Diversity of anti-candidal agents  
Isolation of antifungal metabolites using resin extraction followed by TLC analysis was 
performed for all 20 anti-candidal isolates. The TLC-bioautography profiles demonstrated 
that 16 out of 20 isolates produced extractable metabolites which retained their anti-
candidal activity (Table 6.1 and Figure 6.2). Resin crude extracts obtained from all 11 
Burkholderia isolates and 5 Bacillus isolates showed anti-candidal activity. In contrast, the 
resin crude extracts of the remaining 4 Bacillus isolates (ESH738, ESH741, ESH743 and 
ESH744) failed to exhibit anti-candidal activity on TLC plates. 
 
The B. gladioli isolates produced the greatest diversity of metabolites as well as the most 
potent antifungal compounds. B. gladioli Bcc1668 that produced a 40 mm inhibition zone 
against C. albicans (Table 6.1) had a TLC-bioautography with 6 active anti-candidal 
metabolites at different Rfs: 0.0, 0.12, 0.37, 0.5, 0.71 and 0.75 (Figure 6.2). B. gladioli 
Bcc1672 produced a 30 mm inhibition zone and the TLC-bioautography showed 6 active 
metabolites at different Rfs: 0.12, 0.37, 0.49, 0.70, 0.67 and 0.99.  
(T) A 
17 
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Figure 6.2 TLC-bioautography assay of anti-candidal metabolites secreted by 
bacteria isolated from different environments. 
1 (B. ambifaria, BCC1630), 2 (B. cenocepacia Bcc1631), 3 (B. cenocepacia Bcc1632), 4 (Burkholderia sp. 
Bcc1635), 5 (B. ambifaria Bcc1638), 6 (B. cepacia Bcc1640), 7 (B. cenocepacia Bcc1641), 8 (B. ambifaria 
ESH736), 9 (Bacillus altitudinis ESH737) , 10 (B. gladioli Bcc1667), 11 (B. gladioli Bcc1668), 12 (B. 
gladioli Bcc1671), 13 (Bacillus pumilus ESH738 ), 14 (B. gladioli Bcc1672), 15 (Paenibacillus polymyxa 
ESH739), 16 (Bacillus licheniformis ESH740), 17 (Bacillus altitudinis ESH741), 18 (Bacillus safensis 
ESH742), 19 (Bacillus subtilis ESH743 ), 20(Bacillus sonorensis ESH744). 
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B. gladioli Bcc1671 produced a 60 mm inhibition zone and the TLC-bioautography 
showed 4 active metabolites at different Rfs: 0.0, 0.13, 0.23 and 0.75. B. ambifaria 
Bcc1630 produced a 29 mm inhibition zone and the TLC-bioautography showed 2 active 
metabolites at Rfs 0.0 and 0.10 (Table 6.1 and Figure 6.2). 
 
Bacillus isolates showed different results using the TLC-Bioautography assay. ESH737 
produced a 22 mm inhibition zone against C. albicans and the TLC-bioautography showed 
3 active anti-candidal metabolites at different Rfs: 0.0, 0.11 and 0.68 (Figure 6.2). ESH739 
produced a 14 mm inhibition zone and the TLC-bioautography showed 3 active anti-
candidal metabolites at Rfs 0.1, 0.8 and 0.89 (Figure 6.2). The TLC- bioautography assay 
was not able to detect the active metabolites of the other 4 antifungal Bacillus isolates 
(Table 6.1 and Figure 6.1). 
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6.4 Discussion  
 
Screening a variety of soil and rhizosphere isolates for antifungal activity revealed that 
Bacillus was the only genus of antifungal bacteria isolated from Bridgend UK maize fields. 
Other studies of microbial communities colonising maize rhizospheres all over the world 
have found that Burkholderia is one of the most common bacterial species present 
(Dalmastri, et al., 1999, Estrada, et al., 2002, Dalmastri, et al., 2007). This unexpected 
finding might be due to the following: firstly, the main aim of this work was to isolate the 
antifungal producers. To achieve this, BSM-G medium was used because it had been found 
to enhance the antimicrobial activity whilst screening Burkholderia species (Chapter 3 and 
5). The previous maize rhizosphere studies had used a semi-selective medium, 
Pseudomonas cepacia azelaic acid tryptamine (PCAT), which was formulated to enrich 
Burkholderia species. Another reason could be that the maize samples in this study were a 
different variety to the latter studies. Finally, the reason for the lack of Burkholderia could 
also be because maize was only introduced and cultivated just a few years ago in this area 
of the UK and the natural soils here may contain Bacillus as the dominant bacterial genus.  
 
In general the attempts to extract antifungal agents from isolated bacteria using the resin 
method worked, but was unsuccessful in extraction the antifungal agents from 20% of 
isolates. The reasons for unsuccessful extraction might be due to the nature of the 
antifungal agents, to the solvent and the type of resin used in this study.  Previous studies 
in this field corroborated, as they found that one of the basic parameters that influenced the 
extraction of active compounds was the solvent (Sukhdev, et al., 2008). Different resins 
have different abilities in extracting antimicrobial agent(s) (Ribeiro & Ribeiro, 2003). 
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Different types of resin have been tested for extracting antimicrobial metabolites from B. 
vietnamensis, and it was found that the neutral resin of XAD-4 was able to extract anti-
candidal metabolites when XAD-16 failed on an active isolate (Mahenthiralingam group, 
2011 unpublished data). This could be due to the nature of different active metabolites, 
with the antifungal.  
 
One out of 14 of rhizosphere isolates lost their antifungal activity after isolation as a pure 
culture. This could be because of the synergistic effects of certain metabolites which might 
activate such production. This was consistent with Cain et al., (2003) who found that 
mixture of rhizosphere bacteria became inactive after isolation of pure isolates .  
 
6.5 Conclusions  
 The most frequently isolated genera from Hargrove Farm, Bridgend, Wales, UK., 
maize rhizosphere and Coed Beddick, Tintern UK., deciduous woodland were 
Bacillus and Paenibacillus. 
 Mixed microbial culture may lose their antifungal activity after isolation as a pure 
culture. 
 The resin method was successful in extraction of the antifungal agents from 
Bacillus and Burkholderia species isolated from the rhizosphere. 
 B. gladioli are an interesting source of antifungal metabolites. Crude resin extract 
comprised at least five main antimicrobial compounds. 
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CHAPTER SEVEN 
 
 
 
 
 
 
 
 
 
 
 
 
 
GENETIC ANALYSIS OF ANTIMICROBIAL 
AGENTS PRODUCED BY B. ambifaria AMMD  
 
 
 
 
 
 
 
    
 199 
7.1 Introduction  
Burkholderia ambifaria AMMD (also known as Bcc0207; LMG 19182
T
) was selected for 
genetic analysis of antimicrobial activity because this isolate has a fully sequenced 
genome. Currently, the complete genome of 20 strains of Burkholderia from different 
species and ecological categories has been sequenced. These Burkholderia sequences can 
be examined online at the Burkholderia Genomes Database (BGD; www.burkholderia. 
com). The B. ambifaria AMMD genome is very large (genome size of 7.57 Mb), has a 
high GC content (66.8%), is composed of 3 replicons, and contains a large number of 
insertion sequences. B. ambifaria AMMD was originally isolated from the pea rhizosphere 
and is the representative of Burkholderia species, with biocontrol potential against a range 
of microorganisms (Coenye, et al., 2001). In the current study it was also shown that B. 
ambifaria AMMD has activity against Gram-positive and negative bacteria, C. albicans 
and range of basidiomycetes (Chapter 3). 
 
Genomic information available on the publicly accessible databases such as Genbank or 
BGD can be investigated to increase our understanding of the genes responsible for 
biosynthesis of metabolites with antimicrobial activity. The expression of B. ambifaria 
AMMD genes induced during stationary phase growth on glycerol was recently mapped by 
microarray analysis (Mahenthiralingam, et al., 2011). This growth condition is known to 
induce antimicrobial activity of strain AMMD (see Chapter 3 and 5) and therefore it was 
not surprising to see that 6 putative secondary metabolite gene clusters were significantly 
up-regulated. In the current study, using a TLC-bioautography assay, more than 6 
secondary metabolites with antimicrobial activity were detected and identified (Chapter 5). 
Correlation of these active antimicrobial compounds to specific biosynthetic loci will 
considerably advance our knowledge of antibiotic production by Burkholderia. 
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One of the most powerful approaches used to identify the function of microbial-encoded 
genes is to introduce mutations into the bacterial genome and screen for mutants which 
have lost specific biological functions. Transposition is a recombination process in which 
transposable elements, such as Mu, Tn3, Tn5 or Tn10, move from one site on a genome to 
a new site on the same genome, or move from a mobile element such as plasmid into a 
completely new genome (Kleckner, 1981). The movement of transposons in this way can 
cause genetic rearrangements such as deletions, inversions or duplication of DNA 
sequences, as well as inactivation of the genes within which they insert and sometimes 
activation of genes adjacent to the site of insertion (Steiniger-White, et al., 2004). 
Transposon mutants lacking the ability to produce certain antimicrobial agents have been 
used to demonstrate the role of antibiotics in the biocontrol functions mediated by 
microorganisms such as Pseudomonas (Fravel, 1988, Raaijmakers, et al., 2002).   
 
There are multiple bioinformatics tools available that can aid the identification of known 
secondary metabolite genes within genomes such as that of B. ambifaria AMMD. In 
addition such genome mining may also lead to the discovery of novel antibiotics within 
Burkholderia genomes. Artemis is a genome sequence visualisation and analysis tool 
developed by Rutherford et al. (2000) (http://www.sanger.ac.uk /resources/software/ 
artemis/). The software allows, on one screen, the viewing of the sequence of an entire 
genome in a graphical format; additional tools, such as the Artemis Comparison Tool 
(ACT), also enable the display of pair-wise comparisons between two or more genomes 
(Berriman & Rutherford, 2003). Genome annotation is the identification of putative 
functional roles for genes encoded within a DNA sequence (Lukashin & Borodovsky, 
1998). The BGD (www.burkholderia.com) provides similar features to Artemis but allows 
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Burkholderia genomes to be viewed and compared over the web. Hence, this tool can 
allow the comparison of B. ambifaria AMMD to all the additional Burkholderia genomes 
available. It is a very powerful tool with which to identify the presence of orthologous 
genes in Burkholderia genomes. 
 
A general hypothesis for this chapter was „„transposon mutagenesis combined with 
genomic analysis can identify and predict the B. ambifaria AMMD genes involved in its 
antifungal activity.‟‟ The specific aims of this chapter were: 
 To identify the gene(s) responsible for the production of anti-candidal agents by 
transposon mutagenesis of B. ambifaria AMMD. 
 To characterise previously identified B. ambifaria AMMD mutants with altered 
anit-B. multivorans activity using resin-based metabolite extraction followed by 
TLC-bioautography assay. 
 To bioinformatically analyse the glycerol-induced up-regulated B. ambifaria 
AMMD gene clusters observed by Mahenthiralingam, et al., (2011) and search for 
the presence of orthologs within other Burkholderia genomes.    
 To use the knowledge from the above genetic analysis in combination with 
conventional phenotypic assays to characterise the kinetics B. ambifaria AMMD 
metabolites secretion. 
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7.2 Materials and Methods 
 
7.2.1 Screening B. ambifaria AMMD transposon mutants 
A bank of 2500 B. ambifaria AMMD mini-Tn5-Km2 transposon mutants that had been 
previously created (Mahenthiralingam, et al., 2011) was screened for mutants that lacked 
anti-candidal activity (see section 2.8.1). Individual mutants with altered anti-candidal 
activity were re-plated from the master mutant bank and retested (twice) to confirm the 
stability of their anti-candidal negative phenotype; individual mutants were then stored at – 
80ºC for further characterization. In addition, a selection of 7 mutants with altered activity 
against the bacterium B. multivorans  (Mahenthiralingam et al., 2011) were investigated 
using resin extraction of metabolites from 3 day plate cultures, followed by TLC- 
bioautography assay (section 2.10). The range of bioactive compounds secreted by these B. 
ambifaria mutants, in comparison to the wild type AMMD parent, was compared using 
both C. albicans and B. multivorans TLC overlay (see section 2.10). 
 
7.2.2 Detection of Tn5 insertion site 
To detect the transposon insertion site for each B. ambifaria AMMD mutant that had 
altered activity against C. albicans, B. ambifaria AMMD mutants were grown in TSB 
containing Kanamycin (Km; 50µg/ml) at 37C for 24h. DNA was extracted from each 
mutant culture using a mechanical shearing, bead-beater based, extraction protocol 
(Mahenthiralingam et al., 1996). Random Amplified Polymorphic DNA (RAPD; 
Mahenthiralingam et al., 1996) PCR fingerprinting was performed, as described in section 
2.8.2, to confirm that each transposon mutant was a derivative of B. ambifaria AMMD and 
not a contaminant isolated during the screening process. PCR was used to amplify DNA 
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adjacent to the transposon insertion sites and then this DNA was sequenced as described 
elsewhere (Manoil & Beckwith, 1985) section 2.8.3.  
 
Briefly, the DNA adjacent to the Tn5 insertion was amplified using a two-step PCR 
reaction protocol (step PCR1 and step PCR2) and 4 different primers. PCR 1 amplified the 
end of the transposon and adjacent chromosomal DNA to give sequences of variable 
lengths, due to the random priming of primer 2b at genomic sites flanking the transposon 
(Figure 7.1). Products of PCR1 were further amplified using PCR2. PCR2 products were 
sequenced using primer PCR 3, on an ABI automated sequencer (Cardiff University 
Molecular Biology unit, DNA Sequencing Core). The amplified short sequences adjacent 
to the transposon insertions were matched to the B. ambifaria AMMD genome using 
BLASTN similarity search available at the BGD. 
 
7.2.3 The Time course of production of anti-candidal agents 
 
Changes in bacterial growth, culture pH and anti-candidal agents of B. ambifaria AMMD 
over time were studied using BSM-G broth medium at pH 6. Multiple 250 ml flasks 
containing 100 ml of BSM-G medium and inoculated with approximately 1 x 10
8
 cfu of B. 
ambifaria AMMD were set up. The flasks were incubated either statically or with shaking 
at 30ºC. The initial pH of the growth medium before autoclaving was adjusted to pH 6. 
However, it was noted to move to pH 5.92 after autoclaving. During growth, the pH of the 
AMMD culture was not controlled by extensive buffering, with just a minimal phosphate 
buffer system used in the BSM growth medium. At specific time points, the bacterial 
growth as measured by turbidity at 630 nm was determined (the mean of 3 replicate 
reading was determined). At given time points the antimicrobial compounds were extracted  
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Figure 7.1 PCR Schematic for sequencing transposon insertion site. 
This PCR determines the site of the transposon insertion in the bacterial genome. Chromosomal DNA 
adjacent to the Tn5 insertion is amplified using a two-step PCR reaction procedure shown in the diagram 
above. Primer Sequences: Primer 1, 5‟-ttt tta cac tga tga atg ttc cg -3‟; Primer 2b, 5‟-ggc cac gcg tcg act agt 
acn nnn nnn nnn acg cc -3‟; Primer 3, 5‟ – cgg att aca gcc gga tcc ccg -3‟; Primer 4, 5‟ – ggc cac gcg tcg act 
agt ac.  
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from one set of cultures using XAD16 resin as described in section 2.9.2. The bioactive 
metabolites were then separated using TLC and located with a C. albicans overlay (section 
2.10). 
 
7.2.4 Bioinformatics analysis 
The whole genome sequence of B. ambifaria AMMD was obtained from the Burkholderia 
Genome Database (http://www.burkholderia.com/). Artemis was used to further visualise 
and annotate the B. ambifaria AMMD genome. Information on Burkholderia antimicrobial 
agents was collected from previous literature and the current study. This information 
consisted of the name, chemical structure, nucleotide sequence of the biosynthetic gene(s) 
or the amino acid sequence(s) of the encoded proteins. The biosynthetic genes for the 
following known Burkholderia antibiotics were examined: pyrrolnitrin (Schmidt, et al., 
2009), quinolinone (Vial, et al., 2008), enacyloxin (Mahenthiralingam et al., 2011) and the 
Afc-lipopeptide (Kang, et al., 1998). The genes or proteins were searched against the 
AMMD genome using the BLASTN or BLASTP software at BGD. Located gene clusters 
were then marked onto the B. ambifaria AMMD genome using the Artemis software and 
Navigator tool to match up amino acid or nucleic acid sequence data. The GC content of 
the DNA was also visualised using the Artemis software. After location and further 
annotation, screen shots of the Artemis or BGD plots of the AMMD antibiotic loci were 
made to allow their presentation as figures. 
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7.3 Results 
 
7.3.1 TLC-bioautography analysis of B. ambifaria AMMD mutants 
lacking activity against B. multivorans 
Two of the AMMD mutants, 5.2.7 and 9.7.2, were negative for activity against both C. 
albicans and B. multivorans (Figures 7.2 and 7.3).  Three of the AMMD mutants, 9.11.5, 
10.11.3 and 21.7.2, showed negative anti-B. multivorans activity (Figure 7.3) but retained 
their anti-candidal phenotype in the overlay assay (Figure 7.2). Mutant 5.3.7 had reduced 
anti-B. multvorans activity (Figure 7.3) and normal anti-candidal activity (Figure 7.2). 
Mutant 11.8.2, a mutant which demonstrated both early appearance and enhancement of its 
anti-B. multivorans activity (Mahenthiralingam et al. 2011; Figure 7.3), possessed normal 
activity against  C. albicans (Figure 7.2). 
 
The genetic basis for each transposon mutation and the observed antimicrobial phenotype 
of each mutant is summarised in Table 7.1. Mutants 5.7.2 and 9.7.2 had the same negative 
phenotype against both C. albicans and B. multivorans; sequence analysis of their Tn5 
insertions demonstrated that they were both CepI mutants, the autoinducer synthase 
involved in quorum sensing by B. ambifaria. The resin metabolite extracts from both CepI 
mutants contained no anti-candidal (Figure 7.2) or anti-B. multivorans metabolites, 
demonstrating that all these antibiotics are dependent on an active quorum sensing system 
for their biosynthesis.  
 
Mutants 9.11.5, 10.11.3 and 21.7.2 were only able to produce one anti-candidal compound 
detectable by TLC-bioautography (Rf = 0.73; Figure 7.2) and completely lacked 
enacyloxin (Rf = 0.5; Figure 7.3), the polyketide compound enacyloxin active against  
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Figure 7.2 Analysis of anti-candidal activity of B. ambifaria AMMD mutants unable to 
inhibit C. albicans. 
Overlay assay (panel a) demonstrated anti-candidal activity. TLC-bioautography assay (panel b) confirmed 
the presences and absences of anti-candidal agents in secondary metabolites of B. ambifaria AMMD wild 
type and 7 AMMD mutants. Arrows indicated anti-candidal activity. 
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Figure 7.3 Analysis of anti-B. multivorans activity of B. ambifaria AMMD mutants 
unable to inhibit B. multivorans.  
Overlay assay (panel a) demonstrated anti- B. multivorans activity. TLC-bioautography assay (panel b) 
confirmed the presences and absences of anti- B. multivorans agents in secondary metabolites of B. ambifaria 
AMMD wild type and other 7 AMMD mutants. Arrows indicated anti- B. multivorans activity. 
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B. multivorans (Mahenthiralingam, et al., 2011). Mutants 9.11.5 and 21.7.2 both contained 
transposon insertions in polyketide synthase (PKS) encoding genes within the enacyloxin 
biosynthetic cluster (Mahenthiralingam, et al., 2011); mutant 10.11.3 contained an 
insertion in a gene of hypothetical function which was also linked to enacyloxin production 
(Mahenthiralingam, et al., 2011). The presence of the one anti-candidal compound of Rf 
0.73 in these mutants suggested they retained the capacity to produce the quinolinone 
antifungal compound which separated as this fraction (chapter 4). 
 
Mutant 5.3.7 contained a transposon insertion in a glycosyltransferase encoding gene; TLC 
analysis demonstrated that 5.3.7 had a similar anti-candidal compound profile to B. 
ambifaria AMMD wild type (Figure 7.2), but produced a larger enacyloxin-like fraction 
(Rf = 0.52; Figure 7.3) despite its slightly weaker anti-B. multivorans phenotype in 
standard overlay assays.  Mutant 11.8.2 contained an insertion in a cation diffuser family 
transporter gene and produced the normal range of anti-candidal (Figure 7.2) and anti-B. 
multivorans (Figure 7.3) compounds by TLC bioassay. 
 
7.3.2 TLC-bioautography and genetic analysis of B. ambifaria 
AMMD mutants lacking activity against C. albicans 
The mutant bank created by Mahenthiralingam, et al., (2011) had been screened for 
alterations in anti-B. multivorans activity using an overlay with this test organism. To fully 
explore the antimicrobial phenotype of B. ambifaria AMMD, its antifungal activity was 
further investigated by screening the same transposon mutant bank for defects in the 
production of anti-candidal agents. Out of 2500 isolates the anti-candidal activity of 
individual AMMD mutants varied and many of them showed un-stable activity against    
C. albicans. On the first screen of the mutant bank, 23 mutants with negative or reduced 
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activity were identified and selected for further analysis. After each of these mutants were 
re-screened individually for anti-candidal activity, 17 mutants were stably altered in anti-
candidal activity and 6 reverted to wild type activity. A total of 9 out of 17 stable mutants 
were successfully subjected to DNA sequence analysis of their transposon insertions 
(Table 7.1). All 9 mutant sequences matched an insertion point on the AMMD genome 
(Table 7.1). 
 
The genetic basis for each transposon mutation and their observed antimicrobial phenotype 
of each mutant is summarised in Table 7.1. Mutant 11.12.6, which encoded for an amino-
acid N-acetyltransferase enzyme, was putatively involved in polyketide biosynthesis. 
Mutant 11.10.8 contained transposon insertions in a gene of hypothetical function 
(Bamb6146) which was linked to AfcA locus (Bamb_6128-6153). 
  
7.3.3 The time course of production of anti-candidal agents 
To gain an insight into the kinetics and physiology of B. ambifaria AMMD metabolite 
secretion, the production of anti-candidal compounds, cell density and pH were monitored 
over 170 hours of growth in BSM-G liquid medium static culture (Figure 7.4). The pH 
increased slightly from 5.92 to 5.98 in the early stage of the fermentation up to 14 h, then 
decreased to 5.2 at 78 h; for the last 4 days of culture the pH then increased to 5.56 by the 
end of the 170 h of test period. The optical density of growth culture increased over time, 
reaching a maximum at approximately 98 h, but then decreased for the remaining culture 
period.  
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Table 7.1  Characteristics of B. ambifaria AMMD transposon mutants 
AMMD 
and 
mutants 
No. 
Anti-candidal 
Activity 
Anti-B. multivorans  
activity 
Characteristics of AMMD mutants 
Overlay 
assay 
TLC 
bioassay (Rf) 
Overlay assay TLC 
bioassay (Rf) 
Location of 
transposatnts  
(Chromosome No) 
 
Gene name 
 
 
Putative function 
 
AMMD 
(wild type) 
+ (6) 0.0, 0.08, 0.33, 
0.5, 0.72 & 0.98 
+ (1)  0.47 - 
 
Transposon mutants with altered B. multivorans activity isolated by Mahenthiralingam et al. 2011 
 
5.3.7 + (2) 0.5 & 0.73 + (reduced activity) (1) 0.5 1 Bamb_2222 Glycosyltransferase, group 1 
5.7.2 - - - - 2 Bamb_4118 Autoinducer synthase, CepI 
9.7.2 - - - - 2 Bamb_4118 Autoinducer synthase, CepI 
9.11.5 + (1) 0.73 - - 3 Bamb_5919 trans-AT modular PKS 
10.11.3 + (1) 0.73 - - 2 Bamb_5367 Hypothetical protein 
11.8.2 + (2) 0.5 & 0.73 + (1) 0.53 2 Bamb_5056 Cation diffusion facilitator family transporter 
21.7.2 + (1) 0.73 - - 2 Bamb_5422 cis-AT modular PKS 
 
Transposon mutants with altered anti-candidal activity isolated in this study 
11.10.8 - ND ND ND 3 Bamb_6146 
 
Hypothetical gene  
11.12.3 - ND ND ND 3 Bamb_5771 Acetyl-CoA acetyltransferases 
11.12.6 - ND ND ND 1 Bamb_2193 Amino-acid N-acetyltransferase 
13.1.4 - ND ND ND 1 Bamb_2465 Major facilitator superfamily MFS_1 
13.5.1 - ND ND ND 2 Bamb_3978 
 
Intergenic inserton betweem glucose-methanol-choline oxidoreductase 
and a cytochrome C, class I protein encoding gene 
17.11.6 - ND ND ND 1 Bamb_1389 GTP-binding protein Typ A 
18.1.2 - ND ND ND 2 Bamb_5342 Hypothetical protein 
18.7.6 - ND ND ND 2 Bamb_5047 Peptidase C26 
10.10.8 - ND ND ND 1 Bamb_1541 Ton B-dependent siderophore receptor 
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Figure 7.4 Time course of B. ambifaria AMMD culture tracking optical density, pH 
and secondary metabolites secretion.  
B. ambifaria AMMD liquid cultures (100 ml) were grown statically for different lengths of time. The pH and 
culture optical density were measured. Replicates were harvested after various time periods of incubation and 
subjected to extraction of metabolites as following: The growth medium was centrifuged then the supernatant 
was used to extract bacterial secondary metabolites using Amberlite XAD16 resin. The resin was eluted with 
methanol to extract the anti-candidal components. By correlating the active fractions seen in the TLC-
bioautography to the MS data, the appearance of the following compounds are indicated on the time course: 
polyethylene glycol (PG), 4-hydroxy-3-methyl-2-alkylquinoline (HQ), enacyloxin ΙΙ (EY2), an enacyloxin 
derivative (EYU) and unidentified compounds (UN). The mean (± SEM) is shown for each parameter 
measured.  
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The dry weight yield of resin extractable metabolites increased gradually up to 38 h (787 
mg l
-1
), and then after 62 h increased rapidly to a maximum yield of 1619 mg l
-1
 (Figure 
7.4).  Using the TLC-bioautography assay at least five active anti-candidal metabolites of 
the B. ambifaria AMMD were detected (Figure 7.5). The first active anti-candidal agents 
were produced 6 h after inoculation (Rf 0.10; Figure 7.5 B); from correlation with the MS 
data these metabolites were probably polyethylene glycol (PEG) and unknown peptides 
(see chapter 4).  
 
After this, fractions corresponding to an unknown compound (Rf 0.05) and quinoline (Rf 
0.72 ± 0.02) were detected after 50 h. A fraction corresponding to Enacyloxin II a (Rf 0.50 
± 0.02) appeared after 122 h and another putative enacyloxin isomer (Rf 0.35 ± 0.02) after 
146 h (Figure 7.5). There was no sign of pyrrolnitrin production under these liquid growth 
conditions. Extraction and TLC-bioautography of the un-inoculated growth medium left 
under the same conditions did not demonstrate the presence of any anti-candidal 
metabolites, demonstrating that the activities observed were due to metabolites produced as 
a result of B. ambifaria growth (Figure 7.5). 
 
7.3.4 Bioinformatics analysis of B. ambifaria genome 
The TLC-Bioautography assay had detected more than six secondary metabolites with 
antimicrobial activity (chapter 4 and 5) in the B. ambifaria AMMD resin extracts from 
plate grown bacteria. The anti-candidal compounds were identified as pyrrolnitrin, 
quinolinone and enacyloxin using LC-MS (chapter 4). Bioinformatic characterization of 
known and novel antibiotic loci within the B. ambifaria AMMD genome was therefore 
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                                                                  Time (h)        
Figure 7.5 TLC-bioautography assay of anti-candidal metabolites secreted by B. 
ambifaria AMMD during time course. 
B. ambifaria AMMD liquid cultures (100 ml) were grown statically for different lengths of time (h) as 
indicated at the bottom of each panel. Secreted metabolites were extracted, separated by TLC and visualized 
under UV light (Panel A). Extraction of growth medium without AMMD was performed as a control at three 
different time points (h) as indicated. The TLC plates were overlaid with C. albicans to reveal antifungal 
activity (Panel B). All TLC plates were run simultaneously as replicates and the retention factor (Rf) scale is 
indicated. Arrows indicated the dot point of production of each active metabolite. The appearances of the 
following compounds are indicated on the time course: polyethylene glycol (PG), 4-hydroxy-3-methyl-2-
alkylquinoline (HQ), enacyloxin ΙΙ (EY2), an enacyloxin derivative (EYU), and unidentified compounds 
(UN).  
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performed to correlate the results of the chemical analysis with the putative functional 
biosynthetic capacity of the genome. 
 
A pyrrolnitrin gene cluster was identified in B. ambifaria AMMD genome on chromosome 
2 (Table 7.2). The pyrrolnitrin (prn) operon length was 5800 bases and contained four 
genes (Figure 7.6): prnA (Bamb_4726), prnB (Bamb_4727), prnC (Bamb_4728) and prnD 
(Bamb_4729). The GC content of the operon ranged from 56.9% to 73.4% (Figure 7.7), 
however, the average GC content was 65.7% and close to the average for AMMD genome 
(Table 7.2). Thirteen out of the twenty genome sequenced Burkholderia strains encoded 
the genes homologous to those in the prn operon.  Seven strains were found to contain the 
whole pyrrolnitrin operon (genes prnA to prnD), while six strains contained an incomplete 
operon (Figure 7.8 and Table 7.3). For the seven strains with a complete prn locus, 5 
encoded the operon on chromosome 2 and two encoded it on chromosome 3 (Table 7.3). 
Three of the genome sequenced Bcc strains had been previously tested for antifungal 
activity, B. ambifaria MC-40, B. cenocepacia MC0-03 and B. lata 383 and all were active 
(see chapter 3). 
 
A 4-hydroxyl-3-methyl-2-alkyl-quinoline (HMAQ) gene cluster was identified within the 
B. ambifaria AMMD genome on chromosome 3 (Table 7.2). The length of HMAQ gene 
cluster was 11777 bases and contained 7 genes (Bamb_5763-5769; Figure 7.9). Although 
the GC content of the gene cluster varied from 55.2% to 76.3 %, the average GC content 
across the region was still typical for strain AMMD (Table 7.2). The Bamb_5767 gene 
within the cluster encoded a LuxR family transcriptional regulator (Appendix C; Figure 
C.1) indicating that the cluster was most likely regulated by quorum sensing. The absence 
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Table 7.2 Characterisation of B. ambifaria AMMD genes responsible for synthesis of antimicrobial agents 
  
Chromosome 
No. 
  Cluster name Characteristics 
Number 
of genes 
Gene name Cluster 
length 
(Kb) 
Average GC 
content (%; AMMD 
average = 66.7%) 
No. putative 
orthologs  
LuxR 
gene 
                
3 
Quinolines 7 Bamb_5763- Bamb_5769 11777 66.4 5 - 
Enacyloxin 33 Bamb_5910- Bamb_5943 84284 71.5 9 + 
AfcA  lipopeptide 26 Bamb_6128- Bamb_6153 24238 70.6 13 - 
Unknown B 15 Bamb_6468- Bamb_6482 55082 67.1 5 + 
 
2 
Pyrrolnitrin 4 Bamb_4726- Bamb_4729 5800 65.7 13 - 
Unknown A 21 Bamb_3597- Bamb_3617 23444 67 4 - 
1 No genes responsible for synthesis of  antimicrobial agents  detected 
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Product  
Tryptophan alogenase
Indoleamine/tryptophan 2, 3-dioxygenase
Rieske non-heme iron dependent oxygenase
FADH2-dependent chlorinase
Gene  
4726 
4727 
4728 
4729 
 
Figure 7.6 The pyrrolnitrin operon of B. ambifaria AMMD. 
The amino acid and nucleotide sequences of pyrrolnitrin were searched against the B. ambifaria AMMD 
genome using the BLASTN or BLASTP software. The located gene cluster was then marked onto the B. 
ambifaria AMMD genome (Bamb_4726 to Bamb_4729) and navigator tool to match up amino acid or 
nucleic acid sequence data. Pyrrolnitrin operon genes (prnA, prnB, prnC and prnD), the functional annotation 
and products of genes are also shown. The colour indicated the subcellular localization classes as shown in 
the key. 
 
Key:
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Figure 7.7 Antimicrobial biosynthesis loci encoded on chromosome 2 of B. ambifaria AMMD. 
The linear representations of B. ambifaria AMMD chromosome 2 are viewed with Artemis software. The localisation of putative antimicrobial biosynthetic genes, 
pyrrolnitrin and unknown A, and their GC content are shown. The scale of the map is shown in 1 kb increments. The potential protein coding regions (colour-coded by 
biological role) are depicted as boxes with arrow heads indicating the direction of transcription.  
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Figure 7.8 Orthologous arrangement of pyrrolnitrin biosynthesis genes of 
Burkholderia genomes.  
Pyrrolnitrin genes were identified in 20 Burkholderia genomes. The top panel showed B. ambifaria AMMD 
pyrrolnitrin biosynthesis genes, and other six orthologous loci are shown. The colour indicated the 
subcellular localization classes as shown in the key. 
Key:
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Table 7.3 Putative orthologs of B. ambifaria AMMD pyrrolnitrin genes in other Burkholderia genomes  
 
Burkholderia strains 
Pyrrolnitrin cluster Chromosome 
number prnA 
(7 isolates ±) 
prnB 
(7 isolates ±) 
prnC 
(12 isolates ±) 
prnD     
(13 isolates ±) 
B. ambifaria  AMMD +  + + + 2 
B. ambifaria MC40 + + + + 2 
B. cenocepacia MC0-03 + + + + 3 
B. lata 383  + + + + 3 
B. pseudomallei 1106a  + + + + 2 
B. pseudomallei 1710b  + + + + 2 
B. pseudomallei 668  + + + + 2 
B. mallei ATCC 23344    - - + + 2 
B. mallei NCTC 10229    - - + + 2 
B. mallei NCTC 10247  - - + + 2 
B. mallei SAVP1  - - + + 2 
B. pseudomallei K96243  - - + + 2 
B. cenocepacia J2315 - - - + 2 
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of the quinolinone antibiotics in the metabolite extracts from the two CepI autoinducer 
synthase mutants corroborates this observation. A complete HMAQ gene cluster was found 
in three strains of fully sequenced Burkholderia strains (B. ambifaria MC40-6, B. 
pseudomallei K96243 and B. thailandensis E264; Appendix C; Figure C.2). 
 
An enacyloxin gene cluster encoding 33 genes with a high GC content (71.5%) suggestive 
of its acquisition by horizontal gene transfer was identified on chromosome 3 (Figure 7.9 
and Table 7.2). As with the HMAQ gene cluster, the enacyloxin cluster also encoded two 
LuxR family transcriptional regulator genes, Bamb_5910 and Bamb_5911 (Appendix C; 
Figure C.3), indicating regulation via quorum sensing and correlating with an absence of 
the polyketide in the two CepI autoinducer synthase mutants. Nine out of twenty genome 
sequenced Burkholderia strains possessed a limited number of genes orthologous to those 
within enacyloxin gene cluster (mainly single PKS-like genes), however, none had a 
completely identical cluster (Appendix C; Figure C.4). This also correlated with an 
absence of enacyloxin activity in the genome sequenced Bcc strains previously screened 
(chapter 3).   
 
An AfcA lipopeptide gene cluster was also identified on chromosome 3. The gene cluster 
was 24238 bases in length and contained 25 genes: Bamb_6128 - Bamb_6153 (Appendix 
C; Figure C.5). Its average GC content was atypical for B. ambifaria AMMD at 70.6%, 
again suggesting that it was acquired by horizontal gene transfer (Figure 7.9). A complete 
AfcA lipopeptide gene cluster was found in four strains of fully sequenced Burkholderia 
strains (B. lata 833, B. cenocepacia MCO-3, B. cenocepacia AU1045 and B. cenocepacia 
HI2424; Appendix C; Figure C.6). 
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Figure 7.9 Antimicrobial biosynthesis loci encoded on chromosome 3 of B. ambifaria AMMD.  
The linear representations of B. ambifaria AMMD chromosome 3 are viewed with Artemis software. The localisation of putative antimicrobial biosynthetic genes: 4 
hydroxyl quinolines (Quinolines), enacyloxin, AfcA lipopeptide and unknown B, and their GC content are shown. The scale of the map is shown in 1 kb increments. 
The potential protein coding regions (colour-coded by biological role) are depicted as boxes with arrow heads indicating the direction of transcription.  
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Gene clusters for two unknown antimicrobials, A and B, were identified on B. 
ambifaria AMMD chromosome, 2 and 3, respectively (Table 7.2). The unknown A 
gene cluster length was 24238 bases with an average GC content of 67% (Figure 7.7 
and Table 7.2). It contained 21 genes (Bamb_3597 to Bamb_3617) with Bamb_3608, 
Bamb_3611, and Bamb_3612 all predicted to encode polyketide syntheses hence 
suggesting the unknown A gene cluster encoded an antimicrobial metabolite. Only one 
genome sequenced B. ambifaria MC40-6, possessed a complete gene cluster 
homologous to that of the AMMD unknown A gene locus (Figure 7.7 and Appendix C; 
Figure C.9). The unknown B gene cluster was 55082 bases long and encoded 14 genes: 
Bamb_6468 - Bamb_6482; its GC content was typical of the rest of the AMMD genome 
at 67% (Figure 7.7 and Appendix C; Figure C.10).  
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7.4 Discussion 
The purpose of this work was to identify the genes responsible for the production of the 
anti-candidal metabolites by B. ambifaria AMMD using transposon mutagenesis. 
The transposon insertions interfere directly or indirectly with gene function. However, it 
was difficult to explain the potential mode of action of all transposon insertion mutations. 
Six mutants lacked the ability to produce active antimicrobial agents when screened for the 
first time; these mutants reverted to wild type activity when individually re-screened for a 
second/third time. This instability of mutant phenotype against C. albicans may be due to 
the different Tn5 insertion sites in the AMMD genome, with some less stable than others.  
Another reason may have been that because BSM-G was used as a screening medium 
without the addition of kanamycin which is selective for the transposon used.  A final 
reason for the transposon mutant instability observed could be the fact the B. ambifaria 
AMMD is known to secrete at least 6 anti-candidal agents (see chapters 4 and 5), and 
hence single mutations may not result in a clearly negative antifungal phenotype. This 
phenomenon was also reported by Cornelis, et al. (1992) who were working on stability, 
frequency and multiplicity of transposon insertions of fluorescent Pseudomonads, they 
found the transposons were unstable .   
  
A TLC-bioautography assay was able to confirm the phenotype results of the overlay 
assay. The locations of active antimicrobial genes capable of inactivating antimicrobial 
production of 16 isolates of AMMD Tn5 mutants were detected. The insertions 
demonstrated that there were many genes involved in AMMD antimicrobial production 
and these were located on all chromosomes (1, 2 and 3) within its genome. Half of the 
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mutations altering antimicrobial production in the current study occurred in chromosome 
two, 31.25% were in chromosome one and 18.75% targeted chromosome three.  
 
The TLC-bioautography assay results showed that Tn5 mutants 5.2.7 and 9.7.2 lacked all 
antimicrobial activity against both C. albicans and B. multivorans. Moreover, the results of 
the sequencing showed that the Tn5 insertion in both mutants occurred in the same site, a 
gene encoding the AMMD CepI homologue. CepI is responsible for the synthesis of QS 
molecules, N-octanoyl-homoserine lactone (HSL) derivatives which may have different 
carbon side chain lengths (C6 and C8-HSL have been observed in B. ambifaria AMMD; 
Vial et al., 2008). The lack of antimicrobial activity in the CepI mutants suggests that QS 
controls the biosynthesis of all antimicrobial agents of B. ambifaria AMMD. Different 
studies reported that many antimicrobial metabolites like bactobolin (Seyedsayamdost et 
al., 2010), pyrrolnitrin (Keum, et al., 2009, Schmidt, et al., 2009) and the quinolines (Vial, 
et al., 2008) are controlled by QS molecules. 
 
The 5.3.7 and 11.8.2 mutants were able to produce two compounds (Rf = 0.55±0.02 and 
0.70±0.02) which were identified as enacyloxin and quinolines respectively (see section 
4.42). Here, the Tn5 transposon was flanked in two different locations in the AMMD 
genome, Bamb_2222 and Bamb_5056 respectively, which were responsible for the 
synthesis of glycosyltransferase group 1 and a cation diffusion facilitator family transporter 
respectively. Glycosyltransferase group 1 encoded for an amino-acid N-acetyltransferase 
enzyme which is a matrix enzyme that catalyzes the synthesis of L-Glutamate to N-acetyl-
L-glutamate in the presence of Acetyl-CoA. Bamb_2222 and Bamb_5056 were not a part 
of gene clusters responsible for the synthesis of enacyloxin and quinolines. These results 
    
 226 
suggest that these genes might be indirectly involved in the production process by 
producing precursors or activators including such metabolites. In mutants 9.11.5 and 
10.11.3 one compound with anti-candidal activity was produced (Rf = 0.70 ± 0.02) and 
identified as quinoline (section 4.42). The Tn5 transposon insertion in 9.11.5 was in 
Bamb_5919, a gene encoding a trans-AT modular PKS that was part of polyketide 
biosynthesis pathway for the production of enacyloxin (Mahenthiralingam, et al., 2011). 
 
During the time course of B. ambifaria AMMD fermentation, pH, bacterial growth and 
anti-candidal activity were monitored over time. The determination of the exact time of 
production of anti-candidal agents by Burkholderia under shaking conditions was difficult, 
because active anti-candidal compounds were produced and detected together at early time 
points such as 12 h of growth. The reason for this was not clear but it seems possible that 
these results were due to the early activation of the genes that were responsible for the 
production of such compounds. The very rapid rate of growth occurring with good aeration 
also meant that the cultures reached high cell density rapidly. It is well known that many 
secondary metabolites are produced during the latter stages of microbial growth. In 
addition the high cell density would mean that QS was active, which was to play an 
integral role in antimicrobial production from the isolation of the two CepI mutants.  
 
Under static conditions it was possible to detect the time point of the production of several 
anti-candidal metabolites. Little variation in pH was recorded, and during Burkholderia 
growth the culture remained within the acidic pH range. As expected, the rate of anti-
candidal metabolite production correlated with the growth rate of B. ambifaria AMMD and 
was the highest in the late stationary phase. The resin extract of the culture supernatant 
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inhibited C. albicans and other microorganisms, showing that the antimicrobial metabolites 
were extracellular. Lysis and extraction of the metabolites present within Burkholderia 
cells demonstrated that very little antimicrobial activity resided within the bacteria (data 
not shown). 
 
Genomics provides a powerful tool to detect and predict genes responsible of antimicrobial 
production among a wide range of microorganisms. The results of a transcriptomic 
microarray study of B. ambifaria AMMD found that six gene clusters encoding putative 
bioactive metabolites were highly upregulated when the bacterium was grown on BSM-G 
(Mahenthiralingam, et al., 2011).  These results correlate with the findings from the TLC-
bioassays which separated at least 6 anti-candidal metabolites. Three of these metabolites 
were identified as enacyloxin, pyrrolnitrin and the quinolines (chapter 4), and upregulated 
gene clusters encoding the biosynthesis of these compounds were clearly located within the 
AMMD genome. The remaining 3 compounds, the AfcA lipopeptide and two unknown 
metabolites were not chemically identified in this study, but their gene clusters were 
characterized (Figure 7.10).   
 
GC content varies in different organisms, and is one of the important parameters in helping 
understand the evolutionary relationships between bacteria species; closely related 
bacterial species have an average GC content which does not vary greatly between isolates 
of that species. Hence if GC content varies considerably within a region of genomic DNA, 
it is a hallmark of genes that may have come from a different bacterial species and is 
foreign to the encoding genome. The average B. ambifaria AMMD GC content was 
66.8%. The GC content of pyrrolnitrin, unknown A and quinolines were within this   
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Figure 7.10 Distribution of the antimicrobial biosynthetic genes on B. ambifaria AMMD chromosome two and three. 
The location and the size of the antimicrobial biosynthetic genes are shown. 
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average species range, suggesting that these antimicrobial biosynthesis genes may be quite 
ancestral in Burkholderia species such as B. ambifaria. In contrast, the GC content of 
enacyloxin, AfcA lipopeptide and unknown B antimicrobial biosynthesis clusters was 
above average for the AMMD genome, suggesting that they have originated in another 
species and been acquired by horizontal gene transfer. 
 
Pyrrolnitrin is an antibiotic produced by a few genera of Gram negative bacteria, 
Burkholderia sp (Arima, et al., 1964), Pseudomonads sp, Enterobacter sp and Serratia sp 
(Hammer, et al., 1999). The prn operon was distributed among multiple genome sequenced 
Burkholderia species (Figure 7.8). In B. ambifaria AMMD the prn was composed of four 
genes with typical structure for pyrrolnitrin biosynthesis (Hammer, et al., 1999). The GC 
content and high frequency of the prn operon within other Burkholderia (65% of the 
available genomes) is indicative of the fact that the prn operon might have originated as a 
normal component of Burkholderia genomes. 6 out of 13 fully sequenced Burkholderia 
isolates had an incomplete set of the prn operon (prnC and prnD) and there was no 
information from the literature about the production of pyrrolnitrin in these isolates. These 
results suggest that: (i) that deletion or transfer of all or part the prn operon can occur, and 
(ii) an incomplete prn operon lacking the prnC and prnD genes is not sufficient to 
synthesise pyrrolnitrin. These findings are consistent with Costa et al. (2009) who found 
that B. pseudomallei K96243 missed a prn operon in comparison with the genome of other 
B. pseudomallei strains, and suggested that the prn operon was mobile. B. ambifaria 
AMMD genome contains several LuxR genes which are well-known controllers of 
quorum-sensing. 
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LC-MS detected and identified several quinolines derivatives in the B. ambifaria AMMD 
extracts and all showed anti-candidal activity (chapter 4). Through the time course of the 
experiment conducted with TLC-bioautography, quinolines were produced first at an early 
time of incubation of B. ambifaria AMMD. This finding suggests that quinolines play a 
basic role in anti-candidal activity in B. ambifaria AMMD. Further studies on these potent 
antimicrobial antibiotics, examining its inhibitory, toxicity affects and genetics are needed 
to see if they can be developed into a useful antibiotic. 
 
7.5 Conclusion 
The general hypothesis for this chapter was accepted in that transposon mutagenesis was 
found to be useful in locating genes which play a part in the biosynthesis of anti-candidal 
compounds by B. ambifaria AMMD. Additional conclusions are:  
 The TLC-bioautography assay was able to confirm the phenotype results of the overlay 
assay for the AMMD transposon mutants.  
 Sixteen mutants with altered antimicrobial phenotypes were identified from a total of 
2500 transposon mutants screened. Eleven of the mutants were totally negative in anti-
candidal activity, while the others had variable anti-candidal activity. 
 The Tn5 insertions demonstrated that CepI mutants were totally defective in anti-
candidal and anti-B. multivorans activity and demonstrated that QS plays an integral part in 
antibiotic production in B. ambifaria AMMD. 
 The biosynthesis of antimicrobial agents: enacyloxin, AfcA lipopeptide and quinolines 
of B. ambifaria AMMD were controlled by QS molecules. 
 Static growth conditions were best to screen for detection and the time point analysis of 
anti-candidal production by B. ambifaria AMMD. 
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 B. ambifaria encodes multiple genes which direct for antibiotic biosynthesis and these 
may be either ancestral to the species (such as those for pyrrolnitrin production) or have 
been acquired by horizontal gene transfer (such as those encoding enacyloxin 
biosynthesis).
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Conclusions  
 
The aim of the current work was to screen, isolate, characterise and identify Burkholderia 
antifungal agents, investigating their natural diversity and effect on both ascomycete and 
basidiomycete fungi. A comprehensive survey of the activity and diversity of antifungal 
agents present in a large collection of accurately identified B. cepacia complex and other 
Burkholderia was performed.  The determination of the physiology and genetics of a small 
panel of antifungal B. cepacia complex isolates was also undertaken. The work provided 
detailed information on the range of Burkholderia antifungal metabolites and also 
developed new procedures to produce them and identify them. 
 
8.1 Hypothesis one: All B. cepacia complex and other 
Burkholderia are capable of producing antifungal 
agents (Chapter 3). 
 
The overall hypothesis was rejected, because not all Burkholderia species were found 
to be active in the secretion of antifungal agents. 
 
To date, limited attention has been given to interactions between wood decay 
basidiomycetes and Burkholderia. In addition, no studies have looked at large collections 
of taxonomically well-defined Bcc isolates. Various media formulations were tested prior 
to the optimal media being selected to examine the diversity of anti-fungal activity across a 
collection of 397 Burkholderia isolates. An additional challenge of the work was that 
wood-decay basidiomycete fungi, which grow as mycelia, were used. Initial screening of 
anti-basidiomycete activity was performed using a conventional contact antagonism assay 
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that has been applied to other filamentous fungi. However, a novel overlay assay using 
homogenised mycelia to form an even growth of the basidiomycete was also developed. 
The work presented in this chapter focused on 339 Bcc and 58 other Burkholderia species. 
The antagonism towards 10 representative wood decay basidiomycetes and C. albicans 
was examined for the first time.  
 
A total of 45% of tested Burkholderia isolates produced antifungal agents. The best media 
to support the production and the activity of anti-candidal agents by Burkholderia were SA 
and BSM-G. Growth on rich media like TSA did not result in antimicrobial activity. B. 
ambifaria, B. cepacia and B. cenocepacia were the most antagonistic Bcc species against 
both C. albicans and B. adusta. In contrast, B. multivorans and B. stabilis were highly 
limited in their ability to produce antifungal agents. A basidiomycete overlay assay was 
successfully developed for B. adusta BK1 and T. versicolor D2, and overall, B. adusta 
BK1 was selected as a model basidiomycete species to enable characterization of 
Burkholderia-fungal interactions. 
 
8.2  Hypothesis two: Burkholderia produce more than 
one antimicrobial compound. TLC-bioautography 
can be used to examine Burkholderia antimicrobial 
diversity (Chapter 4). 
 
The hypothesis was accepted because Burkholderia species isolates were found to be 
capable of producing more than one active antifungal agent, and TLC-bioautography 
was a good tool to study antimicrobial diversity. 
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Burkholderia are soil bacteria that are known to produce a range of potent antimicrobial 
agents, however, the extent of this activity across the genus and within the B. cepacia 
complex was not known. By screening for antifungal activity in the large collection of 
Burkholderia it was demonstrated that 45.5 % of isolates had antifungal activity (Chapter 
3). Extraction and partial purification procedures were developed; extraction on Amberlite 
resin followed elution with methanol, applied for the first time to bind Burkholderia 
metabolites, proved to be an excellent means to obtain active antimicrobial extracts. TLC-
bioautography was successfully applied to examine the diversity of Burkholderia 
antimicrobials in these extracts. The number of active metabolites observed using the TLC-
bioautography ranged from 1 to six antifungal agents, with multiple Bcc strains capable of 
producing 2 or more antimicrobials. LC-MS was subsequently used to successfully identify 
Burkholderia antifungal metabolites.  
 
Amberlite XAD-16 resin followed by methanol elution proved to be the simplest method 
for extracting the bioactive compounds at high purity from Burkholderia. TLC combined 
with a bioautography assay was a rapid and accurate method for the localization of 
antimicrobial activity on a chromatogram. It offered the ability to obtain a profile of 
Burkholderia antimicrobial secondary metabolite patterns to study the presence and 
diversity of antimicrobial agents of Burkholderia. The TLC-bioautography and LC-MS 
data showed that Burkholderia comprise a large reservoir of known and novel 
antimicrobial agents, especially for those exhibiting antifungal activity.  
 
Several of the antifungal compounds discovered were described for the first time in this 
group of bacteria, with a striking example being the polyketide antibiotic, enacyloxin, 
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produced by B. ambifaria AMMD. B. ambifaria BCF produced 4 active compounds, with 
a similar bioautography profile to B. ambifaria AMMD, except for a highly active mixture 
of metabolites which were identified as bactobolin A, B, D and a new bactobolin 
containing chlorine. B. ambifaria KW and Mex-5 produced more than 6 active bands 
containing at least 10 detectable, but unknown, active antifungal compounds by LC-MS. 
Pyrrolnitrin, a well known Burkholderia and Pseudomonas antibiotic was detected in 60% 
of tested Burkholderia using comparative TLC with a pure pyrrolnitrin standard. 
Pyrrolnitrin was highly active on C. albicans and all basidiomycetes tested. In addition to 
the above, novel peptide antibiotics were detected in B. ambifaria AMMD, BCF, KW and 
Mex-5.  
 
8.3  Hypothesis three: Chemical and physical factors can 
influence the anti-candidal production and activity of 
Burkholderia (Chapter 5). 
 
This hypothesis was accepted with optimal carbon sources, pH, and phosphate 
concentrations defined for the production of anti-candidal agents by B. ambifaria. 
 
The objective of this work was to improve the composition of BSM to enhance 
antimicrobial production by Burkholderia. Since BSM was a defined minimal salts 
medium it was possible to change the composition of its ingredients and its pH, and 
examine the effects of target nutrients on antimicrobial production. The production of anti-
candidal agents of B. ambifaria AMMD was affected by both biotic and abiotic factors. 
Glycerol and succinate at low concentrations were the most optimal carbon sources for 
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antifungal activity. The pH was also an important growth condition, with pH 6.0 being 
optimal for the secretion of antimicrobials. Lower concentrations of phosphate (10mM or 
below) also improved the production of anti-candidal agents more than higher 
concentrations. Finally, sodium nitrate totally suppressed the activity of anti-candidal 
agents of Burkholderia.  
 
8.4  Hypothesis four: All rhizosphere bacterial isolates 
are capable of producing one or more antifungal 
agents (Chapter 6). 
 
The overall hypothesis was rejected, because not all isolated rhizosphere bacteria 
were found to be active in the secretion of antifungal agents. 
 
The components of synthetic media and different factors such as pH, temperature and 
incubation period altered antibiotic biosynthesis in the model Burkholderia strains. The 
aim of this work was to use this knowledge of antibiotic production conditions to isolate 
and examine the natural diversity of antifungal producing bacteria associated with different  
rhizosphere environments. Enrichment with selective media and bacterial identification 
using the 16S rRNA gene were used to identify the isolated bacteria. 
  
The most common antibiotic-producing genera isolated from the maize rhizosphere and 
deciduous woodland sample in this study were Bacillus and Paenibacillus. One 
rhizosphere bacterial mixture lost its antifungal activity after isolation as a pure culture. 
The resin method was also successful in extracting the antifungal agents from the active 
Bacillus isolates. However, in contrast to the hypothesis, not all the culturable rhizosphere 
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bacteria produced antifungal agents. In particular, the absence of cultivatable Burkholderia 
isolates from the maize rhizosphere samples was very different to that observed in other 
studies of this crop plant. 
 
8.5  Hypothesis five: Can mutants and bioinformatics 
tools predict B. ambifaria AMMD antimicrobial 
activity and genes (Chapter 7). 
 
The general hypothesis was accepted, with a combination of transposon mutation and 
bioinformatic analysis proving very useful in the characterization of genes involved in 
the antifungal activity of Burkholderia. 
 
The main goal of this chapter was to identify the genetic basis for secretion of antifungal 
agents by Burkholderia and also characterize genes involved in antibiotic production from 
the available Burkholderia genome sequences. Transposon mutagenesis was used to 
identify genes involved in the anti-candidal activity of B. ambifaria AMMD. The 
transposon insertions demonstrated that there were multiple genes in the AMMD genome 
which controlled antimicrobial production. Of the mutants characterized, 50% occurred in 
chromosome two, 31.25% located to chromosome 1 and 18.75% located to chromosome 3. 
 
The detection of the time point of the production of anti-candidal metabolites of B. 
ambifaria AMMD under static conditions was essential. Semi-purified extracts of B. 
ambifaria AMMD (Rf 0.60 ± 0.03) containing enacyloxin IIa produced an inhibitory affect 
at a low concentration (15.6 µg/ml) against E. coli, B. multivorans and A. baumannii. 
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Bactobolin isolated from B. ambifaria BCF and Mex-5 showed a strong ability to inhibit C. 
albicans and other fungi belonging to basidiomycetes. 
 
Bioinformatic analysis was a useful tool for characterizing antimicrobial biosynthesis 
genes that were upregulated in B. ambifaria AMMD under growth conditions optimal for 
antibiotic production. Several of these genes and gene clusters were highly conserved 
among other Burkholderia species. The average GC content of B. ambifaria AMMD 
genome was 66.7% and two of the gene clusters responsible for antimicrobial biosynthesis, 
the enacyloxin and AfcA lipopeptide clusters, were found to be higher in GC content 
suggesting they were originally from a foreign microorganism. The B. ambifaria AMMD 
genome contained several LuxR genes were potentially responsive to regulation by 
quorum-sensing molecules. Correlating to this finding, the production of enacyloxin, 
pyrrolnitrin, and the quinolines was not seen in B. ambifaria AMMD CepI AHL synthase 
mutant by TLC-bioautography analysis. 
   
Future work 
 
 
Based on the achievements of the current study a number of future research projects are 
suggested which include: 
 
 Semi-purified extracts of B. ambifaria AMMD produced an inhibitory affect at a 
low concentration against E. coli, B. multivorans and A. baumannii. Further studies 
on this potent anti-Gram-negative antibiotic mixture are worthwhile, to further 
purify the mixtures of enacyloxins, quinolines and unknown antimicrobials present. 
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The inhibitory spectrum, toxicity affects and mode of action of these agents will 
need to be characterised if any of them can be developed into a useful antibiotic. 
 Further purification and identification of novel antibiotics detected in B. ambifaria 
KW and Mex-5 is also worthwhile.  
 One rhizosphere bacterial isolate mixture lost its antifungal activity after isolation 
into pure culture. The investigation of this phenomenon could be useful. 
 Using bioinformatics it was possible to observe that multiple genome sequenced 
Burkholderia strains encoded genes for antimicrobial biosynthesis. These 
promising findings should be investigated using the optimal growth conditions and 
chemistry developed in this study to express and characterize the antibiotics 
encoded. 
 The isolation, characterisation and identification of the Burkholderia antifungal 
metabolites linked to the inhibition of wood decay basidiomycetes should be 
undertaken, to explain their specific mode of action. 
 Determination of whether there is a synergistic or antagonistic affect between the 
multiple antimicrobial metabolites produced by single Burkholderia isolates is 
worthwhile. This could also be expanded to see if mixing different Burkholderia 
isolates results in the expression of novel antimicrobial metabolites. 
 Overall, this study has shown that just under half of all Burkholderia cepacia 
complex species isolates screened produced significant antifungal activity. This 
suggests they are potent sources of novel antimicrobials, with other species such as 
Burkholderia gladioli also being shown as capable of producing novel antibiotics. 
Future detailed characterization of these bioactive secondary metabolites should be 
carried out. 
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Table A. 1 The antifungal activity of the Mahenthiralingam lab bacterial collection. 
 
 
 
No. 
 
 
 
Esh's No. 
 
 
 
Comments  
 
 
 
Source 
 
 
 
Identification 
 
Anti-Candida activity 
(inhibition zone mm) 
 
Anti- 
Bjerkandera 
(BK1) 
activity  
SA 
medium 
BSM-G 
medium 
LPA 
medium 
SA 
medium 
 
1 
 
BCC1079 
 
MDlll-T-209 
 
ENV 
 
B. ambifaria 
 
12 
 
0 
 
n 
 
- 
2 BCC1089 MVP-C1-33 ENV B. ambifaria 0 0; 0 n - 
3 BCC1088 MDlll-T-474(s) ENV B. ambifaria 11 0 n + 
4 BCC1087 MDlll-T-425(s) ENV B. ambifaria 13 0 n + 
5 BCC1086 MDlll-T-401(s) ENV B. ambifaria 10 0 n - 
6 BCC1085 MDlll-T-477 ENV B. ambifaria 5 0 n + 
7 BCC1084 MDlll-T-281 ENV B. ambifaria 0 0 n + 
8 BCC1083 MDlll-T-50 ENV B. ambifaria 0 0 n + 
9 BCC1080 MDlll-T-2 ENV B. ambifaria 0 0 n - 
10 BCC1078 MDlll-T-211 ENV B. ambifaria 24.6 8 (faint) n + 
11 BCC1077 MDlll-P-554(s) ENV B. ambifaria 13 0 n + 
12 BCC1076 MDlll-P-549(s) ENV B. ambifaria 10 0 n + 
13 BCC1075 MDlll-P-516(s) ENV B. ambifaria 11 0 n ++ 
14 BCC1074 MDlll-P-481(s) ENV B. ambifaria 10 0 n + 
15 BCC1073 MDlll-P-431 ENV B. ambifaria 10 0 n + 
16 BCC1072 MDlll-P-170 ENV B. ambifaria 10 0 n + 
17 BCC1070 MDlll-Bt-80 ENV B. ambifaria 10 0 n + 
18 BCC1081 MDlll-T-8 ENV B. ambifaria 13 0 n - 
19 BCC1098 MVP-C1-95 ENV B. ambifaria 0 34.5 n + 
20 BCC1213 MC80-27 ENV B. ambifaria 0 0; 0 n - 
21 BCC1212 MC40-6 ENV B. ambifaria 0 0; 0 n ++ 
22 BCC0410 MVP/C1 64 ENV B. ambifaria 11 36 n - 
23 BCC0411 MCI 13  ENV B. ambifaria 10 0 n +++ 
24 BCC1164 CEP1232 ENV B. ambifaria 5 12.5 n + 
25 BCC1107 MVP-C2-79 ENV B. ambifaria 0 35.5 n + 
26 BCC1105 MVP-C2-73 ENV B. ambifaria 0 0; 0 n + 
27 BCC1103 MVP-C2-44 ENV B. ambifaria 0 34.5 n ++ 
28 BCC1090 MVP-C1-40 ENV B. ambifaria 0 0 n + 
29 BCC1099 MVP-C2-4 ENV B. ambifaria 5 10.5 n + 
30 BCC1069 MDlll-Bt-62 ENV B. ambifaria 11 0 n + 
31 BCC1096 MVP-C1-87 ENV B. ambifaria 7 0 n + 
32 BCC1095 MVP-C1-80 ENV B. ambifaria 0 36 n + 
33 BCC1093 MVP-C1-55 ENV B. ambifaria 6 38 n + 
34 BCC1092 MVP-C1-53 ENV B. ambifaria 12 
(faint) 
0; 32 n - 
35 BCC1216 MW20-13 ENV B. ambifaria 8 
(faint) 
0; 34 n ++ 
36 BCC1064 MDlll-B-306 ENV B. ambifaria 0 0 n + 
37 BCC1218 MW80-16 ENV B. ambifaria 0 53 n - 
38 BCC1214 MA80-5 ENV B. ambifaria 19.6 17 (faint) n - 
39 BCC1100 MVP-C2-25 ENV B. ambifaria 0 37.5 n + 
40 FC0623 HI 2345 (J82) ENV B. ambifaria 18 26 n + 
41 BCC1066 MDlll-B-399 ENV B. ambifaria 18.6 14.5 
(faint) 
n + 
42 FC0767 R-0698 ENV B. ambifaria 0 0 n + 
43 FC0766 R-0697 ENV B. ambifaria 0 0 n - 
44 FC0669 BCF/HG1-A; 
LMG-P 24640 
ENV B. ambifaria 0 39.5 n - 
45 FC0662 ATCC 53266 
LMG 17828;  
ENV B. ambifaria 0 0 n + 
46 FC0661 ATCC 51671 ENV B. ambifaria 0 0 n + 
47 FC0646 BP023 ENV B. ambifaria 0 0 n - 
48 BCC0481 HI-2433  ENV B. ambifaria 9.6 10 n - 
49 FC0625 M54, HI 2347, R-
5142 
ENV B. ambifaria 18 25.5 n ++ 
50 BCC0480 HI-2427  ENV B. ambifaria 0 20.5 n ++ 
51 BCC0588 AMMD ENV B. ambifaria 9 21.5 n + 
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52 BCC0589 AMMDR1 ENV B. ambifaria 6 20 n + 
53 BCC0590 1324 ENV B. ambifaria 0 0 n - 
54 CEP0996 LMG 19467 CF B. ambifaria 0 44 n + 
55 CEP0958 LMG-P 24637 CF B. ambifaria 15 16.5 n - 
56 CEP0617 LMG-P 24636 CF B. ambifaria 11 22 n - 
57 CEP0102 ATCC 53267 ENV B. ambifaria 0 0 n + 
58 BCC0399 R-10725 ENV B. ambifaria 11 29 n + 
59 FC0627 Ral-3; R-8863 ENV B. ambifaria 0 33 n - 
60 BCC1054 MCll-65 ENV B. ambifaria 14 0 n + 
61 BCC1067 MDlll-B-625 ENV B. ambifaria 12 0 n + 
62 BCC1222 MS40-6 ENV B. ambifaria 0 26 (faint) n - 
63 BCC1065 MDlll-B-388 ENV B. ambifaria 0 35 n - 
64 BCC0477 AU0216  CF B. ambifaria 25.3 8 (faint) n ++ 
65 BCC1063 MDlll-B-289 ENV B. ambifaria 6 0 n +++ 
66 BCC1062 MDll-130riz ENV B. ambifaria 14.3 0 n ++ 
67 BCC1059 MDll-135pott ENV B. ambifaria 6 0 n + 
68 FC0768 LMG 19182; 
AMMD   
ENV B. ambifaria 11.6 18 20.6 
faint 
++ 
69 BCC1055 MCll-105 ENV B. ambifaria 14 0 n + 
70 BCC1068 MDlll-Bt-42 ENV B. ambifaria 12 0 n + 
71 BCC1053 MCll-16 ENV B. ambifaria 15 0 n + 
72 BCC1052 MCll-68 ENV B. ambifaria 12 0 n + 
73 BCC1051 MCll-17 ENV B. ambifaria 8 0 n + 
74 BCC1050 MCll-4 ENV B. ambifaria 13 0 n + 
75 BCC1049 MCl-7 ENV B. ambifaria 14 0 n ++ 
76 BCC1041 MVP-C2-51 ENV B. ambifaria 8.6 35 n - 
77 BCC0423 MCI 4 ENV B. ambifaria 0 12.5 n ++ 
78 BCC0478 AU1366 CF B. ambifaria 13.3 33 n - 
79 BCC1057 MCll-126 ENV B. ambifaria 10 0 n + 
80 BCC1269 KC10-29 ENV B. ambifaria 11 0 n + 
81 BCC0372 AU0212 CF B. ambifaria 0 0 n + 
82 BCC1599 MEX-5 ENV B. ambifaria 0 33 n - 
83 BCC1270 KC20-17 ENV B. ambifaria 0 23 n + 
84 BCC1223 MS80-4 ENV B. ambifaria 0 21.75 n - 
85 BCC1265 MC40-7 ENV B. ambifaria 0 15.5 
(faint) 
n - 
86 BCC1259 KW20-2 ENV B. ambifaria 31.6 12.5 
(faint) 
n - 
87 BCC1256 KW420-19 ENV B. ambifaria 31 48.5 n - 
88 BCC1255 KW420-1 ENV B. ambifaria 0 10 n + 
89 BCC1254 KW215-1 ENV B. ambifaria 10.3 13 n - 
90 BCC1252 KW10-1 ENV B. ambifaria 30.75 
(faint) 
34 n ++ 
91 BCC1248 LMG-P 24641 ENV B. ambifaria 8.3 13.5 n - 
92 BCC1241 KC311-6 ENV B. ambifaria 23.6 44.5 15.6  
 
- 
93 BCC1239 KC20-4 ENV B. ambifaria 7.5 16.5 
(faint) 
n - 
94 BCC1232 KC0-18 ENV B. ambifaria 16 24 (faint) n + 
95 BCC1237 KC10-16 ENV B. ambifaria 0 30.5 
(faint) 
n ++ 
96 BCC1228 KA20-1 ENV B. ambifaria 0 0 n - 
97 BCC1236 KC5-54 ENV B. ambifaria 0 12.5 
(faint) 
n ++ 
98 BCC1235 KC5-45 ENV B. ambifaria 0 37.5 n ++ 
99 BCC1224 KS0-1 ENV B. ambifaria 0 0 n - 
100 BCC1233 KC0-24 ENV B. ambifaria 0 24 (faint) n + 
101 BCC1048 MVP-C2-69 ENV B. ambifaria  8.6 28 n + 
102 BCC0766 LMG 2129, 
ATCC 23061 
ENV B. 
sandropogonis 
0 0 n - 
103 BCC1363 HI3849 ENV B. anthina  0 0 n - 
104 BCC0639 LMG 20980  ENV B. anthina  0 0 n - 
105 BCC0485 LMG 21821; 
AU1293 
CF B. anthina  11.6 
(faint) 
0 n - 
106 BCC0637 R-11761 ENV B. anthina  0 0 n - 
107 BCC1351 AU5925 CF B. anthina  0 16.5 
(faint) 
n - 
108 BCC1349 AU3904 CF B. anthina  0 0 n - 
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109 BCC0403 B11 ENV B. anthina  0 0 n - 
110 BCC1358 AU6369 CF B. anthina  0 0 n - 
111 BCC0635 LMG 16670t1 ENV B. anthina  0 12 n - 
112 BCC0638 R-4190 ENV B. anthina  14.3 
(faint) 
17 n - 
113 CEP0202 LMG 20983 CF B. anthina  12.6 
(faint) 
0 n - 
114 BCC0636 LMG 16670 ENV B. anthina  0 11 n - 
115 CEP0171 LMG 20982 ENVH B. anthina  21.25 16.5 n - 
116 BCC1350 HI3541 ENV B. anthina  0 28.5 n ++ 
117 CEP0193 J2543/GOVAN ENV B. arboris 16.3 25  (faint) n +++ 
118 FC0454 LMG 14939 CF B. arboris 13.3 
(faint) 
0 n - 
119 BCC1306 28 ENVI B. arboris  0 0 n ++ 
120 BCC0767 LMG 19076 ENV B.caledonica 0 0 n - 
121 BCC0768 LMG 18531 ENV B. caribensis 10.3 
(faint) 
0 n - 
122 BCC0769 LMG 2155, 
ATCC 25418 
ENV B. caryophylli 12 
(faint) 
0 n - 
123 BCC0753 IST475 CF B. cenocepacia  0 0 n - 
124 BCC0749 IST462 CF B. cenocepacia  8.75 
(faint) 
12.5 
(faint) 
n + 
125 CEP0107a POPR8 ENV B. cenocepacia  20.3 30 (faint) n +++ 
126 CEP0136 C1655/GOVAN; 
CEP0136 
ENVH B. cenocepacia  8 30 (faint) n +++ 
127 CEP0138 LMG 16659 CF B. cenocepacia  16 12 n +++ 
128 CEP0075 MCC136/VIDB6
566; CEP0075 
NON B. cenocepacia  0 0 n - 
129 BCC0999 MCll-168 ENV B. cenocepacia  22 27 (faint) n ++ 
130 BCC1004 MDl-11a ENV B. cenocepacia  0 0 n - 
131 CEP0158 J1054/GOVAN; 
CEP0158 
NON B. cenocepacia  9.3 10 (faint) n + 
132 BCC0961 150-1238 (CZ1 
isolate) 
CF B. cenocepacia  10.6 7 n + 
133 CEP0024 LMG 18829  CF B. cenocepacia  18.6 0 n +++ 
134 FC0127 SCRIPPS; 
FC0127 
CGD B. cenocepacia  0 25 (faint) n + 
135 CEP0942 68 (pt X) 
H111CEP0942 
CF B. cenocepacia  8.6 20 (faint) n + 
136 CEP0931 SG1 CGD B. cenocepacia  0 0 n + 
137 FC0426 LMG 14271 CF B. cenocepacia  11 35 n + 
138 FC0428 ATCC 13945 NON B. cenocepacia  12 14 (faint) n ++ 
139 FC0430 ATCC 25609 NON B. cenocepacia  15.5 25 (faint) n + 
140 FC0435 ATCC 25610 NON B. cenocepacia  11.6 17 (faint) n + 
141 CEP0791 C1631GOVAN CF B. cenocepacia  0 
(faint) 
9 (faint) n ++ 
142 BCC1010 MDll-143pott ENV B. cenocepacia  18 18.5 
(faint) 
n + 
143 BCC0665  LMG 16656  CF B. cenocepacia  9.6 0 n + 
144 BCC0687 IST439 CF B. cenocepacia  9.3 14.5 
(faint) 
n + 
145 FC0504 K30-6 CF B. cenocepacia  18 10 (faint) n +++ 
146 CEP0610 LMG 14274 CF B. cenocepacia  8 14 (faint) n - 
147 CEP0511 LMG 18830 CF B. cenocepacia  10 18 (faint) n + 
148 CEP0497 CEP0497 NON B. cenocepacia  0 0 n ++ 
149 FC0663 LMG 18832; 
ATCC 17765  
NON B. cenocepacia  9 22 (faint) n - 
150 FC0666 BC-1 ENV B. cenocepacia  10 25.5 
(faint) 
n +++ 
151 FC0667 BC-2 ENV B. cenocepacia  17.6 20.5 
(faint) 
n +++ 
152 CEP0244 J626/GOVAN; 
CEP0244 
NON B. cenocepacia  0 
(faint) 
55 (faint) n - 
153 CEP0238 LMG 16654 CF B. cenocepacia  10.6 0 n + 
154 FC0446 LMG 13011 CF B. cenocepacia  16.6 24.5 
(faint) 
n + 
155 BCC0376 AU1097 CF B. cenocepacia  11.3 0 n +++ 
156 C6508 WG1; C6508 CF B. cenocepacia  0 0 n - 
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157 BCC1210 MC0-3 ENV B. cenocepacia  14.3 30 n + 
158 C4455 DB1 CF B. cenocepacia  0 
(faint) 
10 (faint) n - 
159 C6965 MU1 CF B. cenocepacia  11.6 20 (faint) n + 
160 CEP0608 LC; CEP0608 CF B. cenocepacia  0 
(faint) 
0 n - 
161 BCC1322 46 ENVI B. cenocepacia  9.3 28 n - 
162 BCC1318 42 ENVI B. cenocepacia  21.3 30 (faint) n - 
163 BCC1014 MDll-151pott ENV B. cenocepacia  12.3 n n - 
164 BCC1266 MC80-32 ENV B. cenocepacia  15.6 32 n + 
165 C5424 LMG18827 CF B. cenocepacia  8 0 n + 
166 BCC1203 HI2424 ENV B. cenocepacia  10 n n - 
167 BCC1295 15 ENVI B. cenocepacia  10.6 9  
(faint) 
n + 
168 C6433 LMG18828 CF B. cenocepacia  0 0 n + 
169 BCC1291 10 ENVI B. cenocepacia  16.6 24 (faint) n + 
170 C4414 RC1 CF B. cenocepacia  10 14 (faint) n + 
171 BCC1196 D1541 CF B. cenocepacia  13 9 (faint) n + 
172 C3921 MU1 CF B. cenocepacia  0 30 (faint) n + 
173 BCC0379 HI-2455 ENV B. cenocepacia  8.3 14 n +++ 
174 BCC1283 2 ENVI B. cenocepacia  12.5 16.5 
(faint) 
n + 
175 BCC0451 MD II 429 ENV B. cenocepacia  22.6 24 (faint) n ++ 
176 BCC1028 MDlll-T-48 ENV B. cenocepacia  15.3 37 n + 
177 BCC0460 CG 10/3  CF B. cenocepacia  12.3 17 (faint) n - 
178 BCC1143 C9330 CF B. cenocepacia  0 0 n + 
179 C0131 GK1; C0131 CF B. cenocepacia  8 32 (faint) n ++ 
180 BCC1019 MDlll-B-716 ENV B. cenocepacia  18.3 23.5 
(faint) 
n + 
181 BCC1016 MDll-129riz ENV B. cenocepacia  11 18.5 
(faint) 
n + 
182 BCC0382 FC0663 NON B. cenocepacia  9.6 18 (faint) n ++ 
183 BCC1211 MC5-8 ENV B. cenocepacia  16 24.5 
(faint) 
n + 
184 BCC1305 27 ENVI B. cepacia 14.6 
(faint) 
11 n - 
185 BCC1365 AU2837 CF B. cepacia  25 19.5 n + 
186 BCC1404 60 ENVI B. cepacia  17 25.5 
(faint) 
n + 
187 BCC0394 No. 2 NON B. cepacia  13.6 21 n + 
188 CEP0509 LMG18821 CF B. cepacia  10.3 20 n + 
189 CEP0615 DJF; CEP0615 CF B. cepacia  10.6 18 (faint) n + 
190 FC0660 ATCC 49709 ENV B. cepacia  17 9 n ++ 
191 CEP0840 700; CEP0840 NON B. cepacia  10.7 8.5 (faint) n + 
192 CEP0877 MC 0353 ENV B. cepacia  13 13 (faint) n ++ 
193 BCC1275 AU 3206 CF B. cepacia  9.5 15 (faint) n - 
194 BCC1273 AU 6671 CF B. cepacia  19.6 21 (faint) n - 
195 BCC0660 LMG 6964 ENV B. cepacia  15 28 (faint) n ++ 
196 CEP0080 ATCC 17759; 
LMG 2161 
ENV B. cepacia  19 12 n ++ 
197 FC0461 LMG 17997 NON B. cepacia  0 0 n - 
198 CEP0972 AVC1717 CF B. cepacia  21 12 (faint) n ++ 
199 BCC0464 VT  CF B. cepacia  0 10 n + 
200 CEP0031 ATCC 25416; 
LMG1222 
ENV B. cepacia  10.3 12 n + 
201 BCC0977 MVPC2-7 ENV B. cepacia  19 13 n ++ 
202 BCC0974 MDlll-B201 ENV B. cepacia  24 12.5 
(faint) 
n ++ 
203 BCC0972 MDlll-P477 ENV B. cepacia  15.6 17 (faint) n ++ 
204 BCC0971 MDlll-T99 ENV B. cepacia  14.6 17 (faint) n ++ 
205 BCC0970 MCll-61 ENV B. cepacia  27 17 (faint) n ++ 
206 BCC0412 MVP/C1 77 ENV B. cepacia  20.3 9.5 n ++ 
207 CEP0232 J1050/GOVAN NON B. cepacia  10 16 n ++ 
208 BCC0679 IST431 CF B. cepacia  9.6 19.5 n + 
209 FC0668 BC-B ENV B. cepacia  20 
(faint) 
22 n +++ 
210 C8509 MD; C8509 CF B. cepacia  12.3 18.5 
(faint) 
n + 
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211 BCC0367 AU0113 CF B. cepacia  28 10.5 n + 
212 BCC1058 MCll-166 ENV B. cepacia  22.6 16.5 n - 
213 CEP0533 WD1; CEP0533 CF B. cepacia  29 18.5 
(faint) 
n ++ 
214 CEP1054 CEP1054 CF B. contaminans  24 23.5 n ++ 
215 BCC1281 LMG 23254 ENV B. contaminans  0 18 (faint) n +++ 
216 CEP0964 VP1; CEP0964 CF B. contaminans  20.5 15 n +++ 
217 BCC0649 IST410 CF B. contaminans  11.6 17 (faint) n ++ 
218 BCC0823 LMG 23255 CF B. contaminans  20.3 0 n +++ 
219 BCC1315 38 ENVI B. contaminans 18.6 12 n ++ 
220 FC0431 ATCC 29352,  
R-2607 
ENV B. diffusa 0 0 n - 
221 CEP1010 LMG 18943 CF B. dolosa  0 0 n + 
222 CEP1011 AU0746; R-6140 CF B. dolosa  0 22 (faint) n - 
223 FC0380 PC543 CF B. dolosa  0 27 (faint) n - 
224 CEP0766 AU0090, 
AU1293 
CF B. dolosa  12.6 0 n + 
225 BCC1359 AU3960 CF B. dolosa  0 23 (faint) n - 
226 BCC1343 AU794 CF B. dolosa  0 32 (faint) n + 
227 BCC1356 AU3556 CF B. dolosa  8 0 n - 
228 BCC1361 AU2130 CF B. dolosa  9.3 0 n + 
229 FC0377 PC195 CF B. fungorum  0 0 n - 
230 CEP0847 no name ? B. fungorum  12 
(faint) 
0 n - 
231 BCC0770 LMG 16225 CF B. fungorum  13.3 
(faint) 
0 n - 
232 CEP0930 MA4 CF B. gladioli 32 70.6 n + 
233 BCC1620 AU16905 CF B. gladioli 65 82 n + 
234 BCC1621 AU17102 CF B. gladioli 70 70.6 n + 
235 CEP0962 MC3 CF B. gladioli 10.3 41.3 n - 
236 BCC0771 LMG 2216, 
ATCC 10248 
ENV B. gladioli 12.3 
(faint) 
0 n - 
237 BCC1624 AU17145 CF B. gladioli 20 31 n - 
238 BCC1622 AU17110 CF B. gladioli 70 80 n + 
239 BCC1556 07-3 ENVI B. gladioli 70+ 36.6 n - 
240 BCC0507 PF (#428) CF B. gladioli 29.7 80.3 n - 
241 BCC1623 AU17121 CF B. gladioli 35  
(faint) 
66.3 n + 
242 BCC1619 AU10372 CF B. gladioli 15  
(faint) 
27.3 n - 
243 BCC1317 41 ENVI B. gladioli 25 82.3 n +++ 
244 BCC0772 LMG 14190, 
ATCC 29195 
ENV B. glathei 0 0 n - 
245 BCC0773 LMG 2196, 
ATCC 33617 
ENV B. glumae 0 52.3 n - 
246 BCC0774 LMG 18924, 
ATCC 700544 
ENV B. graminis 0 0 n - 
247 BCC1612 LMG 20598 ENV B. hospital  0 0 n - 
248 BCC0775 LMG 19447, 
ATCC 700977 
ENV B. kuruiensis 7.7 
(faint) 
0 n - 
249 BCC0803 LMG 22485  
ATCC 17660  
ENV B. lata 9.3 9 n +++ 
250 BCC1406 (6 = send 
number) 
ENVI B. lata 22 
(faint) 
0 n - 
251 FC0436 ATCC 17769 
LMG 6992 
ENV B. lata 16.6 23.5 n +++ 
252 BCC0402 B5 ENV B. lata 0 0 n +++ 
253 CEP0085 ATCC 17460, 
LMG 6863 
ENV B. lata 21.3 28 n +++ 
254 BCC0400 B1 ENV B. lata 0 0 n ++ 
255 CEP1061 patient 24; 
CEP1061 
CF B. lata 0 0 n + 
256 BCC0404 B14 ENV B. lata 10 12 n +++ 
257 BCC1296 16 ENVI B. lata 0 0 n ++ 
258 BCC1287 6 ENVI B. lata 0 0 n - 
259 BCC1282 1 ENVI B. lata 0 0 n ++ 
260 BCC1625 LMG 24064 CF B. latens 0 0 n - 
261 BCC1626 LMG 24264 CF B. latens 34.3 45.6 n - 
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262 BCC0483 AU0553  CF B. metallica 21.3 20.1 n - 
263 BCC1629 LMG 24068 CF B. metallica 21.6 0 n + 
264 BCC1606 LMG 25256 ENV B. mimosarum 0 9.6 (faint) n - 
265 C0514 KE1; CO514 CF B. multivorans 0 28 (faint) 0 - 
266 CEP0049 LMG 18823;  MUT B. multivorans 0 0 n - 
267 BCC0904 93-N331 NON B. multivorans 0 0 5.3 faint - 
268 CEP0992 EJ; CEP0992 CF B. multivorans 0 35 (faint) 0 - 
269 BCC0375 AU0607 CF B. multivorans 0 35 (faint) 0 - 
270 BCC0390 LMG 18825;  CF B. multivorans 0 40 (faint) 0 - 
271 C6935 C1; C6935 CF B. multivorans 0 39 (faint) 0 - 
272 CEP0109 JT; CEP0178 CGD B. multivorans 0 39 (faint) 0 - 
273 C5393 LMG 18822 CF B. multivorans 0 30 (faint) 0 - 
274 BCC1420 C1978  CF B. multivorans 0 0 n - 
275 CEP0144 ATCC 17616; 
LMG17588 
ENV B. multivorans 0 30 (faint) 0 - 
276 CEP0781 LMG 16660 CF B. multivorans 0 32 (faint) 0 - 
277 CEP0602 YP1; CEP0602 CF B. multivorans 0 37 (faint) 0 - 
278 CEP0600 (J BURNS); 
CEP0600 
NON B. multivorans 0 0 0 - 
279 FC445R LMG 13010 CF B. multivorans 0 0 0 - 
280 BCC0493 BELF 1  CF B. multivorans 0 0 0 - 
281 FC0328  FC0328 CF B. multivorans 0 24 (faint) 0 - 
282 FC0647 BP102 ENV B. multivorans 0 30 (faint) 14.6 
faint 
- 
283 CEP0494 JM; CEP0494 CF B. multivorans 0 38 (faint) 0 - 
284 CEP0445 4F/MATLOW CF B. multivorans 0 38 (faint) 0 - 
285 FC0762 LMG 16665 NON B. multivorans 0 36 (faint) 0 - 
286 CEP0935 KH; CEP0935 NON B. multivorans 0 35 (faint) 0 - 
287 FC0442 GM; FC0442 CGD B. multivorans 0 38 (faint) 0 - 
288 CEP0181 C1664/GOVAN ENVH B. multivorans 0 0 0 - 
289 FC0147 LMG 18824; JTC CGD B. multivorans 0 0 0 - 
290 BCC0702 IST453 CF B. multivorans 0 0 0 - 
291 FC0784 15922-1 ENV B. multivorans 0 35 (faint) 0 - 
292 BCC1605 LMG 23618 ENV B. 
oklahomensis 
22 40.6 n + 
293 BCC0776 LMG 2247 ENV B. phenazinium 25 60.6 n +++ 
294 BCC1611 LMG 22037 ENV B. phenoliruptrix 0 8.6 (faint) n - 
295 BCC1607 LMG 21445 ENV B. phymatum 0 11.3 
(faint) 
n - 
296 BCC1604 LMG 22487 ENV B. phytofirmans 0 0 n - 
297 BCC0777 LMG 9035, 
ATCC 43733 
ENV B. plantarii 14.3 
(faint) 
82.6 n ++ 
298 BCC1020 MDlll-B-65 ENV B. pyrocinia  13.7 12 n ++ 
299 BCC1346 HI3647 ENV B. pyrocinia  18.3 19.5 n - 
300 BCC1104 MVP-C2-46 ENV B. pyrocinia  20.3 21 n + 
301 FC0451 LMG 14191-T ENV B. pyrocinia  0 17 n - 
302 BCC0986 MVPC1-31 ENV B. pyrocinia  24.6 15 n ++ 
303 BCC0662 R-13061; 
(J2542) 
ENV B. pyrocinia  0 0 n - 
304 BCC0734 ES0209 ENV B. pyrocinia  29 
(faint) 
11 n + 
305 FC0433 ATCC 39277; 
LMG 21822 
ENV B. pyrocinia  0 16 n - 
306 BCC0490 ES0153;  R-
13545  
ENV B. pyrocinia  11 
(faint) 
19 (faint) n - 
307 BCC0980 MDl-43 ENV B. pyrocinia  17 0 n + 
308 BCC0979 MCll-94 ENV B. pyrocinia  19.5 0 n + 
309 BCC0488 ES0128;   R-
13543  
ENV B. pyrocinia  21.8 
(faint) 
36 (faint) n - 
310 BCC0735 AU2419 CF B. pyrocinia  12.6 10 (faint) n ++ 
311 BCC0476  LMG 21823 ENV B. pyrocinia  12.8 
(faint) 
13.5 n - 
312 BCC1348 HI3642 ENV B. pyrocinia  0 0 n - 
313 BCC1364 AU5468 CF B. pyrocinia  19.3 26 n - 
314 BCC0778 LMG 19450 ENV B. sacchari 0 0 n - 
315 BCC1627 LMG 24067 CF B. seminalis 20.3 0 n - 
316 BCC1628 LMG 19587 ENV B. seminalis 12.6 0 n - 
317 BCC0479 HI-2482 ENV B. stabilis  0 0 25 - 
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(faint) 
318 BCC0717 P1-5 CF B. stabilis  0 0 28.6 
(faint) 
- 
319 BCC0418 CRUPI  NON B. stabilis  0 0 12.6 
(faint) 
- 
320 CEP0104 ATCC 35254 ENVH B. stabilis  0 0 21.3(fai
nt) 
- 
321 BCC1342 AU6735 CF B. stabilis  0 7 0 - 
322 FC0367 LMG 14294  CF B. stabilis  0  n - 
323 FC0472 LMG 14086;  ENVH B. stabilis  0 0 20.3 - 
324 BCC1325 51 ENVI B. stabilis  0 0 0 - 
325 BCC1347 AU9640 CF B. stabilis  0 0 25 
(faint) 
- 
326 CEP0928 ALBUTEROL 
CEP0928 
ENVH B. stabilis  0 7.5 25 
(faint) 
- 
327 FC0362 LMG 07000 NON B. stabilis  0 0 25  
(faint) 
- 
328 BCC1308 30 ENVI B. stabilis  0 0 25 - 
329 FC0779 LMG 18888  NON B. stabilis  18.3 
(faint) 
0 n - 
330 BCC1352 AU10096 CF B. stabilis  0 0 25.3  
(faint) 
- 
331 CEP0103 ATCC 27515 NON B. stabilis  0 0 25  
(faint) 
- 
332 BCC0899 88-N312 NON B. stabilis  0 0 20 - 
333 BCC0957 146-N491 NON B. stabilis  0 0 0 - 
334 BCC0828 17-474 CF B. stabilis  0 0 12.6  
(faint) 
- 
335 BCC1609 LMG 20594 ENV B. terricola 20.7 
(faint) 
15.6 
(faint) 
n - 
336 BCC1608 LMG 22274 ENV B. tropica 0 12.6 
(faint) 
n - 
337 BCC1610 LMG 21444 ENV B. uberum 0 10.6 
(faint) 
n - 
338 BCC1603 LMG 20358 ENV B. ubonensis 17 
(faint) 
14.3 n - 
339 FC0353 FC0353 CF B. vietnamiensis 0 0 n ++ 
340 CEP0998 BBG1222 ENV B. vietnamiensis 36.0 45.5 n + 
341 FC0369 LMG 10929  ENV B. vietnamiensis 0 52 n + 
342 FC0441 LMG 18836; 
FC0441 
CGD B. vietnamiensis 0 35 (faint) n - 
343 FC0656 ATCC 53617; 
LMG 22486 
ENV B. vietnamiensis 0 0 n - 
344 CEP0626 CLO; CEP0626 CF B. vietnamiensis 0 28.6 n ++ 
345 FC0769_a
m 
LMG 16232; 
FC0466 
CF B. vietnamiensis 0 0 n - 
346 FC0654 CRE-7 ENV B. vietnamiensis 0 42 (faint) n ++ 
347 CEP0255 MO1; CEP0255 CF B. vietnamiensis 0 43 (faint) n ++ 
348 BCC1409 JW13.2a ENVI B. vietnamiensis 20.3 51.5 n + 
349 CEP0160 J1702/GOVAN ENVH B. vietnamiensis 0 0 n - 
350 CEP0040 LMG 18835 CF B. vietnamiensis 0 43 (faint) n ++ 
351 CEP0047 RJ2; CEP0047 NON B. vietnamiensis 0 47 n + 
352 CEP0192 J1742/GOVAN NON B. vietnamiensis 0 0 n + 
353 BCC1408 JW13.1a ENVI B. vietnamiensis 0 49.5 n - 
354 BCC1309 31 ENVI B. vietnamiensis 21.3 36.5 n - 
355 BCC1301 23 ENVI B. vietnamiensis 41.6 11 n - 
356 BCC1172 D0099 ENV B. vietnamiensis 0 0 n - 
357 BCC0657 LB400 ENV B. xenovorans 0 0 n - 
358 BCC1302 24 ENVI BCC group Kc? 0 0 n ++ 
359 BCC0475 BC003 ENV BCC4 32.3 12 n - 
360 BCC0405 T21 ENV BCC4 13.3 
(faint) 
22.5 n ++ 
361 CEP0152 LMG21824 CF BCC4 12 17.5 n ++ 
362 BCC1017 MDll-124riz ENV BCC5 9 12 n - 
363 BCC0419 MC II  141 ENV BCC5 9.6 9 n - 
364 BCC0397 R-10733t1 NON BCC5 9 10 n - 
365 BCC1042 MVP-C2-53 ENV BCC5 9.6 8  (faint) n - 
366 BCC0474 NI (#294) CF BCC5 14.6 10 n - 
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(faint) 
367 BCC1047 MVP-C2-84 ENV BCC6 24.6 20 n - 
368 BCC0985 MVPC1-13 ENV BCC6 17 0 n - 
369 BCC0976 MVPC2-6 ENV BCC6 20 7 n - 
370 CEP0178 C1518/GOVAN; 
CEP0178 
CF BCC6 9.3 0 n ++ 
371 BCC1013 MDll-144pott ENV BCC6 22.3 10 n + 
372 BCC1005 MDl-14a ENV BCC6 23.3 10 n + 
373 BCC1038 MVP-C1-79 ENV BCC6 23.3 11.5 n + 
374 BCC1023 MDlll-P-115 ENV BCC6 22.3 12 n + 
375 BCC1026 MDlll-T-301 ENV BCC6 22.6 13.5 n + 
376 BCC1030 MVP-C1-16 ENV BCC6 23.6 12 n - 
377 BCC1191 D1443 CF BCC8 0 0 n - 
378 C8502 WK1 CF Burk. sp, not 
BCC 
0 9.6 (faint) n - 
379 BCC1387 LMG 1226  D. acidivorans 0 0 n - 
380 BCC0671 IST422 CF NOT BCC 0 10.6 n - 
381 BCC0498 CARBONARO  CF NOT BCC 17.3 0 n - 
382 BCC0696 IST447 CF NOT BCC 0 0 n - 
383 BCC0690 IST442 CF NOT BCC 15 
(faint) 
0 n - 
384 BCC0677 IST429 CF NOT BCC 0 0 n - 
385 BCC0454 A2  ENV NOT BCC 48 45.3 n ++ 
386 BCC0667 IST417 CF NOT BCC 0 0 n - 
387 BCC0473 SD  CF NOT BCC 7.7 
(faint) 
0 n - 
388 BCC0471 ZC1  NON NOT BCC 0 21.3 n - 
389 BCC0469 F6 98150 ENV NOT BCC 0 0 n - 
390 BCC0440 F6 99173 ENV NOT BCC 0 0 n - 
391 BCC0502 PM 16/04 ) CF NOT BCC 7.3 
(faint) 
0 n - 
392 BCC0420 ME CF NOT BCC 0 0 n - 
393 BCC0457 CS Pg  CF NOT BCC 0 7.6 n - 
394 BCC0689 IST441 CF NOT BCC 0 40.6 n - 
395 BCC0421 DV  CF NOT BCC 0 0 n - 
396 BCC0465 A6  ENV NOT BCC 0 0 n - 
397 BCC0435 IK 7/12  CF NOT BCC 0 0 n - 
398 BCC0422 A5  ENV P.  aeruginosa  38 64.3 n +++ 
399 BCC0432 A4  ENV P.  aeruginosa  31.7 47.6 n ++ 
400 BCC0438 A1  ENV P.  aeruginosa  36 50.6 n +++ 
401 BCC1388 LMG 1794 Type 
strain 
ENV P. fluorescens 21.7 
(faint) 
0 n - 
402 BCC1389 LMG 2257  ENV P. putida 0 0 n - 
403 BCC1390 LMG 11199 
Type strain 
 P. stutzeri 14.7 0 n - 
404 FC0330 40 CF Pand. 
Pulmonicola 
13 
(faint) 
0 n - 
405 CEP0633 PATIENT W CF Pand. apista 0 0 n - 
406 C8029 K2 CF Pand. 
pnomenusa 
0 0 n - 
407 C7351 KZ1 CF Pand. 
pnomenusa 
0 0 n - 
408 CEP0734 AU0012 CF Pand. sputorum 0 0 n - 
409 CEP0687 BC259-B1 CF Pand. sputorum 0 0 n - 
410 C4964 QG CF Pand. sputorum 0 0 n - 
411 BCC1391 LMG 6866 Type 
strain 
CLIN R. mannitolytica 0 0 n - 
412 BCC1392 LMG 5942 Type 
strain 
CLIN R. pickettii 13 
(faint) 
0 n - 
413 CEP0115 C1739/GOVAN CF R. pickettii 12 
(faint) 
0 n - 
414 BCC1393 LMG 22203 
Type strain 
CLIN S. aureus 0 0 n 0 
415 BCC1394 LMG 958   CLIN S. maltophilia 0 0 n - 
416 BCC0809 NW stain, 
H044220140 
CLIN A. baumannii 
 
0 0 n - 
417 BCC0811 T strain, 173 CLIN A. baumannii 19.7 0 n - 
418 BCC0810 SE clone, CLIN A. baumannii 20 0 n - 
    
 266 
H043260547 (faint) 
419 BCC0808 OXA-23  CLIN A. baumannii 0 0 n - 
420 BCC0807 OXA-23 clone, 
H074200542 
CLIN A. baumannii 13 
(faint) 
0 n - 
421 BCC1386 LMG 1863  A. xylosoxidans 20 
(faint) 
0 n - 
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Figure B. 1 Fractionation and detection of anti-candidal activity of 16 Burkholderia crude resin extracts using TLC and ethyl acetate methanol 
water (20:1:0.5). 
Crude resin extracts of 16 Burkholderia, pyrrolnitrin (Pyr) Sabouraud agar (SA) and Basal salts agar (BSM) were spotted onto TLC plates in duplicate then fractionated 
using ethyl acetate methanol water (20:1:0.5). One set of developed TLC plates was visualized using UV at 366 nm (Panel N).The other set was used for bioautography 
assays, the plate was overlaid with soft Isosensitest agar seeded with C. albicans, after incubation of plates at room temperature for 3 h and then 24 h at 37C, the anti-
candidal activity of different compounds are clearly visible as a clear zone on the red background of Candida cells which have grown and reduced the tetrazolium chloride 
metabolic indicator (Panel T).A; Sabouraud Agar, B, Basal Salt Agar, 1; B. ambifaria Bcc0276, 2; B. ambifaria Bcc0410, 3; B. ambifaria Bcc0478, 4; B. ambifaria 
Bcc1599, 5; B. lata Bcc1265, 6; B. ambifaria Bcc0372, 7; B. ambifaria Bcc0207, 8; B. ambifaria Bcc0193, 9; B. vietnamiensis Bcc1409, 10; B. contaminants Bcc1315, 
11; B. anthina Bcc1350, 12; B. cepacia Bcc0233, 13; B. cenocepacia Bcc019, 14; B. cenocepacia Bcc0165 15; B. lata Bcc0803, 16; B. pyrrocinia Bcc0171, C1; BSM, C2; 
SA, C3; Pyrrolnitrin.  
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Figure B. 2 Detection of antibacterial agents in Burkholderia crude resin extracts. 
Crude resin extracts of 6 Burkholderia, pyrrolnitrin and pure gladiolin were spotted onto TLC plates in 
duplicate then fractionated using ethyl acetate methanol water (20:1:0.5). One set of developed TLC plates 
was visualized using UV at 366 nm. The other set was used for bioautography assays, the plate was overlaid 
with soft Isosensitest agar seeded with gram negative bacteria, after incubation of plates at room temperature 
for 3 h and then 24 h at 37C, the antibacterial activity of different compounds are clearly visible as a clear 
zone on the red background of bacterial cells which have grown and reduced the tetrazolium chloride 
metabolic indicator. AMMD, B. ambifaria Bcc0207; BCF, B. ambifaria Bcc0250; KW, B. ambifaria 
Bcc1256; MEX-5, B. ambifaria Bcc1599; 233, B. lata Bcc0233; 1409, B. vietnamiensis Bcc1409; Pyr, pure 
pyrrolnitrin; Gla, pure gladiolin. The overlaid bacteria were: A, A. baumannii; B, P. fluorescens; C, S. 
maltophilia ; D, E. coli., B, S. aureus Eagles; C, S. aureus NCTC12981. 
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Figure B. 3 Profile of B. ambifaria BCF and KW metabolites fractionated using silica gel 
preparative TLC. 
Semi-pure fractions fractionated from cured resin extract and cured resin extract of B. ambifaria BCF 
(fractions 1 to 5) and B. ambifaria KW (fractions 1 to 11) were spotted into TLC plates in duplicate. One set 
of TLC plates was developed with ethyl acetate: methanol: water (20:1:0.5) (panels A1 and A2). The other 
set was overlaid with soft Isosensitest agar seeded with C. albicans. After incubation of plates at room 
temperature for 3 h and then 24 h at 37C, the anti-candidal activity of different compounds was visible as a 
clear zone on the red background of Candida cells which had grown and reduced the tetrazolium chloride 
metabolic indicator (panels B1 and B2). Arrows indicated the location of active semi-pure metabolites.  
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Figure B. 4 Profile of B. ambifaria Mex-5 metabolites fractionated using silica gel 
preparative TLC. 
Semi-pure fractions (Fraction 1 to fraction 16) fractionated from cured resin extract and cured resin extract of 
B. ambifaria Mex-5 were spotted into TLC plates in duplicate. One set of TLC plates was developed with 
ethyl acetate: methanol: water (20:1:0.5) (panel T). The other set was overlaid with soft Isosensitest agar 
seeded with C. albicans. After incubation of plates at room temperature for 3 h and then 24 h at 37C, the 
anti-candidal activity of different compounds was visible as a clear zone on the red background of Candida 
cells which have grown and reduced the tetrazolium chloride metabolic indicator (panel N). Arrows indicate 
the location of active semi-pure metabolites. 
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Figure B. 5 The mass spectra of B. ambifaria AMMD fraction 1 (Rf 0.01). 
(a) Polyethylene glycol (PEG); (b) Unknown peptide and (c and d) plasticizer.   
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Figure B. 6 Mass spectra data for B. ambifaria AMMD fraction 7 (Rf 0.98).  
Results indicated that fraction 7 is dominated by different of plasticizer. The chemical structure shown on right panel is plasticizer. 
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Figure B. 7 Mass spectra data for B. ambifaria KW fraction 1.  
Results indicated that fraction 1 was dominated by many of unknowns of un-identified compounds (380.16, 392.12 and 396.15 m/z). 
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Figure B. 8 Mass spectra data of B. ambifaria Mex-5. 
The results indicated that Mex-5 produced many of un-identified compounds. Fraction 1, 506.29; fraction 6, 433.37 m/z; fraction 8, 312.17 m/z; fraction 11, 282.16 
m/z ;and fraction 14, 297.1 m/z. 
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Figure B. 9 The broth dilution assay used to determine the activity of Burkholderia 
antimicrobial extracts. 
The minimum inhibitory concentrations (µg/ml) of B. ambifaria AMMD, BCF, KW and Mex_5, and B. 
gladioli extracts against C. albicans (Sc5314), Staphylococcus aureus (NCTC12981), B. multivorans 
(ATCC17210), Escherichia coli (NCTC12241) and Pseudomonas aeruginosa (NCTC12903). Control 1 was 
sterilised BSM-G medium, Control 2 was Burkholderia extracts alone, MeOH; was crude resin extract and 
Acetone; was crude acetone extract. 
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AMP-dependent synthetase and ligase (EC: 6.2.1.32) 
 
AMP-dependent synthetase and ligase 
Hypothetical protein 
3-Oxoacyl-(acyl-carrier-protein) synthase 
Beta-lactamase domain protein 
3-Oxoacyl-(acyl-carrier-protein) synthase(C: 2.3.1.180) 
 
Hypothetical protein 
Function  
Genes   
 
Figure C. 1 The hydroxy-2-alkylquinolines (HQA) cluster of B. ambifaria AMMD. 
The amino acid and nucleotide sequences of HQA were searched against the B. ambifaria AMMD genome 
using the BLASTN or BLASTP software. The located gene cluster was then marked onto the B. ambifaria 
AMMD genome (Bamb_5763 to Bamb_5769) and navigator tool to match up amino acid or nucleic acid 
sequence data. The HQA cluster genes and the functional annotation and products of genes are also shown. 
The color indicated the subcellular localization classes as shown in the key. 
Key:
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Burkholderia ambifaria
MC40-6
Burkholderia ambifaria
AMMD
Burkholderia pseudomallei
K96243
Burkholderia thailandensis
E264
Burkholderia xenovorans
LB400
Burkholderia phymatum
STM815
Burkholderia ambifaria
MC40-6
Burkholderia ambifaria
AMMD
Burkholderia pseudomallei
K96243
Burkholderia thailandensis
E264
Burkholderia xenovorans
LB400
Burkholderia phymatum
STM815
Figure C. 2 Orthologous arrangement of 4 hydroxy-2-alkylquinolines (HQA) biosynthesis 
genes of Burkholderia genomes (Bamb_5763 to Bamb_5769). 
HQA genes were identified in 20 Burkholderia genomes. The top panel showed B. ambifaria AMMD HQA 
biosynthesis genes, and other five orthologous loci are shown. The color indicated the subcellular localization 
classes as shown in the key. 
Key:
 
 
    
 280 
PQQ-dependent enacyaloxin oxidase
MATE efflux family protein
a-ketoglutarate and non-heme iron-dependent hydroxylase
Type II Thioesterase
Hypothetical protein
a-ketoglutarate and non-heme iron-dependent chlorinase
Hypothetical protein
Porin
Beta-lactamase domain containing protein 
Transport-associated
Carbamoyl transferase
FADH2-dependent chlorinase
6-aminohexanoate-dimer hydrolase
Major facilitator transporter   
Acyl-CoA dehydrogenase domain protein (EC:1.3.99.3)
AMP-dependent synthetase and ligase
Transcriptional regulator, LysR family
Transcriptional regulator, LuxR family
Shikimate 5-dehydrogenase
NRPS condensation domain involved in polyketide offloading
Cis-AT modular polyketide synthase
Trans-AT modular polyketide synthase
Lux R family transcriptional regulator
Acyl carrier protein
Dehydratase involved in DHCCA biosynthesis
Cis-AT modular polyketide synthase
Cis-AT modular polyketide synthase
Cis-AT modular polyketide synthase
Cis-AT modular polyketide synthase 
Cis-AT modular polyketide synthase
Isomerase involved in DHCCA biosynthesis
Enoyl reductase involved in DHCCA biosynthesis
Enoyl reductase involved in DHCCA biosynthesis
Hypothetical protein
Products  Genes  
 
Figure C. 3 The enacyloxin cluster of B. ambifaria AMMD.  
The amino acid and nucleotide sequences of enacyloxin were searched against the B. ambifaria AMMD 
AMMD genome using the BLASTN or BLASTP software. The location of enacyloxin gene cluster was then 
marked onto the B. ambifaria AMMD genome (Bamb_5910 to Bamb_5943) and navigator tool to match up 
amino acid or nucleic acid sequence data. Enacyloxin cluster and the functional annotation and products of 
genes are also shown. The color indicated the subcellular localization classes as shown in the key. 
Key:
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Putative orthologs of putative 
enacyloxin of B. ambifaria AMMD
B. cenocepacia AU 1054
B. cenocepacia HI2424
B. cenocepacia J2315
B. cenocepacia MCO-3
B. lata 383
B. multivorans ATCC 17616
B. phymatum STM815
B. xenovorans LB400
 
Figure C. 4 Orthologous arrangement of enacyloxin biosynthesis genes of 
Burkholderia genomes.  
Enacyloxin genes (Bamb_5910 to Bamb_5943) were identified in 20 Burkholderia genomes. The top panel 
showed B. ambifaria AMMD enacyloxin biosynthesis genes, and other eight orthologous loci are shown. The 
color indicated the subcellular localization classes as shown in the key. 
Key:
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Hypothetical protein
Hypothetical protein
ABC transporter related
Methyltransferase type 11
ABC-2 type transporter
Taurine catabolism dioxygenase TauD/TfdA
Citrate synthase-like protein
Acyl-CoA dehydrogenase domain protein ( EC:1.3.99.3 )
AMP-dependent synthetase and ligase
Hypothetical protein
Orn/DAP/Arg decarboxylase 2( EC:4.1.1.20 )
hypothetical protein
Phosphopantetheine-binding
Hypothetical protein
Hypothetical protein
hypothetical protein
Hypothetical protein
hypothetical protein
Hypothetical protein
Protein of unknown function DUF214
afcA, AMP-dependent synthetase and ligase
ABC transporter related
Fatty acid desaturase
Transcriptional regulator, LysR family
Hypothetical protein
D-lactate dehydrogenase (cytochrome) ( EC:1.1.2.4 )
 
Figure C. 5 The AfcA lipopeptide operon of B. ambifaria AMMD.  
The amino acid and nucleotide sequences of AfcA were searched against the B. ambifaria AMMD genome 
using the BLASTN or BLASTP software. The location of gene cluster was then marked onto the B. 
ambifaria AMMD genome (Bamb_6128 to Bamb_6153) and navigator tool to match up amino acid or 
nucleic acid sequence data. The AfcA operon genes, the functional annotation and products of genes are also 
shown. The color indicated the subcellular localization classes as shown in the key. 
Key:
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B. cenocepacia MC0-3
B. lata 833
B. mallei ATCC 23344
B. pseudomallei 1106a
B. pseudomallei 668
B. mallei NCTC 10229
B. mallei NCTC 10247
B. mallei SAVP1
B. pseudomallei 1710b
B. cenocepacia AU 1054
B. cenocepacia HI2424
B. pseudomallei K96243
Putative orthologs of putative AfcA 
of B. ambifaria AMMD
B. cenocepacia BAS0222
Figure C. 6 Orthologous arrangement of AfcA lipopeptide antibiotic cluster biosynthesis 
genes of Burkholderia genomes. 
AfcA genes were identified in 20 Burkholderia genomes. The top panel showed B. ambifaria AMMD AfcA 
biosynthesis genes, and other thirteen  orthologous loci are shown. The color indicated the subcellular 
localization classes as shown in the key. 
Key:
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Hypothetical protein
Phosphopantetheine-binding
Phospholipid/glycerol acyltransferase 
Putative acyl-carrier-protien
Hypothetical protein
AMP-dependent synthetase and ligase
Glycosyl transferase, family 2
Histidine ammonia-lyase (EC: 4.3.1.3)
Thioesterase super family protein
Putative signal peptide protein 
Putative lipoprotein transmembrane
Beta-ketoacyl synthase (EC: 2.3.1.41)
Beta-ketoacyl syntheses (EC: 2.3.1.179)
Beta-ketoacyl syntheses (EC: 2.3.1.41)
Conserved hypothetical signal peptide 
protein
Excinuclease ATPase subunit
Methyltransferase type ІІ
Tryptophan halogenase
Beta-glycosidase (EC: 3.2.1.21)
Beta-hydroxyacyl-(acyl-carrier-
protein) dehydratase, FabA/FabZ
3-Oxoacyl-(acyl-carrier-protein) 
reductase, putative (EC: 1.1.1.100)
 
Figure C. 7 The unknown A cluster of B. ambifaria AMMD. 
The amino acid and nucleotide sequences of unknown A were searched against the B. ambifaria AMMD 
genome using the BLASTN or BLASTP software. The location of unknown A gene cluster was then marked 
onto the B. ambifaria AMMD genome (Bamb_3597 to Bamb_3617) and navigator tool to match up amino 
acid or nucleic acid sequence data. Unknown A cluster genes, the functional annotation and products of 
genes are also shown. The color indicated the subcellular localization classes as shown in the key. 
Key:
 
 
    
 285 
Putative orthologs of putative unknown A 
of B. ambifaria AMMD
B. ambifaria MC40-6
B. phymatum STM815
B. vietnamiensis G4
B. xenovorans LB400
 
 
Figure C. 8 Orthologous arrangement of unknown A biosynthesis genes of Burkholderia 
genomes.  
Unknown A cluster genes were identified in 20 Burkholderia genomes. The top panel showed B. ambifaria 
AMMD unknown A biosynthesis genes, and other four orthologous loci are shown. The color indicated the 
subcellular localization classes as shown in the key. 
Key:
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LuxR family, transcriptional regulator
Glycosyl transferase, family
Cyclic peptide transporter
hypothetical protein
Amino acid adenylation domain protein
Amino acid adenylation domain protein
Amino acid adenylation domain protein
Amino acid adenylation domain
Beta-ketoacyl syntheses
Oleoyl-(acyl-carrier-protein) hydrolase
( EC:3.1.2.14 )
2,4-diaminobutyrate 4-transaminase 
( EC:2.6.1.76 )
Thioesterase super family protein
Beta-lactamase domain protein
Short-chain dehydrogenase/reductase SDR
Taurine catabolism dioxygenase TauD/TfdA
NAD-dependent epimerase/dehydratase
( EC:4.2.1.46 )
Function Genes  
 
Figure C. 9 The unknown B cluster of B. ambifaria AMMD.  
The amino acid and nucleotide sequences of unknown B were searched against the B. ambifaria AMMD 
genome using the BLASTN or BLASTP software. The location of unknown B gene cluster was then marked 
onto the B. ambifaria AMMD genome (Bamb_6468 to Bamb_6482) and navigator tool to match up amino 
acid or nucleic acid sequence data. Unknown B gene cluster, the functional annotation and products of genes 
are also shown. The color indicated the subcellular localization classes as shown in the key. 
Key:
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Putative orthologs of putative unknown B 
of B. ambifaria AMMD
B. mallei ATCC 23344
B. mallei ATCC 10229
B. mallei ATCC 10247
B. phymatum STM815
B. pseudomallei 1106a
 
Figure C. 10 Orthologous arrangement of unknown B biosynthesis genes in Burkholderia 
genomes. 
Unknown B gene cluster was identified in 20 Burkholderia genomes. The top panel showed B. ambifaria 
AMMD unknown B biosynthesis genes, and other five orthologous loci are shown. The color indicated the 
subcellular localization classes as shown in the key. 
Key:
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Summary 
Gram-negative Burkholderia cepacia complex (Bcc) isolates were screened for 
antimicrobial activity against cystic fibrosis microbial pathogens, and the ability 
of B. ambifaria to inhibit B. multivorans was identified. The activity was mapped to a 
cluster of cryptic, quorum-sensing-regulated modular polyketide synthase (PKS) genes. 
Enacyloxin IIa and its stereoisomer designated iso-enacyloxin IIa were identified as 
metabolic products of the gene cluster, which encoded an unusual hybrid modular PKS 
consisting of multiple proteins with sequence similarity to cis-acyltransferase (cis-AT) 
PKSs and a single protein with sequence similarity to trans-AT PKSs. The discovery of 
the potent activity of enacyloxins against drug-resistant bacteria and the gene cluster that 
directs their production provides an opportunity for engineered biosynthesis of innovative 
enacyloxin derivatives and highlights the potential of Bcc bacteria as an underexploited 
resource for antibiotic discovery. 
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